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Abstract
Ephrin ligands and their Eph receptors play an essential role in angiogenesis during 
development. Both ephrins and Eph receptors are membrane-tethered proteins and 
their interaction at sites of cell-cell contact triggers bi-directional signalling, with 
signals transduced from the receptor (forward signalling) and ligand (reverse 
signalling). I have used two model systems to study ephrin-B2 signalling: Swiss 3T3 
fibroblasts expressing exogenous ephrin-B2 and Human Umbilical Arterial 
Endothelial Cells (HUAECs) endogenously expressing ephrin-Bs. Stimulation of 
ephrin-B2 with soluble EphB receptors, has enabled the characterisation of the 
cellular responses, and signalling pathways, triggered by ephrin-B2 activation.
I have shown that clustering of expressed ephrin-B2 in cultured fibroblasts induces a 
loss of cell-cell contact, dependent on the presence of serum factors and independent 
of actin-myosin contractility. The intracellular domain of ephrin-B2 is essential: 
tyrosine phosphorylation of the ligand via Src, and binding of the adaptor protein 
Grb4 are required for loss of cell-cell contact.
Stimulation of endogenous ephrin-B2 in cultured endothelial cells results in dramatic 
cell retraction, and in a proportion of cells membrane blebbing. I have shown that the 
small GTPase Rho and activation of its downstream effector ROCK are essential for 
membrane retraction to occur, which is driven by an actin-myosin contraction event. 
In addition, I find that the c-Jun amino terminal kinase (JNK) is required for 
retraction, acting upstream of Rho/ROCK, and retraction occurs independently of 
Grb4. The cell contraction response to ephrin-B2 activation is rapid and transient 
with cells recovering to re-spread lamellipodia within minutes. Re-spreading is 
coupled to a loss of actin stress fibres and concomitant with down regulation of Rho 
and ROCK activity.
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Chapter 1 
Introduction
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Cell migration and adhesion, involving precise cell movements, cell-reorganisation 
and intercellular communication, is critical throughout development to enable cells 
to reach their correct targets and ultimately for their correct function. Receptor 
tyrosine kinases are already known to play a role in many fundamental cell processes 
including cell migration, survival, proliferation, differentiation and cell cycle control. 
Co-ordinated changes in cell shape and motility form the basis of many of the events 
controlled by the family of receptor tyrosine kinases known as the Eph receptors and 
their ligands the ephrins, such that many of the intracellular signalling pathways 
initiated by Eph receptor-ephrin signalling ultimately regulate the actin cytoskeleton.
Ephrin ligands and their Eph receptors are membrane-tethered proteins known to 
regulate both repulsive and attractive interactions between contacting cells, and have 
been shown to function in a wide range of developmental processes. They are 
particularly important for the tissue patterning and morphogenesis events that give 
rise to a structured embryo. However, many of the emerging signalling pathways 
downstream from Eph receptor-ephrin interactions remain poorly characterised, as 
are the cellular events triggered by such signalling cascades.
1.1 Background
The first Eph receptor, EphAl, was discovered in 1987, through a screen for genes 
up-regulated in epithelial tumours, and termed Eph after the erythropoietin- 
producing hepatocellular carcinoma cell line from which it was cloned (Hirai et al., 
1987). Subsequent members of the Eph receptor family were discovered from 
screens for tyrosine phosphorylated proteins and for tyrosine kinase domains (Letwin 
et al., 1988; Lindberg and Hunter, 1990; Pasquale and Singer, 1989). Eph receptors 
were initially described as ‘orphan receptors’, since they were without known 
ligands. However, in the mid 1990s proteins capable of binding their extracellular 
domains were identified (Bartley et al., 1994; Beckmann et al., 1994; Cheng and 
Flanagan, 1994; Fletcher et al., 1994; Shao et al., 1994). The first ligand, B61/ephrin- 
A l, had previously been isolated as a protein with unknown function (Holzman et 
al., 1990) but was later shown to be the ligand for Eck/EphA2 (Bartley et al., 1994).
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The Eph receptor family is the largest known subfamily of receptor tyrosine kinases, 
and a similarly large number of ephrin ligands also exist. To date 16 receptors and 9 
ligands have been identified in vertebrates, (14 receptors and 8 ligands in mammals) 
(Murai and Pasquale, 2003). Eph receptors have been identified in species as diverse 
as Caenorhabditis elegans (George et al., 1998), zebrafish (Xu et al., 1994), and 
Drosophila melanogaster (Scully et al., 1999). Much work, encompassing genetic, 
biochemical and cell biological studies, has been carried out over the last 15-20 years 
to determine their structure, localisation and function.
1.2 Eph receptor and ephrin subclasses
Ephrin ligands are divided into two subclasses based on their attachment to the 
membrane. The A class ephrins are attached to the outer leaflet of the cell membrane 
by a glycosyl-phosphatidyl-inositol (GPI) linkage, whereas the B class ephrins are 
transmembrane proteins (Gale et al., 1996b). Eph receptors are also divided into two 
subclasses, the EphAs and the EphBs, based on sequence homology and ligand 
binding affinity (Gale et al., 1996b). EphA receptors bind to ephrin-A ligands and 
EphB receptors bind to ephrin-B ligands. Binding within classes is known to be 
promiscuous, however interactions are thought to be restricted such that binding to 
members of another subclass does not occur. The exception to this is EphA4, which 
can bind to both ephrin-As and ephrin-Bs (Gale et al., 1996b). Although there is a 
high degree of promiscuity between Eph receptors and ephrins of the same class, 
they are unlikely to be functionally interchangeable. There are wide variations in 
binding affinities between different receptor-ligand pairs. For example, the only 
known ligand for EphB4 is ephrin-B2, where as EphB2 is known to bind ephrin-B 1, 
ephrin-B2 and ephrin-B3 (Flanagan and Vanderhaeghen, 1998). Recently however it 
has been shown that ephrin-A5 is capable of binding to and activating the EphB2 
receptor (Himanen et al., 2004). Signalling between subclasses may occur more 
readily than previously thought (Fig. 1.1).
18
Figure 1.1: Eph receptor and ephrin fam ilies and their b inding
partners
Eph Receptors ephrins
EphAI
tphA4
EphA7
GPt-linked
Trans membrane
Modified from O leary  & Wilkinson 1999
Ephrins are divided into two subclasses based on their attachment to the membrane. 
Two classes of Eph receptors also exist, with the division based on sequence 
homology and ligand binding affinity. Generally EphA receptors bind to ephrin-A 
ligands and EphB receptors bind to ephrin-B ligands (black arrows). However, 
instances of binding across subclasses have been shown to occur (red arrows). At 
present the ligands(s) for EphB5 are not known.
1.2.1 Structure of Eph receptors and ephrins
Both ephrins and Eph receptors are membrane-tethered proteins and therefore 
interactions between Eph receptors and ephrins require direct cell-cell contact. 
Signalling is bi-directional as, not only can a signal be transduced from the receptor- 
bearing cell (forward signalling) but the ephrin ligand also becomes activated and 
transmits a signal into its respective cell, known as reverse signalling (Fig. 1.2). 
Physiological roles for ephrin-B signalling have now been described (Davy and 
Soriano, 2005).
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Figure 1.2: Bi-directional Signalling
Ephrin-B ligands EphB receptors
Forward
Signal
Ephrin-A ligands EphA receptors
Eph receptors and ephrins become activated upon direct cell-cell contact. Eph 
receptor/ephrin binding results in clustering of both the receptor and ligand, 
triggering bi-directional signalling. A signal is generated through both the Eph 
receptor (forward signalling) and the ephrin ligand (reverse signalling).
1.2.1.1 Ephrins
There are three members of the ephrin-B subclass and they each possess an 
extracellular receptor-binding domain, a transmembrane fragment and cytoplasmic 
domain (Fig. 1.3). The crystal structures of both the ephrin-B 1 and ephrin-B2 
ectodomains have recently been elucidated (Nikolov et al., 2005; Toth et al., 2001), 
revealing the overall structure of ephrin-B 1 to be similar to that of ephrin-B2. 
Although, two main differences are apparent, which affect ligand oligomerisation 
and receptor-ligand binding specificity (Nikolov et al., 2005). There are five 
members of the ephrin-A subclass (ephrin-Al-ephrin-A5). They each have an 
extracellular receptor-binding domain and are attached to the membrane via a GPI 
anchor. The ephrin-As do not posses an intracellular domain (Fig. 1.3).
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Figure 1.3: Schematic representation of the structure of ephrins
Ephrin-A Ephrin-B
GP1 Linkage
Extracellular Receptor Binding Receptor Binding
Domain Domain
Transmembrane Domain
Cytoplasmic Tail
Intracellular ^  poz-binding Motif
Ephrin ligands are membrane-tethered proteins. Ephrin-As are attached to the 
membrane via a GPI linkage and possess an extracellular receptor-binding region. 
Ephrin-Bs exist as transmembrane proteins. They also possess an extracellular 
domain responsible for receptor-binding, together with a cytoplasmic domain, which 
is important for signal transduction downstream of ephrin-Bs.
A striking feature of the ephrin-B ligands is their highly conserved carboxy-terminal 
tails, which are 90-100 residues in length. The last 33 amino acids are particularly 
conserved; across this region ephrin-B 1 and ephrin-B2 are identical and only 3 
amino acids differ in ephrin-B3. Interestingly, this region shows no detectable 
homology with other proteins, indicating its functional role in ephrin-B signalling 
(Song et al., 2002).
The last 33 residues of the carboxy-terminal region contain five functionally 
important tyrosine residues, three of which become phosphorylated upon ephrin 
clustering in response to receptor binding (Bruckner et al., 1997; Holland et al., 
1996; Kalo et al., 2001). At the extreme carboxy terminus lies a PDZ binding domain 
(Lin et al., 1999). Numerous studies over the last few years support a functional role 
for the cytoplasmic domain in the propagation of the reverse signal. Downstream 
signalling events involved in cytoskeletal changes and cellular guidance result from 
the binding of PDZ domain proteins as well as tyrosine phosphorylation of ephrin-Bs
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and consequent binding of adaptor proteins (Fig. 1.4) (Bruckner et al., 1999; Cowan 
and Henkemeyer, 2001; Lu et al., 2001).
Figure 1.4: C-terminal region of human ephrin-B2
Function unknown
Eph receptor Binding Domain
Extracellular Domain
[TR = Transmembrane Region]
Try 330 Tyr 331
Tyr 304 Tyr 311 Tyr316
Binds to the SH2 Binds to the PDZ domain
domain of Grb4 ofthePDZ-RGS protein
C ytosk e leta l D yn am ics Cellular G u id an ce
Modified from Song et aL. 2002
Ephrin-Bs possess a highly conserved C-terminal tail, known to contain five 
functionally important tyrosine residues and a PDZ binding motif. Phosphorylation 
on tyrosine has been shown to be an important feature of ephrin-B signalling and 
numerous PDZ domain proteins have been shown to bind ephrin-Bs. Reverse signals 
from ephrin-Bs are known to regulate cytoskeletal dynamics and cellular guidance.
1.2.1.2 Eph receptors
Like all receptor tyrosine kinases, the Eph receptors are type I transmembrane 
proteins (van der Geer et al., 1994). Their extracellular region contains a highly 
conserved N-terminal globular domain (Fig. 1.5), which is necessary and sufficient 
for ligand recognition and binding (Labrador et al., 1997), and is structurally similar 
to the carbohydate-binding domain of lectins (Himanen et al., 1998). The crystal
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structure of the extracellular, ligand-binding domain of EphB2 has been elucidated 
and shown to fold into a compact jelly roll p sandwich composed of 11 anti-parallel 
p strands (Himanen et al., 1998). Immediately adjacent is a cysteine rich region 
(containing an epidermal growth factor (EGF)-like motif), which may be involved in 
receptor-receptor interactions modulating oligomerisation often observed upon 
ligand binding (Boyd and Lackmann, 2001). This is followed by two fibronectin type 
III repeats (Fig. 1.5). A transmembrane domain separates this ligand-binding region 
from the intracellular domain.
The cytoplasmic region of Eph receptors contains a juxtamembrane segment where 
two tyrosine residues lie that are highly conserved throughout the Eph receptor 
family (Fox et al., 1995; Sajjadi and Pasquale, 1993). This is followed by a centrally 
located, highly conserved kinase domain (Fig. 1.5) which catalyses tyrosine 
phosphorylation of protein substrates including the Eph receptors themselves (Kalo 
and Pasquale, 1999b). It has been shown, however, that one receptor from each class 
(EphAlO and EphB6) lacks essential residues for catalytic activity, suggesting that 
these two receptors may not function by phosphorylating cytoplasmic target proteins 
(Murai and Pasquale, 2003). At the C-terminus of the molecule resides a sterile alpha 
motif (SAM) usually followed by a PDZ-binding motif (Fig. 1.5). The function of 
the Eph SAM domain is not well understood and despite its conservation, its removal 
does not disrupt Eph function (Boyd and Lackmann, 2001). Structural studies 
indicate that the SAM domain may modulate receptor dimerisation or clustering 
(Stapleton et al., 1999; Thanos et al., 1999), while other experiments suggest it may 
bind adaptor proteins (Boyd and Lackmann, 2001).
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Figure 1.5 Structure of Eph receptors
Extracellular
Globular domain
Cystein* Rich Domain 
Fibronectin Type III Domain
Flbronectln Type III Domain
Transmembrane Domain
Intracellular
Tyrosine Kinase Domain
SAM Domain 
PDZ Binding Motif
Eph receptors are transmembrane proteins. The extracellular region is composed of a 
globular ligand-binding domain, a cysteine rich region followed by two fibronectin 
type III repeats. The intracellular region is composed of the tyrosine kinase domain, 
a sterile a  motif (SAM) and a PDZ binding domain.
1.2.1.3 Structural features influencing receptor-ligand binding  
specificities
In vivo, many ephrins have overlapping expression patterns (Flenniken et al., 1996). 
Therefore differences in binding affinities are likely to be crucial where ligands are 
co-expressed (Feldheim et al., 2000). Mutational and chimeric analyses of the EphB2 
ligand-binding domain identified an extended loop important for ligand binding and 
class specificity. This loop is conserved within a subclass, but not across subclasses 
and the length of the loop appears to confer class discrimination (Himanen et al., 
1998). In addition, analyses of the sequence conservation of ephrin ectodomains has 
led to the proposal that a surface region consisting of a small concave hydrophobic 
pocket surrounded by charged amino acids represents a crucial site for receptor 
recognition and class specificity of ephrins. Varying degrees of amino acid
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conservation provide a mechanism to influence receptor binding, while allowing 
some promiscuity within a class as seen in vitro (Toth et al., 2001). Both receptors 
and ligands appear to possess structural features enabling a mechanism of class 
discrimination to occur. The recent elucidation of the crystal structure of the ephrin- 
B1 ectodomain illustrates potential structural differences between two ephrin-Bs that 
could result in a greater affinity for one receptor than another (Nikolov et al., 2005).
1.3 Eph receptor/ephrin binding and activation
The membrane-bound nature of ephrins and Eph receptors means that their 
interaction requires intimate cell-cell contact. Activation of ephrins and Eph 
receptors leads to the multimerisation of both molecules into plasma membrane 
clusters (Davis et al., 1994). The degree of multimerisation required to achieve 
receptor activation varies between receptor-ligand pairs but it is thought that ephrins 
must be presented as higher order clusters to fully activate the Eph receptor response 
(Davis et al., 1994; Gale and Yancopoulos, 1997; Stein et al., 1998b).
Prior to cell-cell contact, unbound ephrins and Eph receptors are loosely pre­
clustered into homodimers and found localised to cholesterol-rich lipid rafts 
(Bruckner et al., 1999). Interestingly, however, ephrin-Bl has recently been shown to 
be present as a monomer (Nikolov et al., 2005). Upon cell-cell contact, the ephrin 
ligands and Eph receptors bind with high affinity and 1:1 stoichiometry to form 
heterodimers (Himanen et al., 2001). The ligand molecules become re-orientated 
after receptor binding, and through complementary interaction surfaces dimer pairs 
join to form tetramers, consisting of two ephrins and two Eph receptors (Himanen 
and Nikolov, 2002; Himanen et al., 2001). The formation of this stable tetramer, 
where the carboxyl termini of both ephrin-B2 molecules are on the opposite side to 
the carboxy termini of the two EphB2 receptor molecules, allows signals to be 
generated in opposite directions at the cell-cell interface (Himanen et al., 2001).The 
tyrosine kinase domains of the paired receptor molecules /ra«s-autophosphorylate 
each other and initiate forward signalling (Himanen et al., 2001). Interestingly, it has 
recently been demonstrated that new Eph receptors can be recruited into existing 
Eph-ephrin signalling clusters, resulting in a lateral association between Eph receptor
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molecules on the same cell surface and this can occur independently of ephrin- 
binding. This could be responsible for an expansion of receptor clusters beyond the 
region of cell-cell contact (Wimmer-Kleikamp et al., 2004). Disruption of ephrin- 
ephrin homodimers and tetramer formation stimulates a conformational change in the 
transmembrane domain of the ephrin, altering the accessibility of tyrosine residues 
on the cytoplasmic tail (Himanen et al., 2001; Toth et al., 2001), known to become 
phosphorylated upon Eph receptor binding by cytoplasmic tyrosine kinases 
(Bruckner et al., 1997; Holland et al., 1996; Kalo et al., 2001). This initiates reverse 
signalling. A further conformational change in the cytoplasmic tail then occurs, 
changing it from a closed to an open conformation, leading to recruitment of various 
proteins involved in downstream signalling (Song, 2003). Ephrin-As do not possess a 
cytoplasmic domain but a region of ephrin-As has been postulated to be responsible 
for interaction with an ADAM metalloprotease, which has been shown to cleave the 
ephrin-A2 ectodomain from the cell surface after receptor binding providing a 
mechanism for cell-cell separation following high affinity binding of membrane 
bound Eph receptors and ephrins (Hattori et al., 2000).
1.4 Eph receptors and ephrins: Control of cell movements 
during morphogenesis
1.4.1 Development of the vasculature
During vertebrate development the vascular system is one of the first organ systems 
to function. Development of the mammalian vasculature is a highly specialised 
process requiring the organisation of blood vessels into a highly structured network. 
Initially this occurs through a process called vasculogenesis and is followed by 
angiogenesis (reviewed in Weinstein, 1999). Vasculogenesis involves the 
differentiation of angioblasts from mesoderm and the formation of primitive blood 
vessels at or near their site of origin. This results in the formation of the primary 
plexus, a basic undifferentiated structure lacking fine capillary networks, although a 
few major blood vessels are present such as the dorsal aorta (reviewed in Risau and 
Flamme, 1995). During angiogenesis, the primary vascular plexus undergoes 
remodelling to form the mature vascular network, involving the branching and
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sprouting of new vessels together with the splitting and pruning o f existing 
projections (reviewed in Risau, 1997). This is a complex process involving 
endothelial cell proliferation, chemotactic migration and functional maturation. A 
major aspect of angiogenesis is endothelial cell migration. Angiogenesis occurs 
throughout embryogenesis and also has roles in the adult during wound healing, the 
uterine cycle and placental growth as well as inflammatory responses and tumour 
neovascularisation.
1.4.1.1 Venous EphB4 and arterial ephrin-B2 expression
Until relatively recently it was thought that the difference in functional properties 
exhibited by mature arteries and veins arose as a reflection of vascular physiology. 
However, a number of groups have recently provided evidence that arterial and 
venous endothelial cells are molecularly distinct from the outset of angiogenesis, 
suggesting that the different functions exhibited by the two vessels are in part 
genetically determined. This distinction was revealed when arterial endothelial cells 
were found to endogenously express the transmembrane ligand ephrin-B2, and 
venous endothelial cells its cognate receptor EphB4 (Adams et al., 1999; Gerety et 
al., 1999; Wang et al., 1998).
EphB4/ephrin-B2 bi-directional signalling between arteries and veins was found to 
be necessary for remodelling the capillary network (Adams et al., 1999; Gerety et al., 
1999; Wang et al., 1998). Mice lacking either ephrin-B2 or EphB4 die during 
embryogenesis around E l0.5 with severe cardiovascular defects. Targeted disruption 
of the ephrin-B2 gene prevents the remodelling of both veins and arteries (Adams et 
al., 1999; Wang et al., 1998), yet the major vessels in the trunk form normally 
indicating vasculogenesis is not affected. A targeted mutation in EphB4 essentially 
phenocopies the defects seen in the ephrin-B2 mutant (Gerety et al., 1999), 
suggesting that EphB4 is the main functional partner of ephrin-B2 in the vasculature 
(Gerety et al., 1999), and that bi-directional signalling is required for correct 
angiogenic remodelling. In addition, the reciprocal expression pattern of ephrin-B2 
on arteries and EphB4 on veins, and the maintenance of arterial/venous identity into 
fine capillary beds, where arteries and veins make contact (Wang et al., 1998),
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suggests a role for EphB4/ephrin-B2 signalling in defining arterial/venous 
boundaries possibly by preventing cell mixing (Adams et al., 1999; Gerety et al., 
1999; Wang et al., 1998). In support of this, endothelial cell lines expressing EphB4 
or ephrin-B2 will segregate when mixed (Fuller et al., 2003).
In order to elucidate the importance of reverse signalling in maintaining the 
arterial/venous boundary, the role of the ephrin-B2 cytoplasmic domain in vivo was 
investigated. Knock-in mutant mice were generated in which endogenous ephrin-B2 
was replaced with truncated ephrin-B2 lacking the cytoplasmic domain (ephrinB2AC) 
(Adams et al., 2001). Truncated ephrin-B2 is unable to exert reverse signals via its 
cytoplasmic domain, therefore is restricted to the induction of forward signalling by 
Eph receptors on adjacent cells. Homozygous ephrinB2AC/AC mice exhibited defects 
in angiogenic remodelling reminiscent of the ephrin-B2 knock-out mice (Adams et 
al., 2001). Truncated ephrin-B2 was able to rescue the neural crest cell defects seen 
in ephrin-B2 knockout mice confirming that forward signalling through the receptor 
was functioning (Adams et al., 2001). This finding indicated that the ephrin-B2 
cytoplasmic domain, and reverse signalling generated through ephrin-B2, was 
required for correct vascular morphogenesis. However, this observation was 
challenged in a later study where the cytoplasmic domain was replaced by 6- 
galactosidase, which did not result in angiogenic defects (Cowan et al., 2004). This 
indicated the C-terminal domain of ephrin-B2 was not required for early vascular 
development. The different outcomes observed could be due to the type of mutations 
used leading to altered protein localisation which may prevent interaction with EphB 
receptors, or could affect their ability to cluster and function. Cowan and colleagues 
demonstrated that a truncated ephrin-B2 became trapped in the trans-golgi network 
failing to reach the plasma membrane, in effect acting as a protein null (Cowan et al.,
2004). This could have been the case in the earlier study. However, despite not 
playing a role in early vascular development, the cytoplasmic domain of ephrin-B2, 
and therefore reverse signalling, was found to be necessary for the correct formation 
of the cardiac valve (Cowan et al., 2004).
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In embryos EphB4 expression is restricted to the cardiovascular system (Gerety et 
al., 1999). However, delayed expression (onset E l2.5) of ephrin-B2 has been shown 
in mesenchymal cells, pericytes and vascular smooth muscle cells (Adams et al., 
1999; Gale et al., 2001; Shin et al., 2001a; Wang et al., 1998). Since expression of 
ephrin-B2 is not restricted solely to the vasculature, previous studies could not 
definitively distinguish between a vascular or mesenchymal requirement. Knocking 
out ephrin-B2 specifically in the vasculature demonstrated the absolute requirement 
for ephrin-B2 in order for correct angiogenic remodelling of both arteries and veins 
to occur (Gerety and Anderson, 2002). Mesenchymal ephrin-B2 alone is not 
sufficient to support angiogenesis in the absence of vascular ephrin-B2, 
demonstrated by indistinguishable cardiac defects exhibited in the vascular ephrin- 
B2 knockout and the conventional knockout (Gerety and Anderson, 2002; Wang et 
al., 1998).
1.4.1.2 Other Eph/ephrin interactions in the developing vasculature
Eph/ephrin expression in the vascular system is not simply restricted to EphB4 and 
ephrin-B2, other receptors and ligands are also expressed although their role in 
angiogenesis is less clear. Ephrin-Bl is co-expressed with ephrin-B2 in arteries, 
together with EphB3 on aortic arches. Ephrin-Bl and EphB3 are co-expressed with 
EphB4 in veins (Adams et al., 1999) and expression of EphB2, EphB3 and EphB4 
together with ephrin-Bl and ephrin-B2 was found in yolk sacs (Adams et al., 1999). 
In addition EphB2 and ephrin-B2 are expressed in mesenchymal cells adjacent to 
endothelial cells (Adams et al., 1999). This expression analysis suggests complex 
cell-cell interactions, via ephrins and Eph receptors, between endothelial cells 
throughout the vasculature and between endothelial and mesenchymal cells.
Although ephrin-B 1 is co-expressed with ephrin-B2 in arteries, it is unable to rescue 
the vascular defects resulting from the ephrin-B2 mutation, suggesting these ligands 
have distinct functions in the developing vasculature (Adams et al., 1999). Neither 
EphB2 or EphB3 knockout mice show any vascular defects (Adams et al., 1999). 
However, EphB2/EphB3 double mutant embryos display a 30% penetrant phenotype 
that resembles the ephrin-B2 mutant, although less severe (Adams et al., 1999).
29
Prominent expression of EphB2 and ephrin-B2 in mesenchymal cells adjacent to 
endothelial cells also implicates ephrins and Eph receptors in interactions between 
endothelial and mesenchymal cells (Adams et al., 1999).
In mice, intersomitic vessels that form at somite boundaries express EphB3 and 
EphB4 receptors (EphB4 in Xenopus) at a time when ephrin-B2 is expressed in the 
caudal half of the somites (ephrin-Bl and ephrin-B2 in Xenopus) (Adams et al., 
1999; Helbling et al., 1999). This close contact between ephrin-B expressing cells of 
the dermomyotome and EphB expressing endothelial cells suggested a functional 
interaction of intersomitic vessels and the connecting capillary network. Ephrin-B2 
null mutants showed aberrant organisation and branching of intersomitic vessels, 
compared to their wild-type counterparts (Adams et al., 1999). In addition, 
constitutive, ubiquitous overexpression of ephrin-B2 results in an abnormal 
segmental arrangement of intersomitic vessels (Oike et al., 2002). However, 
overexpression of ephrin-B2 solely in vascular endothelial cells does not, suggesting 
non-endothelial ephrin-B2 expression alters the migration of EphB expressing 
endothelial cells into the intersomitic region where ephrin-B2 expression is normally 
absent (Oike et al., 2002). In Xenopus, expression of dominant negative EphB4 
lacking the intracellular tyrosine kinase domain or overexpression of ephrin-B2 
resulted in abnormal projection of intersomitic veins into adjacent somites. Ephrin-B 
reverse signalling was not required. Therefore, forward signalling through EphB4 is 
sufficient for directional growth of intersomitic veins (Helbling et al., 2000). 
Abnormal dorsal branches were also observed in EphB2/EphB3 double mutants 
(Adams et al., 1999). A function of the interaction between somitic ephrin-B2 and 
endothelial EphB receptors may be to suppress sprouts which are therefore seen in 
the mutant (Adams et al., 1999).
Various Eph A receptors and ephrin-A ligands are expressed in the developing 
vasculature of the mouse (Flenniken et al., 1996; McBride and Ruiz, 1998). 
However, no vascular defects have been detected as a result of knocking out EphA 
receptors or ephrin-A ligands (Dottori et al., 1998; Feldheim et al., 2000; Frisen et 
al., 1998). It remains to be determined whether EphA receptors and ephrin-As have a 
function in vascular development.
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1.4.1.3 Eph/ephrin regulation of cell migration and angiogenic 
sprouting
During angiogenesis, migration of endothelial cells to their correct targets is 
essential. Numerous in vitro studies have investigated the effects of Eph receptors 
and ephrin ligands on endothelial cell migration and sprouting. However, conflicting 
results have been obtained from such experiments. Some studies describe Eph 
receptors and/or ephrins as positive regulators of migration and sprouting while 
others describe the opposite result. These discrepancies could be due to the many 
different cell types involved, which express different Eph receptors and ephrins, and 
the promiscuous binding capabilities of Eph receptors and ephrins. In addition the 
experimental conditions are varied. Further work is needed to clarify the situation.
Stimulation of EphB receptor expressing endothelial cells with ephrin-B2-Fc or 
contact with ephrin-B2 expressing cells can result in increased cell migration 
(Maekawa et al., 2003; Nagashima et al., 2002; Sawai et al., 2003; Steinle et al., 
2002), proliferation (Steinle et al., 2002), and sprouting (Adams et al., 1999; Stein et 
al., 1998b; Zhang et al., 2001). For example, stimulation of adrenal cortex-derived 
microvascular endothelial (ACE) cells expressing EphB receptors, with soluble 
ephrin-B 1-Fc or ephrin-B2-Fc induced significant sprouting activity (Adams et al., 
1999). Interestingly, unclustered ephrin-B 1 was sufficient to induce sprouting where 
as ephrin-B2 had to be pre-clustered in order to show the same response (Adams et 
al., 1999). In contrast, other studies have demonstrated that EphB forward signalling 
results in a decrease in cell migration, proliferation and sprouting (Fuller et al., 2003; 
Hamada et al., 2003; Kim et al., 2002; Sturz et al., 2004).
EphB4-Fc stimulation of ephrin-B2, and activation of ephrin-B2 reverse signalling, 
has also been shown to increase cell migration (Fuller et al., 2003; Hamada et al., 
2003; Huynh-Do et al., 2002; Steinle et al., 2003), sprouting (Adams et al., 2001) 
and proliferation (Steinle et al., 2003). Both ephrin-Bl and ephrin-B2 display an in 
vitro capillary sprout-inducing ability (Adams et al., 1999). In addition, soluble 
EphB3-Fc and EphB4-Fc (Adams et al., 2001; Palmer et al., 2002), but not EphB2- 
Fc (Adams et al., 2001) or EphBl-Fc (Adams et al., 1999) were able to induce
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sprouting, suggesting there is a degree of specificity required, perhaps mediated 
through receptor-ligand binding affinities (Adams et al., 2001). However the 
opposite effects have also been documented. Growing ephrin-B2 expressing cells on 
EphB4 expressing cells inhibits angiogenic sprouting (Zhang et al., 2001).
In vivo evidence also exists for EphB/ephrin-B signalling influencing cell migration 
and sprouting. Ephrin-B2 deficient embryos show defective vascularisation of the 
nervous system, which normally occurs via angiogenic sprouting from the perineural 
vascular plexus. Therefore, ephrin-B2 may induce capillary sprouting in vivo (Adams 
et al., 1999). Furthermore, ephrin-B2-Fc stimulation of EphB expressing HUVECs 
promotes angiogenesis in vivo during a mouse corneal neovascularisation assay 
(Maekawa et al., 2003).
EphA/ephrin-A signalling has also been shown to play a role in endothelial cell 
migration. Ephrin-Al promotes angiogenesis in vivo as well as endothelial cell 
migration in vitro (Brantley et al., 2002; Daniel et al., 1996; Pandey et al., 1995). 
EphA activation has been shown to be required for VEGF-mediated endothelial cell 
sprouting in an in vitro capillary sprouting assay (Cheng et al., 2002b). In addition, 
EphA2 receptor signalling is required for capillary sprouting in HUVECs (Ogawa et 
al., 2000). Interestingly, it has recently been reported that EphA2 activation triggers 
an inhibition of endothelial cell migration (Ojima et al., 2006).
Genetic studies have unambiguously demonstrated a requirement for Eph/ephrin 
signalling during angiogenesis. However in vitro data, dissecting the cellular 
responses to Eph receptor and ephrin activation, presents a conflicting picture of both 
repulsive and attractive outcomes of Eph and ephrin activation.
1.4.1.4 Role of Eph/ephrin signalling during adult angiogenesis
Arterial ephrin-B2 expression and venous EphB4 expression is maintained 
throughout later embryogenesis and in the adult, with expression extending to the 
microvasculature in a variety of tissues (Gale et al., 2001; Shin et al., 2001a). 
Expression of ephrin-B2 is also found in the smooth muscle cells surrounding the
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vessels (Gale et al., 2001; Shin et al., 2001a). In the adult, ephrin-B2 expression in 
newly forming blood vessels was observed both in normal and pathological settings, 
such as in the female reproductive system, during wound healing and in tumours (see 
1.6.2 for Eph/ephrin involvement in cancer).
One example of EphB/ephrin-B signalling in physiological angiogenesis in the adult 
is during follicular and corpus luteum formation in the adult ovary (Egawa et al., 
2003; Gale et al., 2001). High levels of ephrin-B2 expression have been described 
during follicular maturation and differentiation of the ovum, to form a highly 
vascularised corpus luteum (Gale et al., 2001). EphBl, B2 and B4 together with 
ephrin-B 1 and B2 are expressed in human corpora lutea of the early luteal phase. A 
rapid increase in ephrin-B 1 expression was observed on human luteinizing granulosa 
cells after ovulation, and ephrin-Bl was able to bind EphB2-Fc suggesting ephrin-Bl 
expressing cells may directly interact with Eph bearing cells in vivo during corpus 
luteum formation (Egawa et al., 2003). EphB4 and ephrin-B2 have also been 
implicated in the hormone-dependent morphogenesis of the mammary gland. 
Expression of EphB4 and ephrin-B2 are induced at the onset of puberty. EphB4 
expression is localised to the myoepithelial cells of ducts and alveoli, and ephrin-B2 
to the luminal epithelial cells. Expression is oestrogen induced and levels are at their 
highest during the proliferative stages, associating them with growth and/or tissue 
remodelling (Nikolova et al., 1998).
Eph/ephrin signalling is also involved in pathological angiogenesis. 
Neovascularisation in the retina is a critical component of conditions that can result 
in blindness, such as age-related macular degeneration, diabetes mellitus and 
retinopathy of prematurity (ROP) (Lee et al., 1998), and Eph receptors and ephrins 
have recently been identified as mediators of retinal neovascularisation. Ephrin-B2, 
EphB2 and EphB3 are expressed in the endothelial cells of fibroproliferative 
membranes of patients with proliferative diabetic retinopathy (PDR) and ROP 
(Umeda et al., 2004) and ephrin-Al stimulates corneal angiogenesis in vivo (Pandey 
et al., 1995). In support of in vitro data demonstrating the presence of ephrin-B2 and 
EphB4 expression in retinal endothelial cells (Steinle et al., 2003) and regulation of 
endothelial cell migration via both forward and reverse signalling (Steinle et al., 
2003; Steinle et al., 2002), soluble ephrin-B2 and EphB4 have been shown to reduce
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retinal neovascularisation in a murine model of proliferative neuropathy (Zamora et 
al., 2005), and recently, ephrin-Al has been shown to do the same (Ojima et al., 
2006). Inhibition of EphA receptors by blocking the interaction between ephrin-A 
ligands and endogenous EphA receptors using soluble EphA2-Fc treatment has been 
shown to inhibit the severity of abnormal retinal neovascularisation in a rat model of 
ROP, without affecting normal vessel development. In addition, soluble EphA2-Fc 
inhibits ephrin-Al induced corneal angiogenesis in vivo (Chen et al., 2005; Cheng et 
al., 2002b). Soluble EphA2-Fc treatment inhibited retinal endothelial cell migration 
and the formation of tube-like structures in response to either ephrin-Al or VEGF 
and the results from EphA2 deficient mice would suggest that the specific receptor 
involved is EphA2 (Chen et al., 2005).
1.4.1.5 Cross-talk with other mediators of vascular development
Three main families of receptor tyrosine kinases are known to be mediators of 
angiogenesis: vascular endothelial growth factor receptor (VEGFR), Tie and Eph 
receptors. They act with their ligands: vascular endothelial growth factors (VEGFs), 
Angiopoietins and ephrins respectively, to pattern the vasculature (reviewed in 
Yancopoulos et al., 2000).
VEGF has been found to co-localise with ephrin-Al and EphA2 in tumour sections 
(Brantley et al., 2002), and EphA2-Fc can inhibit VEGF-induced endothelial cell 
migration suggesting cooperation between these signalling pathways (Brantley et al., 
2002). Furthermore, VEGF-induced angiogenesis in vivo specifically requires EphA 
receptor activation (Cheng et al., 2002b). Cross-talk is not simply restricted to 
VEGF, the angiogenic phenotype in the head and yolk sac of the ephrin and Eph 
knockout mice appears similar to that of mutations in mice where the receptor Tie-2 
and its ligand angiopoietin-1 have been knocked out (Sato et al., 1995; Suri et al.,
1996), and Tie2 has been shown to phosphorylate the cytoplasmic domain of ephrin- 
Bl (Adams et al., 1999).
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1.4.1.6 Ephrin-B signalling during lymphangiogenesis
Ephrin-B2 signalling has recently been shown to play a role not only in the 
development of blood vessels but also in the lymphatic system (Makinen et al.,
2005). The major roles of the lymphatic system are to maintain tissue fluid balance, 
provide a route for fat absorption in the gut and immune surveillance. Lymphatic 
vessels appear to originate from a subset of venous endothelial cells and like the 
blood vasculature the lymphatic system undergoes remodelling. However, the 
development of the lymphatic vasculature is less understood. Makinen and 
colleagues, demonstrated a requirement in vivo for the PDZ binding motif at the C- 
terminal end of ephrin-B2 in order for correct lymphangiogenic remodelling 
(Makinen et al., 2005). Two knock-in mice were generated. Ephrin-B2AV/AV mice 
expressed ephrin-B2 lacking the C-terminal valine in the PDZ binding site and 
ephrin-B25F/5F mice expressed ephrin-B2 with 5 conserved tyrosine residues mutated
cr/cr
to phenylalanine. Homozygous ephrin-B2 mutant mice survived the requirement 
for ephrin-B2 in the vascular system, however, homozygous ephrin-B2AV/AV mutant 
mice exhibited major lymphatic defects (Makinen et al., 2005). Interestingly, ephrin- 
B2 reverse signalling was also implicated in the elongation and guidance of 
sprouting lymphatic endothelial cells. Wild-type mice showed filopodial extensions 
at sites of initiation of lymphatic endothelial cell sprouting. However, sprouting was 
disrupted in the ephrin-B2 PDZ mutant mice resulting in blunt ended protrusions 
(Makinen et al., 2005). Interaction with PDZ proteins but not tyrosine 
phosphorylation was found to be required for lymphatic remodelling.
1.4.2 Regulation of cell migrations and tissue segmentation
During embryogenesis many invertebrates and all vertebrate embryos undergo the 
basic process of segmentation. In vertebrates there are two clearly segmented regions 
of the body axis, the paraxial mesoderm and the hindbrain region of the neural plate. 
Eph receptors and ephrins exhibit multiple functions in tissue patterning and 
boundary formation during segmentation and regulate cell migrations during these 
events. Expression of Eph receptors and ephrins can be reciprocal or overlapping and 
interactions can lead to both attractive and repulsive responses.
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1.4.2.1 Vertebrate hindbrain
Development of the vertebrate hindbrain occurs by the formation of a series of 
distinct segments via subdivision of the neural epithelium into at least 5 
compartments called rhombomeres, numbered r2 through to r6 (Fraser et al., 1990). 
Rhombomere formation depends on the expression of genes encoding transcription 
factors such as the Hox group 1-4 protein, Krox-20 and Valentino/Kreisler/MafB 
whose expression is restricted to specific segements (Cooke and Moens, 2002). As 
each rhombomere is formed, cell mixing across segment boundaries is restricted 
(Fraser et al., 1990).
Donor-to-host transplantation, where quail rhombomeres were grafted into a chick 
host, demonstrated that negligible cell mixing occurred when r4 was positioned 
adjacent to r3. However, no boundary was formed when r3 was placed next to r5 or 
r3. Interestingly, cell mixing was more extensive when identical rhombomeres were 
grafted next to each other (Guthrie et al., 1993). Taking this further, Guthrie and 
colleagues demonstrated that upon grafting of fluorescently labelled chick 
rhombomere tissue into various rhombomeres of chick hosts, sorting would occur 
when cells were transplanted into an adjacent segment. However, cells grafted into 
the same position or two segments distant would not undergo sorting, cells would 
disperse throughout the population. For example, cells from r3 would mix when 
grafted into r3 or r5 of the host (Guthrie et al., 1993).
Eph receptors and ephrins are expressed segmentally in the developing hindbrain. 
EphB2, EphB3 and EphA4 are expressed in the odd numbered rhombomeres r3 and 
r5 (Becker et al., 1994; Henkemeyer et al., 1994; Nieto et al., 1992). Ephrin-Bl, -B2 
and -B3 are expressed in the even numbered rhombomeres r2, r4 and r6 (Bergemann 
et al., 1995; Flenniken et al., 1996; Gale et al., 1996a). Eph receptor and ephrins are 
therefore in contact at rhombomere boundaries, ideally located for restriction of cell 
intermingling. The segmental expression of Eph receptors and ephrins in this way is 
likely to be under the control of transcriptional regulators, which also have a 
rhombomere specific expression. EphA4 has been shown to be a direct 
transcriptional target of Krox-20, and Valentino is required to establish
36
complementary domains of EphA4 and ephrin-B2 in the caudal hindbrain of 
zebrafish (Cooke and Moens, 2002).
Experiments in zebrafish suggested that Eph receptor kinases were indeed required 
for the segmental restriction of cells (Xu et al., 1995; Xu et al., 1999). Expression of 
truncated EphA4 receptor resulted in disruption of hindbrain segmentation. Cells 
with r3/r5 identity were found within even numbered rhombomeres (Xu et al., 1995). 
Further evidence was obtained through mosaic analyses of exogenous ephrin-B2 
expression in zebrafish embryos. Control RNA injected at the 8-cell stage illustrated 
a scattered distribution of expressing cells throughout the hindbrain. Ephrin-B2 
expression resulted in sorting of ephrin-B2 expressing cells to the boundaries of 
r3/r5, while in rhombomeres r2/r4/r6 many expressing cells were located centrally. 
Cells expressing truncated ephrin-B2 exhibited a similar expression pattern 
indicating that mosaic activation of Eph receptors by ephrin-B2 is sufficient for cell 
sorting (Xu et al., 1999). However, cells expressing truncated EphA4 or truncated 
EphB2 were found to sort to the boundaries of r2/r4/r6 and centrally within r3/r5. 
This result suggests that signalling via ephrin-Bs may also occur at rhombomere 
boundaries to restrict cell intermingling (Xu et al., 1999).
In order to analyse further whether unidirectional or bidirectional signalling between 
complementary expression patterns of Eph receptors and ephrins restrict 
intermingling, an assay was developed by Mellitzer and colleagues using zebrafish 
animal caps. Mixing two cell populations from zebrafish animal caps, each labelled 
with a fluorescent tracer, resulted in extensive cell intermingling (Mellitzer et al., 
1999). If cells were co-injected with RNA so that ephrin-B2 was expressed in one 
cell population and EphB2/EphA4 in another cell intermingling was restricted. 
Sorting of cells to different domains in this way was shown to be dependent on bi­
directional signalling. Allowing only unidirectional signalling by injection of 
truncated versions of either ephrin-B2 or EphB2, lacking the intracellular domain, 
adjacent to the full-length binding partner, failed to restrict cell intermingling 
(Mellitzer et al., 1999). Transfer of the dye Lucifer Yellow between cells also 
assessed gap junctional communication. Although bidirectional signalling did disrupt 
gap junctional communication, unidirectional signalling through Eph receptors was 
shown to be sufficient for this to occur (Mellitzer et al., 1999) and gap junctional
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communication is a feature o f rhombomere boundaries in vivo . Whereas 
unidirectional signalling was sufficient to restrict cell mixing in the context of the 
hindbrain this was not the case in this “fishball” assay. Perhaps additional 
mechanisms compensated for the lack of bidirectional signalling in the hindbrain 
situation, allowing cell sorting to occur (Cooke and Moens, 2002).
Recently, Cooke and colleagues eliminated EphA4 and ephrin-B2a expression in 
zebrafish using antisense morpholinos (EfnB2, the gene encoding ephrin-B2, has two 
orthologs in zebrafsh ephrinB2a and ephrin-B2b). Loss of EphA4 function results in 
disruption of rhombomere boundaries consistent with a role for EphA4 signalling. 
However, in mosaic embryos, EphA4 loss of function cells sorted from wild type 
EphA4 expressing cells, suggesting that EphA4 promotes cell adhesion within the 
rhombomeres in which it is expressed. This led to the hypothesis that two 
mechanisms are operating in parallel, the well-known EphA4-dependent repulsion 
together with EphA4-dependent adhesion within rhombomeres (Cooke et al., 2005).
1.4.2.2 Somitogenesis
The process of somitogenesis is the formation of somites, which form progressively 
along the antero-posterior axis from the pre-somitic mesoderm, by the aggregation of 
mesenchymal cells and their transformation into epithelial balls (somites), separated 
by intersomitic furrows. The genetic factors that underlie the early patterning of the 
pre-somitic mesoderm are well known (Maroto and Pourquie, 2001). These 
repeating units are the precursors to the vertebral column and each somite is 
subdivided into a rostral (anterior) and caudal (posterior) domain, the morphogenetic 
capabilities of which differ (Goldstein and Kalcheim, 1992). It has been 
demonstrated by grafting experiments in the chick that interfaces between anterior 
and posterior regions of the somite are required for the maintenance o f somite 
boundaries (Stem and Keynes, 1987). Like rhombomeres, somites display alternating 
patterns of Eph receptor and ephrin expression. However, Eph receptor and ephrin 
expression domains are restricted to the anterior and posterior halves o f a single 
somite. EphB receptors are expressed in the anterior half of somites and ephrin-B 
ligands in the posterior half (Bergemann et al., 1995; Flenniken et al., 1996; Holder
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and Klein, 1999). In zebrafish, interference with Eph receptor/ephrin signalling by 
expressing dominant negative EphA4 or soluble ephrins results in abnormal 
boundary formation (Durbin et al., 1998), indicating a role for Eph receptor/ephrin 
signalling in restricting intermingling between the anterior and posterior halves. It 
has also been shown that re-expressing EphA4 and ephrin-B ligands in alternating 
patterns can rescue segmentation should the somites become fused (Barrios et al., 
2003; Durbin et al., 1998) and Eph/ephrin signalling is essential for a correct 
mesenchymal to epithelial transition (Barrios et al., 2003).
1.4.2.3 Trunk neural crest cell migration
Neural crest cells arise by delamination of cells from the dorsolateral edge of the 
neural epithelium and migrate along specific pathways to their destinations where 
they differentiate into an array of cell types from neurons to pigment cells. Trunk 
neural crest cells take two distinct migratory pathways and have different 
developmental fates. Initially the majority of neural crest cells migrate ventrally 
through the anterior half of the somites avoiding the posterior half (Bronner-Fraser, 
1993), and differentiate into dorsal root and sympathetic ganglia, schwann cells and a 
number of other derivatives (Goldstein and Kalcheim, 1991). Cells migrating from 
the neural tube 12-18 hours later invade the dorsolateral pathway between the 
dermomyotome and the overlying ectoderm (Erickson et al., 1992; Serbedzija et al., 
1989), where they differentiate into melanocytes.
The segmental expression of ephrins in the somites is thought to guide early neural 
crest cell migration. Trunk neural crest cells, which express EphB receptors, will 
migrate from the neural tube avoiding the posterior half of the somites, which 
express ephrin-B ligands. Different B receptors and ligands can perform the task in 
different species. In the chick, crest cells and cells in the anterior half of the somite 
express EphB3 and the posterior half of the somites express ephrin-Bl (Krull et al.,
1997). In rodents EphB2 and ephrin-B2 are the receptor and ligand involved (Wang 
and Anderson, 1997). This was demonstrated by the repulsive response seen to 
ephrin-B proteins, which repelled trunk neural crest cells during in vitro stripe assays 
(Krull et al., 1997; Wang and Anderson, 1997). Stripes of ephrin-Bl or ephrin-B2
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were laid down on a matrix and the behaviour of cells on the stripes analysed. It was 
demonstrated that neural crest cells migrating out of a dissected neural tube avoid 
ephrin-B stripes, contact with which causes the collapse and retraction o f cell 
processes (Krull et al., 1997; Wang and Anderson, 1997). Blocking experiments 
using soluble ephrin-Bl have also demonstrated that EphB-ephrin-B signalling is 
required to prevent neural crest cells entering the posterior half of the somite in 
rodent and avian explants (Koblar et al., 2000; Krull et al., 1997) and time-lapse 
analysis revealed that cells become disorientated and even moved backwards into the 
neural tube (Krull et al., 1997). Inhibition of neural crest cell migration was also 
demonstrated using a chemotaxis assay (Wang and Anderson, 1997). However, a 
null mutation in ephrin-B2 does not affect neural crest cell migration. This could be 
due to the continued presence of other guidance cues, which can compensate for the 
mutation (Wang and Anderson, 1997).
Neural crest cells migrating at later stages differentiate to form melanoblasts that 
migrate along a dorsolateral route. The restriction to a ventral route is in part 
regulated by ephrin-B ligands expressed in the posterior half of the somites (Krull et 
al., 1997; Wang and Anderson, 1997) and in the dermomyotome (Santiago and 
Erickson, 2002) acting as a repulsive cue to early migrating cells so they are unable 
to enter the dorsolateral pathway. However, dorsolateral expression of ephrin-B 
ligands is not downregulated at the time of melanoblast migration (Koblar et al., 
2000; Santiago and Erickson, 2002). A switch occurs where ephrin-B ligands now 
appear to act as a positive cue required for the migration of these cells along the 
dorsolateral pathway (Santiago and Erickson, 2002). The work of Santiago and 
Erickson puts forward three lines of evidence to support this switch to an attractive 
role. Firstly, melanoblasts express several EphB receptors and blocking receptor 
activation by addition of soluble ligand to trunk explants resulted in cells no longer 
migrating via a dorsolateral route. Secondly, a chemotaxis assay demonstrated that 
soluble ephrin-B 1 inhibits the migration of early neural crest cells, but promotes the 
migration of those leaving the neural tube later. Finally, engagement of Eph 
receptors by substrate bound ephrin-B ligands promotes melanoblast attachment to 
fibronectin. Early neural crest cells lose their actin stress fibres and round up in 
response to binding ephrin-B, whereas late neural crest cells form microspikes
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containing filamentous actin (Santiago and Erickson, 2002). It is currently not known 
how the switch in cell responses to EphB activation is achieved.
1.4.2.4 Cranial neural crest cell migration
Segmental migration of neural crest also occurs from rhombomeres to specific 
branchial arches, where they differentiate to form distinct patterns of cartilage and 
skeletal structures (Lumsden and Guthrie, 1991; Serbedzija et al., 1992). In Xenopus, 
mouse and chick, the neural crest is divided into three streams corresponding to 
specific rhombomeres (r) and branchial arches. Neural crest cells migrate from r2, r4 
and r6 to the first, second and third plus fourth branchial arches respectively (Fig.
1.6). The third stream splits into two parts during migration in order to enter both the 
third and fourth arch (Fig. 1.6) (Sadaghiani and Thiebaud, 1987; Sechrist et al., 1993; 
Serbedzija et al., 1992).
Figure 1.6 Cranial neural crest cell migration
bal ba2 ba3/4
Key:
r = rhombomere 
ba = branchial arch 
I  ephrin-B ligand 
EphA4/EphB receptors
41
Figure legend 1.6 - Cranial neural crest cells migrate in separate streams from 
specific rhombomeres. Rhombomere 2 gives rise to cells that populate branchial arch 
1, rhombomere 4 gives rise to cells that populate branchial arch 2 and neural crest 
cells from rhombomere 6 migrate to branchial arches 3 and 4. Neural crest cells from 
rhombomeres 3 and 5 migrate with the adjscent streams. The complementary 
expression of ephrin-B2 and EphA4/EphB 1 in specific rhombomeres is thought to be 
involved in the targeted migration of cranial neural crest cells.
In Xenopus the complementary expression of ephrin-B2 in second arch neural crest 
and mesoderm and of EphA4 plus EphB 1 in third arch neural crest and mesoderm 
has been implicated in the targeted migration of cells (Smith et al., 1997). Expression 
of truncated EphA4 or EphBl resulted in migration of 3rd arch neural crest cells into 
the normally restricted adjacent 2nd arch territory, while the migration of 2nd arch 
neural crest cells remained unaffected (Smith et al., 1997). Overexpression of a 
kinase dead form of EphA2 also results in cranial neural crest defects where the third 
and fourth streams do not separate properly. The defects are rescued upon expression 
of full-length EphA2 (Helbling et al., 1998).This suggests a functional role for Eph 
receptors in the migration of cranial neural crest cells in Xenopus. Ectopic expression 
of ephrin-B2 led to 3rd arch neural crest cells interacting with ephrin-B2 from all 
directions masking the normal unidirectional signal at the interface of 2nd and 3rd 
arch neural crest (Smith et al., 1997). This data is consistent with ephrin-B2 acting as 
a repulsive cue to restrict cell intermingling between second and third arch neural 
crest. Neural crest cells migrate along specific pathways to the branchial arches and 
differentiate into vascular smooth muscle cells in the vascular system. Disruption of 
ephrin-B2 expression by constitutively and ubiquitously overexpressing ephrin-B2 in 
the mouse results in aberrant neural crest cell migration. Defective recruitment of 
smooth muscle progenitors in the ascending aorta and aortic arch were detected 
(Oike et al., 2002).
In mice, branchial arch morphogenesis has been shown to be defective in ephrin-B2 
null mutants. The second arch was either absent or reduced in size and there was an 
absence of aortic arches (Adams et al., 2001). However in truncated ephrin-B2 
mutants where the cytoplasmic domain of ephrin-B2 was missing, no such defects
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occurred. Therefore, truncated ephrin-B2 rescued the branchial and aortic defects 
seen in ephrin-B2 null mutants. The guidance of neural crest cells was also disrupted 
in ephrin-B2 null mutants. The cells did not migrate in a well-defined stream and 
entered areas they were normally restricted from. Once again, however, truncated 
ephrin-B2 could largely restore the normal cell migration pattern (Adams et al.,
2001). This work demonstrates a requirement for the extracellular domain of ephrin- 
B2, but not the cytoplasmic domain, for cranial neural crest cell migration.
However, a requirement for ephrin-Bl forward and reverse signalling for correct 
branchial neural crest cell migration has recently been demonstrated (Davy et al., 
2004). Ephrin-Bl mutant mice exhibit a cleft palate and disordered migration that is 
also seen when ephrin-B 1 is conditionally knocked out in neural crest cells or when 
ephrin-B 1 with a defect in the cytoplasmic domain is expressed indicating reverse 
signalling through ephrin-Bl is playing a role (Davy et al., 2004).
1.5 Axon guidance
During development, neurons project axons at great distances to reach their final 
targets in order to establish a functional nervous system. At the leading edge of a 
growing axon is a structure known as the growth cone, which is composed of 
lamellipodia, containing cross-linked networks of actin filaments, and filopodia, 
which are tensile structures composed of bundled F-actin that probe the extracellular 
environment. It is the response to extracellular guidance cues detected by the growth 
cone that determines whether axons terminate at their appropriate location, 
regulating the speed and direction of axon outgrowth.
There are a large number of both positive and negative regulators of axon guidance, 
and many of these guidance cues are bi-fimctional; able to act as both repellents and 
attractants. The main families known to be involved so far include the netrins, slits, 
semaphorins and ephrins, together with their cell-surface receptors, which have been 
shown to govern cytoskeletal dynamics in axonal growth cones. Although 
Eph/ephrin signalling has been shown to function widely throughout the nervous 
system, such as in the guidance of commissural axons (Imondi and Kaprielian, 2001;
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Imondi et al., 2000), and guidance of corticospinal tract axons (Dottori et al., 1998), 
one of the most widely used models to study axon guidance is the projection of 
retinal axons to the midbrain. This section will focus on the involvement of Eph 
receptors and ephrins specifically, in the guidance of axons to their appropriate 
targets for the formation of topographic maps.
1.5.1 Formation of the retinotectal map
A topographic map is a projection from one set of neurons to another with the 
receiving cells mirroring the relationships of the projecting cells. In the retinotectal 
map, axons from the temporal retina project to the optic tectum (OT) in the chick, 
amphibians and fish, and to the superior colliculus (SC) in mammals. Mapping 
occurs along two axes: the temporal-nasal (TN) axis of the retina along the anterior- 
posterior (AP) axis of the OT/SC, and the dorsal-ventral (DV) axis of the retina 
along the lateral-medial (LM) axis of the OT/SC. Therefore, axons from increasingly 
nasal parts of the retina project to increasingly posterior parts of the tectum (Fig.
1.7), and a similar projection of axons occurs along the dorsal-ventral axis, with 
axons from the dorsal retina migrating to the ventral retina and vice versa (Fig. 1.8) 
(reviewed in Thanos and Mey, 2001). In mice, the primary axons overshoot their 
ultimate target position (Roskies and O'Leary, 1994) and interstitial branches are sent 
out at the anterior-posterior level corresponding to the final termination position. 
These branches then extend laterally and medially towards the termination zone (TZ) 
appropriate to the NT and DV retinal origin, where they finally arborise. Eph/ephrin 
signalling has been found to be crucial for all steps throughout this process.
1.5.1.1 Patterning the anterior-posterior axis
The Eph/ephrin family of receptors and ligands meet all the criteria for a topographic 
guidance molecule: they are expressed in a graded manner in the retina or OT/SC; 
Retinal ganglion cell (RGC) axons from different parts of the retina exhibit different 
responses to them; they affect RGC mapping in vivo. A gradient of ephrin-A 
expression is found in the tectum, which guides retinal axons to form the AP axis 
(Fig. 1.7). Ephrin-A2 (Cheng et al., 1995) and ephrin-A5 (Drescher et al., 1995) are
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expressed in high posterior to low anterior gradients in the tectum (Cheng et al., 
1995; Connor et al., 1998; Drescher et al., 1995). Ephrin-A2 is expressed in a fairly 
shallow gradient across the entire tectum, whereas ephrin-A5 is expressed along a 
steeper gradient, but is restricted to the posterior half (Monschau et al., 1997). 
Complementary to ephrin-A2 and ephrin-A5 expression in the tectum, EphA3 
(chick) or EphA5/EphA6 (mouse) are expressed in an increasingly nasal to temporal 
gradient in the retina (Cheng et al., 1995; Connor et al., 1998; Feldheim et al., 1998). 
Temporal axons express high levels of EphA3 and are sensitive to activation by 
ephrin, such that repulsion occurs in the anterior tectum, where there are low levels 
of ephrin expression. In contrast, nasal axons, which express low levels of EphA3, 
are less sensitive and can therefore migrate further into the posterior tectum, where 
there are high levels of ephrin expression. Repulsion of EphA expressing retinal 
ganglion cells in this way allows establishment of the AP axis.
Figure 1.7 Gradients of Eph receptor and ephrin expression along  
the AP axis in the chick
Retina T ectum
Nasal ^  Temporal
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Modified from Knoll & Drescher 2002 and Mclaughlin & Oleary 2005
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Figure legend 1.7 - Axons from the nasal and temporal retina terminate in the 
posterior and anterior tectum respectively. EphA receptors are expressed in a low 
nasal to high temporal gradient, and ephrin-A ligands in a high nasal to low temporal 
gradient in the retina. In the tectum, EphA receptors are expressed in a high anterior 
to low posterior gradient while ephrin-A ligands are expressed in a low anterior to 
high posterior gradient.
In support of this, when retinal axons grow up artificial gradients of ephrin-A ligands 
in vitro, they have been shown to stop at a fixed level of ephrin-A regardless of the 
steepness of the gradient (Rosentreter et al., 1998). In addition, homozygous null 
mutants of ephrin-A5 or ephrin-A2 or double heterozygotes, exhibit abnormal axon 
guidance. Temporal retinal ganglion cells lacking ephrin-A5 or ephrin-A2 project to 
TZ posterior to the appropriate position, while nasal RGCs are not affected 
(Feldheim et al., 2000; Frisen et al., 1998). Reduction of ephrin-A2 expression in the 
anterior tectum, using an avian retrovirus encoding ephrin-A2, resulted in the 
abnormal projection of RGC to TZ anterior to their target while nasal axons are not 
affected (Nakamoto et al., 1996). Nasal RGCs from ephrin-A2/A5 knock-out mice 
project to TZ anterior to their appropriate position (Feldheim et al., 2000). It has 
been demonstrated both in vitro and in vivo that ephrin-A2 is important for temporal 
but not nasal axon guidance (Ciossek et al., 1998; Feldheim et al., 2000; Nakamoto 
et al., 1996), while ephrin-A5 is important in vitro for both nasal and temporal axon 
outgrowth, but is biased towards temporal axons (Monschau et al., 1997; Nakamoto 
et al., 1996).
However, in the absence of both ephrin-A2 and ephrin-A5 many temporal axons 
continue to project to the correct region and RGCs terminate across the entire SC 
surface, not just at the posterior pole (Feldheim et al., 2000). One explanation for this 
is competition between nasal and temporal axons, having different sensitivities to 
repulsion, to terminate in the superior colliculus. In wild-type embryos, temporal 
axons are confined to the anterior superior colliculus and out-compete nasal axons 
that can enter more posterior regions. In the double ephrin mutants, projection into 
similar domains occurs, and when ephrin gradients are decreased in the single 
mutants, an intermediate situation results.
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In support of this, ectopic expression of EphA3 in a subset of retinal axons, leads to 
neurons expressing ectopic EphA3 being more sensitive to ephrin-As and therefore 
biased to a more anterior projection, but collectively still fill the anterior-posterior 
extent of the superior colliculus. Neurons that do not ectopically express EphA3, or 
those that express dominant negative Eph A3, induce a shift to a more posterior 
projection (Brown et al., 2000; Feldheim et al., 2004). This can be explained by them 
having been outcompeted by the axons with elevated EphA3 expression. Taken 
together, these results show that the relative levels of EphA expression by retinal 
axons underlie a graded response to ephrin gradients and that sensitivity to repulsion 
biases success when competing for space in the target tissue, rather than regulating 
the absolute length of a projection.
However, the situation is more complicated than this. Both EphA and ephrin-As are 
expressed on retinotectal axons. In addition to EphA3, at least four other EphA 
receptors are expressed uniformly across the retina (Connor et al., 1998; Homberger 
et al., 1999; Marcus et al., 1996), together with a high nasal to low temporal gradient 
of ephrin-A5 and ephrin-A6 (Marcus et al., 1996; Menzel et al., 2001). EphA4 is 
expressed uniformly across the NT axis, but is normally only phosphorylated in nasal 
retina (Connor et al., 1998; Homberger et al., 1999). This phosphorylation gradient 
corresponds to a high nasal to low temporal expression of high affinity ephrin-A 
ligands for EphA4 in the retina (Connor et al., 1998; Marcus et al., 1996). The 
overlap in expression pattern causes persistent activation of EphA4 in nasal axons 
(Connor et al., 1998), which desensitises axons to repulsion by exogenous ephrin-A 
ligands (Homberger et al., 1999). In vitro, EphA4 is required for the repulsion of 
nasal but not temporal axons by exogenous ephrin-A5 (Walkenhorst et al., 2000). 
The overlapping expression pattern of EphA4 and ephrin-A5 seems to be important 
in the graded sensitivity of nasal retinal axons.
Ephrins also have a role in regulating the branching and arborisation of the RGCs. 
Ephrin-As inhibit branch formation along RGC axons in an in vitro branching assay 
(Yates et al., 2001). In addition, rat RGCs grown on alternating stripes of membranes 
from anterior or posterior regions of the SC only branch on membranes from their 
correct target regions (Roskies and O'Leary, 1994). It has also been demonstrated
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that an inactivation of ephrin-As in vivo, using CALI (chromophore assisted laser 
inactivation) leads to enhanced RGC axon branching in the OT (Sakurai et al., 2002).
1.5.1.2 Patterning the dorsal-ventral axis
In the avian and mammalian systems RGCs from a specific DV position in the retina 
enter the OT or SC over a broad LM range and extend interstitial branches towards 
their appropriate TZ (Hindges et al., 2002; Simon and O'Leary, 1992). In addition to 
the graded expression pattern of EphA receptors and ephrin-A ligands throughout the 
AP axis, there is a graded expression of EphB receptors and ephrin-B ligands across 
the DV axis. EphB2 and EphB3 are expressed by retinal ganglion cells in a low to 
high DV gradient, complemented by a high to low DV gradient of ephrin-Bs 
(McLaughlin et al., 2003). In chick OT and mouse SC, ephrin-B 1 is expressed in a 
low to high LM gradient (Braisted et al., 1997; Hindges et al., 2002), complemented 
by a high-to-low LM EphB gradient (Hindges et al., 2002).
In EphB2/EphB3 null mice RGC axons orient and grow normally towards the optic 
disk, but as they approach the centre of the retina, a small proportion of axons 
defasciculate from their neighbours, bypass the optic nerve head and extend 
abnormally into the opposite side of the retina. A lack of both EphB2 and EphB3 
simultaneously was necessary, possibly reflecting the functional redundancy of 
EphBs in the retina. Interestingly, although EphB2 and EphB3 are predominantly 
expressed in ventral retina, RGC axons from the dorsal retina are the most severely 
affected. In addition, rescue of the phenotype occurs in mice that express a mutant 
EphB2 lacking the cytoplasmic domain, suggesting that EphB2 functions in this 
system in a kinase-independent manner (Birgbauer et al., 2000). EphB ectodomains 
have been shown to cause collapse of ephrin-B expressing neurons (Birgbauer et al., 
2001; Mann et al., 2003).
Ephrin-B 1 and ephrin-B2 are expressed in dorsal RGCs (Braisted et al., 1997; 
Marcus et al., 1996), which appear to be attracted to EphBl expressed in the lateral 
tectum. In Xenopus, ephrin-B reverse signalling has been implicated in retinotopic 
mapping (Mann et al., 2002). Increasing ephrin-B2 expression in ventral RGCs
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results in a lateral shift of axonal projections to tectal positions, where higher levels 
of EphB 1 are expressed, consistent with an attractive response for retinally expressed 
ephrin-Bs being activated on RGC axons by EphBs expressed in the OT (Mann et al., 
2002). Expression of a truncated ephrin-B2 in dorsal retina led to a medial shift also 
consistent with an attractive effect of ephrin-Bs acting via reverse signalling (Mann 
et al., 2002).
In addition to their axonal projections, RGCs that are medial to their TZ 
preferentially extend interstitial branches laterally, down the ephrin-B 1 gradient, 
whereas those that are lateral to their TZ extend branches medially, up the ephrin-B 1 
gradient. Analyses of EphB2 and EphB3 mutant mice, with and without reverse 
signalling intact, show abberant LM mapping due to defects in the guidance of 
interstitial branches. In EphB2/B3 knock-out mice branches always grow laterally 
down the ephrin-B 1 gradient, regardless of whether the axon is lateral or medial to 
its TZ. In addition dominant negative EphA2 expression results in similar defects 
(Hindges et al., 2002). These data suggest that axons respond to an ephrin-B 1 
mediated attractive signal via EphB2/B3 forward signalling. In addition, the fact that 
interstitial branches do not go randomly in the EphB2/B3 knockouts, but all grow 
laterally, indicates that bi-directional branch extension requires a branch repellent in 
a distribution paralleling ephrin-B 1 (Hindges et al., 2002; McLaughlin et al., 2003). 
This model is supported by the demonstration that high levels of ephrin-B 1 repel 
interstitial branches in a selective manner (Hindges et al., 2002). These studies show 
that in mice and chicks ephrin-B 1 acts through EphB forward signalling as both an 
attractant and a repellant: A branch located lateral to its nascent TZ is attracted up 
the gradient of ephrin-B 1 towards it future TZ, whereas a branch located medial to 
its nascent TZ is repelled down the ephrin-B 1 gradient towards its future TZ 
(Hindges et al., 2002; McLaughlin et al., 2003).
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Figure 1.8 G radients o f  Eph receptor and ephrin expression along
the DV axis in the chick
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Axons from the dorsal retina terminate in the lateral tectum and axons from the 
ventral rtetina terminate in the medial tectum. Eph receptors and ephrins are 
expressed in gradients thoughout the retina and tectum. EphA7 receptors is expressed 
in a low ventral to high dorsal gradient in the retina and EphB receptors are 
expressed in a low dorsal to high ventral gradient. Ephrin-B ligands are expressed in 
a high dorsal to low ventral gradient. In the tectum, EphB receptors are present and 
while ephrin-B 1 is expressed in a low lateral to high medial gradient.
1.6 Eph receptors and ephrins: Roles in the adult
Eph/ephrin signalling has been shown to function widely throughout development as 
has already been discussed. However, signals from both Eph receptors and ephrins 
have also been implicated in the adult in partitioning of gut epithelia (Batlle et al.,
2002), synaptic plasticity and cancer.
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1.6.1 Synaptic plasticity
Neurons communicate through highly specialised structures known as synapses and 
in this way regulate cell behaviour. Every synapse is made up of a neuron that 
conducts an impulse to the presynpatic side and another that receives the stimulus at 
the post-synaptic side. Electrical stimulation causes the release of neurotransmitters 
from synaptic vesicles on the pre-synaptic side, which cross the synaptic cleft and 
activate their receptors on the post-synaptic side. Glutamate is the primary 
neurotransmitter in the central nervous system and glutamate receptors of the N- 
methyl-o-aspartate (NMDA) type are implicated in synaptic plasticity processes 
(Katz et al., 1996). Dendritic spines are the main post-synaptic targets for excitatory 
synapses (Harris, 1999).
NMDA receptors cluster with EphB receptors upon activation, through a direct 
interaction between the extracellular region of the EphB receptor and the NR1 
subunit of the NMDA receptor, which is independent of kinase activity. However, 
subsequent steps of synapse formation in neuronal cell cultures require EphB kinase 
activity (Dalva et al., 2000). Ephrin-B2 stimulation of EphB receptors was later 
shown to modulate NMDA-receptor-dependent calcium influx. Interestingly, in 
transfected neurons, this also requires the presence of the EphB2 cytoplasmic region. 
EphB activation led to Src tyrosine kinases mediated phosphorylation of NMDA 
receptors and an increase in the ability of the NMDA receptor to flux calcium in 
response to glutamate (Takasu et al., 2002). In addition, EphB2 can bind to and 
phosphorylate syndecan-2, which can induce the formation of excitatory synapses in 
hippocampal neurons. This leads to syndecan-2 clustering and spine formation. The 
association between syndecan-2 and EphB2 is dependent on the kinase activity of 
EphB2 (Ethell et al., 2001). Eph receptor signalling mediated by Rho GTPases has 
been shown to be important for dendritic spine morphogenesis. This will be 
discussed later (see 1.9.1.1).
Genetic studies have shed light on the role of EphB receptors in synaptic plasticity. 
Mice that lack EphB2 (EphB2 7 ) are viable and have normal hippocampal synapse 
morphology. However, EphB2'/_ mice do show impaired hippocampal long-term
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potentiation. Furthermore, in hippocampal slices derived from EphB2'/‘ mice, two 
forms of synaptic depression were absent. However, EphB2 kinase signalling is not 
required for these EphB2-mediated functions since expression of a truncated EphB2 
receptor lacking kinase activity can rescue the EphB2 A mutant phenotype (Grunwald 
et al., 2001; Henderson et al., 2001).
1.6.2 Cancer
There is evidence for the involvement of both EphB/ephrin-B and EphA/ephrin-A 
signalling in tumour angiogenesis during cancer progression from a variety of 
different sources as well as for tumour growth, survival and metastasis. Elevated 
expression of both Eph receptors and ephrins has been shown to be a factor in many 
human cancers including, lung, breast, prostate, melanoma and leukaemia (reviewed 
in Surawska et al., 2004).
EphAl was the first Eph receptor to be cloned, from an erythropoietin-producing 
human hepatocellular carcinoma cell line, where EphAl was more than ten-fold 
overexpressed suggesting a role in tumourigenesis (Hirai et al., 1987). The most 
studied Eph receptor in cancer is EphA2, which is upregulated in prostate, colorectal 
and lung tumours as well as melanomas (Heroult et al., 2005). Ephrin-Al is 
expressed in tumour and tumour associated vasculature, together with EphA2 
(Brantley et al., 2002; Ogawa et al., 2000). Inhibition of EphA signalling by addition 
of soluble EphA receptors has been shown to inhibit tumour induced endothelial cell 
migration in culture (Brantley et al., 2002; Cheng et al., 2002b), and reducing 
EphA2 levels using RNAi inhibits cellular invasiveness and VEGF-induced 
endothelial cell migration (Cheng et al., 2002b). Soluble EphA receptors have been 
shown to inhibit angiogenesis in a number of tumour models using a tumour vascular 
window assay, as well as tumour growth in vivo, by blocking endogenous EphA 
receptor activation (Brantley et al., 2002; Cheng et al., 2002b). Furthermore, in an in 
vitro angiogenesis assay, a dominant negative form of EphA2 receptor inhibited 
capillary tube formation by HUVECs (Ogawa et al., 2000).
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Overexpression of EphA2 in non-transformed mammary epithelial cells induced 
malignant transformation and conferred tumorgenic potential (Zelinski et al., 2001). 
In two very recent studies the role of EphA2 has again been highlighted. The 
expression of an EphA2 mutant lacking the cytoplasmic domain or carrying a point 
mutation that inhibits its kinase activity decreased tumour volume and increased 
tumour apoptosis in primary tumours. The number of lung metastases was also 
reduced. The defects were not due to angiogenesis as there is no significant 
difference in tumour vessel density. In contrast the EphA mutants are defective in 
RhoA GTPase activation and cell migration. Therefore, receptor phosphorylation and 
kinase activity of the EphA2 receptor, at least in part, contribute to tumour 
malignancy (Fang et al., 2005). EphA2 deficient mice have also highlighted the 
specific role of EphA2 expression on the endothelium for the progression of breast 
metastasis and tumour angiogenesis (Brantley-Sieders et al., 2005).
High levels of EphA2 expression appear to be indicative of poor clinical prognosis. 
In a study of oesophageal squamous cell carcinoma, patients with EphA2 positive 
tumours had poorer survival rates compared with patients with EphA2 negative 
tumours (Miyazaki et al., 2003). In addition, high levels of EphA2 expression 
correlated with a high degree of lymph node metastasis (Miyazaki et al., 2003). 
EphA2 may be an important therapeutic target in the fight against cancer.
The involvement of EphB receptors and ephrin-B ligands in tumour progression has 
not been as well characterised as that of the EphA/ephrin-A family. However, EphB2 
has been shown to be upregulated in gastrointestinal and liver tumours and is 
detected in ovarian, lung and renal cancers, and EphB4 is expressed in mammary, 
lung colorectal and ovarian tumours and has actually been identified as a potential 
diagnostic marker for mammary tumours (Heroult et al., 2005).
Extensive ephrin-B2 expression has been observed within the tumour vasculature of 
a number of mouse tumour models (Gale et al., 2001; Shin et al., 2001a). In addition, 
soluble Eph receptors have been used successfully in animal models to block tumour 
neovascularisation via EphB receptors (Martiny-Baron et al., 2004), and ephrin-B 1 
promotes tumour growth by initiating tumour angiogenesis in hepatocellular 
carcinoma cells (HCC) (Sawai et al., 2003). It has recently been shown that EphB4
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may promote the growth of tumours by stimulating angiogenesis through ephrin-B2. 
It is proposed that EphB4 expressing tumour cells function as support cells for 
ephrin-B2 positive vascular cells and promote the formation of blood vessels that 
drive increased tumour growth (Noren et al., 2004). Ephrin-B2 reverse signalling 
looks likely to be involved, since overexpression of truncated EphB4 with a 
signalling defective cytoplasmic mutation still leads to enhanced tumour growth 
(Noren et al., 2004). Consistent with this, blocking bi-directional signalling between 
ephrin-B2 and EphB4 using a soluble EphB4 monomer inhibited A375 melanoma 
growth and tumour angiogenesis (Martiny-Baron et al., 2004). The levels of EphB4 
correlate with the degree of tumour malignancy in transgenic mouse models of breast 
cancer (Andres et al., 1994; Nikolova et al., 1998), and de-regulated expression of 
ephrin-B2 and EphB4 normally present throughout mammary gland morphogenesis 
was seen in invasive metastasising mammary tumours. Ephrin-B2 expression was 
lost at the earliest stages of carcinogenesis and a transition of EphB4 expression from 
myoepithelial to tumour cells occurs as the cancer progressed (Nikolova et al., 1998). 
The loss of ephrin-B2 at the onset of tumourigenesis suggests that loss of ligand 
results in uncontrolled growth and presence of the ligand is vital for normal 
mammary gland morphogenesis to occur (Nikolova et al., 1998). EphB4 is thought to 
be an early indicator of malignant development (Berclaz et al., 2003).
EphB4 has also been implicated as a survival factor in tumour cells. Downregulation 
of EphB4 in prostate tumours or mesotheliomas with oligodeoxynucleotides leads to 
a reduction in tumour growth and angiogenesis as well as an increase of tumour cell 
apoptosis (Xia et al., 2005a; Xia et al., 2005b). In contrast however, EphB2 has 
recently been reported to be a tumour suppressor in prostate and colorectal tumours 
(Batlle et al., 2005; Huusko et al., 2004).
1.6.3 Wound Healing
Expression of Eph receptors and ephrins has been found at sites of would healing in 
a number of different models. For example, Shin and colleagues observed strong 
ephrin-B2 staining in what appeared to be blood vessels in wounded tissue 
undergoing healing (Shin et al., 2001a). In addition, a complex expression pattern of
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Eph receptors and ephrins exists in the normal human adult intestinal mucosa. 
EphA2, EphB2 together with ephrin-Al, ephrin-B 1 and ephrin-B2 are expressed in 
the human intestine, with other members expressed at lower levels. Upregulation of 
ephrin-B2 was observed in the perilesional and lesional intestinal epithelial cells of 
patients with inflammatory bowel disease (IBD) and activation of ephrin-B2 
signalling results in acceleration of wound healing during an in vitro scratch wound 
assay, and accompanied by increased stress fibre formation and enhanced 
lamellipodia directed towards to the wound (Hafner et al., 2005).
1.7 The actin cytoskeleton
Eukaryotic cells move using cycles of protrusion at the front of the cell and retraction 
at the rear and these movements rely on the correct regulation of the actin 
cytoskeleton. The mechanisms of actin filament assembly and disassembly necessary 
for cell motility have been widely studied (reviewed in Pollard and Borisy, 2003)). It 
is known that actin polymerisation at the leading edge of cells drives the formation of 
protrusive structures, which push the membrane forward, while actin 
depolymerisation occurs at the rear (Pollard and Borisy, 2003). Actin stress fibres, 
bundles of actin-myosin contractile filaments, attach to the matrix via focal 
adhesions and lead to shortening/contraction of the cell body to pull the cell along 
(Cramer, 1999).
1.7.1 The Rho family of GTPases
GTPase switches control a wide variety of signal transduction pathways in 
eukaryotic cells. Mammalian cells contain hundreds of GTPases and members of the 
Ras superfamily have been shown to regulate many aspects of cell behaviour. There 
are over 60 of these small monomeric GTPases known in mammals and they can be 
divided into five major groups: Ras, Rho, Rab, Arf and Ran.
The Rho family of small GTPases are important regulators of the actin cytoskeleton. 
22 mammalian Rho GTPases have been described but the three best-characterised 
members of the family are Rho, Rac and Cdc42. Rho GTPases are small (21kDa)
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proteins that cycle between an active (GTP-bound) conformation and an inactive 
(GDP-bound) conformation, hydrolysing GTP to switch between active and inactive 
states (Fig. 1.9). The active, GTP-bound, protein binds to effector molecules and 
transduces intracellular signals. Three classes of protein regulate the cycle. Guanine 
nucleotide exchange factors (GEFs) bind the inactive form of the GTPase and 
catalyse the nucleotide exchange of GDP for GTP, mediating activation (Nobes and 
Hall, 1994; Schmidt and Hall, 2002). GTPase activating proteins (GAPs) stimulate 
GTP hydrolysis to GDP, which leads to inactivation (Bernards, 2003). Guanine 
nucleotide dissociation inhibitors (GDIs) block spontaneous activation and stabilise 
the inactive GDP-bound GTPase (Olofsson, 1999) (Fig. 1.9). In their active GTP- 
bound state Rho GTPases perform their regulatory function through a conformation- 
specific interaction with target (effector) proteins, over 50 of which have been 
identified for Rho, Rac and Cdc42.
Rho GTPases regulate a wide range of signalling pathways controlling a number of 
cellular processes such as cell polarity and G1 cell cycle progression. However, they 
are best known for their role in the regulation of actin structures via a series of well- 
defined signal transduction pathways that lead to both the formation (actin 
polymerisation) and organisation (filament bundling) of actin filaments. Activation 
of Rho itself leads to the formation of contractile actin-myosin filaments known as 
stress fibres (Ridley and Hall, 1992). Activation of Rac and Cdc42 leads to the 
formation of protrusive actin-rich lamellipodia (Ridley et al., 1992), and finger-like 
filopodia (Nobes et al., 1995), respectively (reviewed in Etienne-Manneville and 
Hall, 2002), requiring actin polymerisation together with stabilisation of existing 
filaments. This occurs by antagonising the actomyosin contraction that underlies 
Rho-mediated changes in the actin cytoskeleton.
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Rho GTPases cycle between an active GTP-bound state, and an inactive GDP-bound 
state, catalysed by the hydrolysis of GTP. This cycle is regulated by three classes of 
protein: GEFs (guanine nucleotide exchange factors) which trigger the release of 
GDP allowing GTP binding; GAPs (GTPase activating proteins) which catalyse GTP 
hydrolysis; GDIs (guanine nucleotide dissociation inhibitors) which block 
spontaneous activation.
The Rho induced formation of contractile actin and myosin stress fibres occurs 
through the Rho effector, Rho kinase (ROCK). ROCK is a serine threonine kinase 
and consists of an amino-terminal kinase domain, followed by a potential coiled-coil 
forming region. At the carboxyl-terminus there is a Rho-binding domain and a 
pleckstrin homology domain, which has an internal cysteine-rich region. There are 
two isoforms of ROCK, which have 65% overall sequence similarity, with the 
highest similarity (92%) found in the kinase domain (Nakagawa et al., 1996). Rho 
binding moderately enhances the kinase activity of ROCKs (Ishizaki et al., 1996; 
Matsui et al., 1996). In addition, ROCK inhibitors and dominant negative ROCK 
constructs inhibit Rho-induced stress fibre formation, although a complex between 
endogenous ROCK isoforms and Rho has not been shown (Amano et al., 1997; 
Uehata et al., 1997).
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One of the main substrates of ROCK is myosin light chain (MLC). In non-muscle 
cells phosphorylation of myosin II has an important role in regulating actomyosin 
contractility. ROCK has been shown to phosphorylate the regulatory chain of 
myosin II (myosin light chain; MLC) directly in vitro (Amano et al., 1996) and 
possibly also in vivo (Totsukawa et al., 2000), increasing myosin II ATPase activity 
(Amano et al., 1996). In addition, ROCK acts indirectly on MLC. Myosin 
phosphatase is an enzyme responsible for dephosphoryaltion of MLC, and so 
negatively regulates actomyosin contractility. ROCK phosphorylates, and therefore 
inhibits, myosin phosphatase, resulting in an increase in MLC phosphorylation and 
actomyosin contractility. Myosin phosphatase is composed of three subunits: a 
catalytic subunit, a myosin binding subunit (also known as myosin phosphatase 
targeting subunit, MYPT) and a small non-catalytic subunit (Hartshome, 1998). 
ROCK phosphorylates myosin phosphatase on threonine residues in the carboxy- 
terminal half of MYPT (Feng et al., 1999a; Kimura et al., 1996; Velasco et al.,
2002). Inactivation of myosin phosphatase therefore leads to increased 
phosphorylation of MLC (Kimura et al., 1996), which promotes actin filament cross- 
linking by myosin II, leading to the assembly of contractile stress fibres and 
increased actomyosin contractility (Kimura et al., 1996). Therefore, Rho activation 
leads to an increase in cell contractility via ROCK, which is important for numerous 
processes such as smooth muscle cell contraction, cell adhesion and migration 
(reviewed in Riento and Ridley, 2003).
1.7.2 Actin polymerisation
Actin polymerisation occurs via the coordinated activities of filament severing and 
capping proteins, and the Arp2/3 complex and the formins are the two major actin 
polymerisation factors. Rac and Cdc42, together with their role in the formation of 
lamellipodia and filopodia respectively, initiate peripheral actin polymerisation 
through the Arp2/3 complex, activation of which occurs through members of the 
Wiskott-Aldrich syndrome protein (WASP) family. Actin related proteins, Arp2 and 
Arp3, form the Arp2/3 complex, an actin-nucleation complex that associates with 
existing actin filaments to initiate new, branched filaments (Millard et al., 2004).
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Actin nucleation, site-directed branching, and elongation of actin filaments are 
essential for the extension of membrane protrusions such as filopodia and 
lamellipodia, and cell motility.
Activation of Arp2/3 by Cdc42 occurs via N-WASP. In vitro, GTP-bound Cdc42 
binds directly to N-WASP or WASP, relieving the auto-inhibition of N-WASP and 
exposing a binding/activation site for the Arp2/3 complex at its C-terminus. 
However, N-WASP/WASP is mainly found bound to WIP (WASP interacting 
protein) family members such as the brain specific CR16 and this serves to stabilise 
its inactive conformation and suppress activation by Cdc42 in vitro (Ho et al., 2001). 
Recently however, Toca-1 (transducer of Cdc42-dependent actin assembly), a new 
Cdc42 target has been identified (Ho et al., 2004), which is required for activation of 
the N-WASP/WIP complex (Ho et al., 2004), and this then leads to activation of 
Arp2/3.
The WAVE family of proteins mediates activation of the Arp2/3 complex by Rac. 
There are thought to be two mechanisms of Arp2/3 activation by WAVEs. WAVE1 
is found in a complex with HSPC300, Napl25 and PIR121 (Eden et al., 2002). 
Nap 125 and PIR121 are direct Rac targets and it has been proposed that Rac 
promotes the disassembly of this inactive complex, allowing WAVE to interact with 
Arp2/3. A similar complex has been isolated containing WAVE2, but with Abil as 
an extra component. Unlike the WAVE1 complex, this one is active in actin 
polymerisation assays (Innocenti et al., 2004). It has been proposed that the role of 
Rac in actin polymerisation, is to localise this complex to the cell periphery and 
promote actin nucleation. Further studies are needed to clarify the situation.
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1.8 Ephrin signalling
1.8.1 Ephrin-B signalling
Although there is evidence that both ephrin-As (Davy et al., 1999; Davy and 
Robbins, 2000; Huai and Drescher, 2001) and ephrin-Bs (Bruckner et al., 1997; 
Cowan and Henkemeyer, 2001; Lu et al., 2001) can signal into their respective cells, 
much more is known about the mechanisms involved in the activation and signalling 
of B class ligands. There are a growing number of effector molecules that have been 
shown to interact with ephrin-Bs and the consequent signalling pathways can be 
divided into two main types, phosphorylation-dependent and phosphorylation- 
independent.
1.8.1.1 Phosphorylation-dependent signalling
Phosphorylation of ephrin-Bs is known to occur at specific tyrosine residues situated 
within the C-terminal 33 residues of the cytoplasmic tail, both in vivo and in vitro 
(Bruckner et al., 1997; Holland et al., 1996; Kalo et al., 2001). It has been shown that 
this phosphorylation can occur both as a result of Eph receptor binding (Bruckner et 
al., 1997; Cowan and Henkemeyer, 2001) and through interactions with other 
receptor tyrosine kinases (Bruckner et al., 1997).
Stimulation of ephrin-B phosphorylation by EphB receptors is thought to be 
mediated by Src family kinases. Ephrin-B 1 has been shown to be phosphorylated by 
Src in vitro (Bruckner et al., 1997; Palmer et al., 2002), and Src family kinases and 
ephrin-B ligands co-localise in discrete signalling centres within lipid rafts after Eph 
receptor induced clustering (Palmer et al., 2002).
The cytoplasmic domain of ephrin-B 1 can also be phosphorylated, on tyrosine 
residues, by platelet derived growth factor (PDGF) receptors in the absence of Eph 
receptor binding, suggesting crosstalk between ephrin signalling and signalling 
cascades activated by other tyrosine kinases (Bruckner et al., 1997). In addition Tie-2 
has been shown to directly phosphorylate the cytoplasmic domain of ephrin-B2 and
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may play a role in the Eph/ephrin interactions that occur during endothelial cell 
communication throughout angiogenesis (Adams et al., 1999).
The FGF receptor has been shown to directly bind to and phosphorylate 
transmembrane ephrin-Bs in vivo and in vitro, and modulate their effect on cell 
adhesion. In Xenopus  embryos, FGF receptor activation can inhibit the cell 
dissociative effects of x-ephrin-Bl (Chong et al., 2000; Jones et al., 1998). Also, 
during retinal development in Xenopus, FGF modulation of ephrin-B reverse 
signalling is required to regulate the positioning of retinal progenitors within the eye 
field (Moore et al., 2004).
In order to transduce reverse signals ephrin-Bs associate physically with other 
cytoplasmic proteins, and at least one protein containing a Src homology 2 (SH2) 
domain has been shown to be involved. The SH2/SH3 adaptor protein Grb4 is known 
to bind to the cytoplasmic domain of ephrin-B 1 in a phosphotyrosine dependent 
manner (Cowan and Henkemeyer, 2001). In Baby Hamster Kidney (BHK) cells 
activation of ephrin-B 1 regulates loss of actin stress fibres and after long periods of 
exposure the cells round up, indicating adhesive contacts are lost. There is also a 
redistribution of paxillin, which is lost from focal contacts, and an increase in FAK 
catalytic activity. These effects can be blocked by a dominant negative Grb4 
construct, indicating involvement of this adaptor protein in the propagation of the 
reverse signal. Grb4 has been shown to bind to a number of proteins involved in 
cytoskeletal regulation via its SH3 domains (Cowan and Henkemeyer, 2001), such as 
cyclase associated protein (CAP), which has been proposed to regulate actin stress 
fibres and focal adhesions (Ribon et al., 1998). In mammalian cells the tyrosine 
residue important for Grb4 binding is Tyr304 (Su et al., 2004), and in Xenopus the 
equivalent residue is Tyr298 (Bong et al., 2004).
Recently, ephrin-B 1 was found to create an in vivo complex with claudinl (CLD1) 
and claudin4 (CLD4) via the extracellular domains of these proteins (Tanaka et al., 
2005). This is the first report of an ephrin-B ligand binding a protein, other than its 
cognate Eph receptor, via its extracellular domain. EphB2 and claudins may 
competitively associate with the extracellular domain of ephrin-B 1 (Tanaka et al., 
2005). Claudins are the major constituents of the tight junctions of epithelial cells,
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which serve as barriers to restrict the movement of ions and proteins across cell 
boundaries. Claudin was found to associate with ephrin-B 1 in cis (on the same cell 
surface) but not in trans and the association of claudin with ephrin-B 1 induced 
phosphorylation of cytoplasmic tyrosine residues, which was enhanced by cell-cell 
contact. The claudin-ephrin-Bl complex attenuates cell-cell adhesion through the 
phosphorylated cytoplasmic domain of ephrin-B 1 (Tanaka et al., 2005). 
Phosphorylation allowed binding of the adaptor protein Grb4 and most probably 
occurred via Src family kinases (Tanaka et al., 2005).
1.8.1.2 Phosphorylation-independent Signalling
The PDZ binding domain at the C-terminus of the B ephrin cytoplasmic tail is 
important for the recruitment of numerous proteins that have been shown to be 
involved in the signalling cascades downstream of ephrins.
Several binding partners of ephrin-Bs have been found including FAP-1 (PTP-BL), 
PHIP, Syntenin (Lin et al., 1999), GRIP (Bruckner et al., 1999; Lin et al., 1999; 
Torres et al., 1998), GRIP-2 (Bruckner et al., 1999), and PICK1 (Torres et al., 1998). 
Some of these PDZ domain interactions are important for the correct localisation of 
transmembrane proteins, such as NMDA receptors and potassium channels at 
synaptic sites (Torres et al., 1998). Since clustering of ephrins and Eph receptors and 
localisation at sites of cell-cell contact is known to be necessary for their activation, 
PDZ domain associations with the carboxyl-terminus of ephrin-Bs may play a role in 
presenting the ligand in the correct oligomeric state, in order to elicit specific 
responses from the receptor (Lin et al., 1999). Co-localisation of GRIP and ephrin- 
B2 (and ephrin-B 1, but to a lesser extent), has been shown on dorsal aorta and aortic 
branches and suggests a possible role for ephrin-GRIP interactions in angiogenesis 
(Bruckner et al., 1999).
Another PDZ domain containing protein implicated in reverse signalling is the 
cytoplasmic protein PDZ-RGS3, that can regulate heterotrimeric G protein signalling 
(Lu et al., 2001). The role of the RGS domain is to act as a GTPase-activating 
protein (GAP) for the a  subunits of trimeric G proteins, catalysing hydrolysis from
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GTP to GDP, inactivating signalling. In cerebellar granule cells, chemotaxis 
mediated by the G-protein coupled chemokine receptor CXCR4 is inhibited in 
response to EphB receptor binding to ephrin-B 1, presumably though the activity of 
PDZ-RGS3 (Lu et al., 2001). SDF-1 (stromal-cell derived factor 1), the ligand for 
CXCR4, functions as a chemoattractant and is thought to promote cerebeller granule 
cell migration towards the fine vascular membrane covering the brain. It has been 
proposed that ephrin-B reverse signalling mediated by PDZ-RGS3 may act to 
neutralise CXCR4 attraction to SDF-1, and allow inward migration of cerebellar 
granule cells in vivo (Lu et al., 2001).
An interesting idea has been proposed concerning the PDZ containing protein PTP- 
BL. This protein interacts with ephrin-B 1 via its fourth PDZ domain. After Src 
activation and ephrin phosphorylation resulting from EphB/ephrinB binding, 
signalling pathways are activated downstream of these molecules. Subsequently, 
ephrin-B clusters recruit PTP-BL through its PDZ domain. This initiates 
dephosphorylation of both Src and ephrinB, effectively turning off signalling. This 
may not completely terminate ephrin-B signalling, but rather switch it from 
phosphotyrosine dependent to PDZ domain dependent (Palmer et al., 2002). In this 
way PTP-BL is thought to function as a negative regulator of B-ephrin reverse 
signalling.
The MAP kinase JNK has been identified as an important mediator of ephrinB 1 
signalling and again seems to point to a role for reverse signalling in rearrangements 
of the actin cytoskeleton and cell adhesion. Overexpression of ephrin-B 1 in 293T 
cells dramatically increases the activity of JNK. Ephrin-B 1 reverse signalling 
resulted in a rounded cell morphology and this was found to be dependent upon JNK 
activity and independent of phosphorylation (Xu et al., 2003).
Recruitment of dishevelled may also be important in loss of cell adhesion/cell 
repulsion. Xenopus Dishevelled has been shown to form a complex with ephrin-B 1 
via binding directly to the C-terminal region of ephrin-B 1, or indirectly through 
interaction with Grb4, upon tyrosine phosphorylation of ephrin-B 1 (Tanaka et al.,
2003) and interaction with Dishevelled is required for ephrin-B 1-mediated cell 
sorting in Xenopus embryos, mediated by RhoA and ROCK activity. A recent study
63
has also reported a role for ephrin-B 1 in the control of cell migration to the eye field 
during Xenopus development (Lee et al., 2006). This ephrin-B 1 mediated cell 
movement ocured via the PCP pathway and required Daaml, PKCd, Rho A and JNK 
activity downstream from the ligand (Lee et al., 2006).
1.8.1.3 Internalisation of ephrin-Bs
A recent study from our laboratory has described a novel mechanism for cell-cell- 
repulsion where Rac activation is triggered upon contact of an EphB4 receptor 
expressing cell, with an ephrin-B2 expressing cell, this causes localised membrane 
ruffling at contact sites followed by cell-cell retraction concomitant with endocytosis 
of activated Eph receptor and bound full-length ephrin-B ligand into the receptor 
expressing cell (Marston et al., 2003). Another group has also provided evidence for 
bi-directional endocytosis of both activated EphBl and ephrin-B 1, either by 
presentation of their respective signalling partners in soluble forms, or as a result of 
cell-cell contact (Zimmer et al., 2003). Interestingly, co-localisation of EphB-ephrin- 
B clusters with markers of the endocytic pathway such as clathrin were not found 
(Marston et al., 2003; Zimmer et al., 2003).
Recently, an independent study has reported reverse endocytosis of activated ephrin- 
B l, via a clathrin dependent pathway (Parker et al., 2004). Internalisation of both 
receptor and ligand into their respective cells was found upon contact of an EphB 1 
and an ephrin-B 1 expressing cell. Reverse endocytosis of ephrin-B 1 was also found 
upon stimulation of ephrin-B 1 expressing cells with soluble EphBl-Fc. Co­
expression of a dominant negative dynamin construct with ephrin-B 1, or potassium 
depletion, resulted in reduced internalisation (Parker et al., 2004).
1.8.2 Ephrin-A signalling
Unlike the ephrin-B subclass, ephrin-A ligands are anchored to the membrane by a 
GPI linkage and as such do not possess an intracellular domain. However, signalling 
via ephrin-A ligands has been shown to occur, binding of EphA ectodomains to 
ephrin-A ligands can trigger a cellular response (Kullander and Klein, 2002). In
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C.elegans the only known Eph receptor is VAB-1, and it is expressed together with 
four potential ephrin-As. Genetic studies indicated that many of the functions of 
VAB-1 were kinase-independent, suggesting the presence of reverse signalling by 
C.elegans ephrins (Wang et al., 1999). Activation of ephrin-A5 by EphA5 
stimulation led to an increase in integrin-mediated adhesion, dependent on the Fyn 
tyrosine kinase (Davy et al., 1999; Huai and Drescher, 2001) and an increase in MAP 
kinase activation (Davy and Robbins, 2000). Furthermore activation of ephrin-A 1 
inhibited T-cell chemotaxis by increasing Rho activation (Sharfe et al., 2002).
The mechanism of ephrin-A signal transduction is not well understood, but it is 
possible that their GPI anchorage may localise them to membrane rafts rich in 
signalling complexes (Sargiacomo et al., 1993; Shenoy-Scaria et al., 1994) and a 
raft-localised potential co-receptor has been implicated (Huai and Drescher, 2001). 
In addition cleavage of ephrin-As by the metalloprotease ADAM 10 may provide a 
mechanism for ephrin-A induced cell repulsive events (Hattori et al., 2000).
1.9 Eph receptor signalling
Throughout development, the biological functions of Eph receptors and ephrins 
involve the control of cell shape and movement, which depend on co-ordinated 
changes in the cell cytoskeleton and cell adhesion. In vitro, activation of Eph 
receptors has been shown to impinge on the actin cytoskeleton and cell-matrix 
adhesion in a variety of situations.
1.9.1 Eph receptor regulation of actin dynamics via Rho GTPases
As discussed above, the small GTPases Rac and Cdc42 are known to regulate 
protrusive structures known as lamellipodia and filopodia respectively, whereas Rho 
is important for the formation of actin stress fibres and cell contractility. Many of the 
responses to Eph receptor activation are repulsive in nature, therefore it may be 
expected that the predominant family member to feature downstream of Eph 
receptors is Rho. Interestingly, Rac/Cdc42 have also been implicated in Eph receptor 
signalling.
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1.9.1.1 Rho GTPases downstream from EphB receptors
EphB receptors have been shown to interact with exchange factors for Rho family 
GTPases. In hippocampal neurons EphB2 signals to Racl and Cdc42 by binding the 
exchange factors Kalirin and Intersectin respectively (Irie and Yamaguchi, 2002; 
Penzes et al., 2003), and regulates dendritic spine morphogenesis.
Endogenous EphB2 activation in hippocampal neurons, increases Cdc42 levels as a 
result of the functional interaction between Intersectin and EphB2. Expression of a 
kinase dead EphB2, or truncated Intersectin, lacking GEF activity inhibits the 
formation of dendritic spines (Ethell et al., 2001; Irie and Yamaguchi, 2002). Kalirin 
is a member of the Trio family of GEFs, which is expressed predominantly in the 
nervous system, and also plays a role in dendritic spine morphogenesis (Penzes et al.,
2001). Both EphB2 activation by ephrin-B 1 in hippocampal neurons, and 
overexpression of kalirin, results in an increased number and size of dendritic spines 
(Penzes et al., 2003; Penzes et al., 2001), and changes in spine morphology were 
found to be both Eph receptor and Rac-dependent (Penzes et al., 2003). Ephrin-B 1 
stimulation of hippocampal neurons results in Kalirin phosphorylation on tyrosine 
and upregulates activation of the serine/threonine kinase PAK, a downstream 
effector of Racl, specifically in dendritic spines (Penzes et al., 2003). It was actually 
determined that EphB2 activation triggers the redistribution of Kalirin to EphB2 
membrane clusters in the post-synaptic site, and in this way promotes dendritic spine 
morphogenesis, rather than changing Kalirins GEF activity towards Rac (Penzes et 
al., 2003).
Another GEF for Racl and Cdc42 is aPix (Pak interacting exchange factor), which 
associates with activated EphB2, probably mediated by the adaptor Nek, which binds 
both to Pak and EphB receptors (Becker et al., 2000; Holland et al., 1997; Stein et 
al., 1998a). It has also been shown that Racl, together with the adaptor protein Crk 
is required for cell spreading and membrane ruffling in human aortic endothelial 
cells treated with ephrin-B 1 (Nagashima et al., 2002). Crk involvement in this Racl- 
mediated process suggests the involvement of Dock 180, a newly discovered Racl 
GEF that associates with Crk (Brugnera et al., 2002; Cote and Vuori, 2002).
66
EphB activation, as well as inducing Racl activation, has also been shown to 
decrease Racl activity in intestinal epithelial cells (Batlle et al., 2002). It remains to 
be determined whether EphB receptors signalling is cell type dependent or if Racl 
inactivation is only transient, as has been shown to be the case downstream o f EphA 
receptors (Jumey et al., 2002).
In addition to a role for Racl and Cdc42 downstream from EphB receptors, there is 
evidence to suggest Rho A activation can occur downstream from EphB receptors. 
Xenopus Dishevelled has been shown to associate with EphB 1 and EphB2, probably 
through an SH2 domain-containing adaptor like Nek or Grb4, although this has not 
been determined, and is phosphorylated on tyrosine in cells where EphB2 is 
activated (Tanaka et al., 2003). Ephrin stimulation of EphB2 promotes activation of 
RhoA and ROCK, which is inhibited by dominant negative Dishevelled and 
contributes to the sorting of EphB2 expressing cells from ephrin-B 1 expressing cells 
in Xenopus animal cap assays. Another possible connection between EphB receptors 
and RhoA is through the GTPase-activating protein pl20RasGAP, which binds to 
activated EphB receptors and also associates with pl90RhoGAP (Holland et al., 
1997).
1.9.1.2 Rho GTPase activation downstream from EphA receptors
In neurons, RhoA activation is known to mediate growth cone collapse and inhibit 
axon regeneration (Dergham et al., 2002; Fournier et al., 2003; Lehmann et al.,
1999). In addition, Eph receptor activation has also been shown to regulate growth 
cone collapse (Cheng et al., 2003; Wahl et al., 2000). It is therefore not surprising 
that there is a functional link between Rho and Eph receptors. Stimulation of EphA 
receptors in cultured retinal ganglion cells (RGCs) with ephrin-A5 induces Rho- 
ROCK dependent growth cone collapse (Wahl et al., 2000). Interestingly, addition of 
ephrin-A5 also decreases the amount of active Rac, indicating that the activation 
state of both these GTPases is influenced by ephrin-A5. Decreasing Rac or Cdc42 
results in retraction of lamellipodia and filopodia, which could potentiate the 
repulsive signal (Jumey et al., 2002; Wahl et al., 2000). However, Racl activity is 
only transiently downregulated by ephrin-A ligands in cultured RGCs (Jumey et al.,
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2002). Resumption of Rac is actually necessary for reorganising actin filaments to 
the centre of the collapsing growth cone during ephrin-A2 induced growth cone 
collapse (Jumey et al., 2002), and for promoting actin polymerisation that drives 
membrane internalisation by endocytosis (Fournier et al., 2000).
Regulation of GTPases by Eph receptors to achieve the correct guidance response 
occurs via the activity GEFs and GAPs for Rho family proteins. In neurons, Ephexin, 
a GEF that activates RhoA and to a lesser extent Cdc42, binds constitutively to the 
kinase domain of EphA4 (Shamah et al., 2001). Binding to inactive EphA receptors 
may regulate the membrane localisation of Ephexin, and therefore RhoA and Cdc42 
activity, at sites of EphA receptor expression. The catalytic activity of Ephexin is 
increased upon EphA receptor activation, resulting in enhanced RhoA activation in 
cortical neurons. Concomitantly, Racl and Cdc42 activity are downregulated as 
described earlier in response to EphA activation in retinal neurons (Jumey et al., 
2002; Wahl et al., 2000). Ephexin is highly expressed in RGCs during the 
establishment of their topographical connections in the visual centres of the brain, 
suggesting a role in guiding these axons to their targets (Shamah et al., 2001).
An exchange factor closely related to Ephexin, and exclusively expressed in vascular 
smooth muscle cells, is Vms-RhoGEF. Like Ephexin, Vms-RhoGEF binds 
constitutively to EphA4 and mediates RhoA activation in rat vascular smooth muscle 
cells stimulated with ephrin-A 1-Fc (Ogita et al., 2003), resulting in actin stress fibre 
assembly, probably leading to vascular contractility. EphA4 overexpression does not 
substantially activate RhoA in HEK 293 cells unless Vms-RhoGEF is also expressed 
(Ogita et al., 2003), indicating that the ability to activate RhoA depends on the 
presence of this exchange factor. Interestingly, presenting ephrin-A 1 immobilised on 
a substrate rather than as a pre-clustered soluble protein, inhibits Racl, and this 
inhibition is critical for the morphological effects induced by immobilised ephrin-A 1 
in rat vascular smooth muscle cells (Deroanne et al., 2003). It has been shown that 
EphA4 phosphorylates Vms-RhoGEF upon ephrin-A 1 binding (Ogita et al., 2003), 
so regulation of these exchange factors may occur by tyrosine phosphorylation.
RhoA activity downstream from EphA receptors has also been demonstrated in non­
neuronal cells. Stimulation of EphA3 expressing 293T cells with ephrin-A5 causes
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activation of RhoA, leading to retraction of cellular protrusions, cell rounding and 
membrane blebbing. This effect appears to be mediated by the adaptor protein Crk 
(Lawrenson et al., 2002). In addition, stimulation of EphA expressing 293T cells 
with ephrin-A 1 also causes activation of RhoA, while concomitantly blocking 
chemokine-induced activation of Cdc42, which leads to an inhibition of chemotaxis 
(Sharfe et al., 2003). It is not known whether exchange factors are involved in the 
activation of RhoA in these instances.
Another possible link between EphA receptors and RhoA is via the phosphatase Shp- 
2. In PC-3 prostate epithelial cells Shp-2 is recruited to activated EphA2 (Miao et al.,
2000), and negatively regulates RhoA activation (Schoenwaelder et al., 2000).
1.9.2 Eph receptor regulation of cell-matrix adhesion
Integins are transmembrane heterodimers that link the extracellular matrix (ECM) to 
the cytoskeleton. Engagement of integrins by ECM proteins results in the recruitment 
of signalling molecules at sites of cell-matrix adhesion, and activation of so called 
“outside-in signalling”. Integrin-mediated adhesion can be influenced by intracellular 
signals and this is known as “inside-out” signalling. Eph receptors are known to 
regulate cell adhesion through integrins, and this can modify cell adhesion (Huynh- 
Do et al., 1999; Huynh-Do et al., 2002).
EphBl activation seems to result in an increase in integrin-mediated cell-matrix 
attachment. For example, EphBl signalling enhances a5Bl integrin-mediated cell 
attachment in transfected human kidney cells, and ayB3 integrin mediated attachment 
in endothelial cells endogenously expressing EphBl, a process which required 
EphBl kinase activity, recruitment of low molecular weight protein tyrosine 
phosphatase (LMW-PTP) and the SH2-SH3 adaptor protein Nek (Huynh-Do et al.,
1999). In addition, downstream activation of the Nck-interacting kinase (NIK) 
couples EphBl to activation of integrins and increased cell attachment (Becker et al.,
2000).
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Integrin-mediated increases in cell attachment have also been reported downstream 
from other Eph receptors. The EphA8 receptor, independently of tyrosine kinase 
activity, can localise the pllOy regulatory subunit of phosphatidylinositol 3-kinase 
(PI3Ky) to the plasma membrane, which has been shown to be required for integrin- 
mediated cell adhesion (Gu and Park, 2001). In addition, ephrin-A3 stimulation of 
EphA2 dendritic cells has recently been shown to result in an increase in betal 
integrin-mediated attachment to fibronectin (de Saint-Vis et al., 2003), and 
furthermore, overexpression of ephrin-B2 in B16 mouse melanoma cells results in 
constitutive activation of FAK, and a significant increase in betal-integrin-mediated 
attachment to the matrix (Meyer et al., 2005).
EphB 1 activation induces the formation of a protein complex composed of RasGAP 
and phosphorylated p62DOK, which can bind to and inactivate RasGAP (Becker et 
al., 2000; Kashige et al., 2000). Since RasGAP can downregulate R-Ras (Rey et al., 
1994) and R-Ras activity can be correlated with an increase in cell-matrix adhesion 
(Kinashi et al., 2000; Kwong et al., 2003), it is possible that EphB 1-mediated 
phosphorylation of p62DOK inhibits RasGAP, and the resulting increase in R-Ras 
activity leads to an increase in cell-matrix adhesion.
In contrast, decreased cell adhesion has been reported downstream from EphB2. 
Activation of EphB2 by multimerised ephrin-B 1, or by receptor overexpression, 
inhibits cell adhesion through phosphorylation of R-Ras, which suppresses the ability 
of R-Ras to support integrin activity (Zou et al., 1999), and binding of SHEP1 (SH2 
domain-containing Eph receptor-binding protein 1) provides a physical link between 
R-Ras and EphB2 (Dodelet et al., 1999). In addition, overexpression of EphB2 in 
glioma cells was recently found to result in reduced cell adhesion, mediated by R- 
Ras activation (Nakada et al., 2005). The involvement of the small GTPase R-Ras is 
not surprising since increased cell-matrix adhesion is known to occur upon activation 
of the small GTPase R-Ras and inhibition of R-Ras prevents cells from maintaining 
integrin-mediated attachment (Kinashi et al., 2000; Kwong et al., 2003).
Once again, decreased cell attachment as a consequence of Eph receptor activation is 
not restricted to one receptor. Activation of endogenous EphA2 in prostate 
carcinoma cells suppresses integrin-mediated spreading, migration and adhesion, by
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inducing dephosphorylation of focal adhesion kinase (FAK) and paxillin, which 
leads to reduced adhesion (Miao et al., 2000). FAK dephosphorylation is likely to be 
mediated by the phosphatase SHP2, which is recruited to EphA2 following ephrin- 
A1 stimulation (Miao et al., 2000). In addition, ephrin-B 1 stimulation of LS174T 
colorectal epithelial cells endogenously expressing EphB receptors inhibits integrin- 
mediated adhesion (Miao et al., 2005) Using 293 cells stably transfected with wild- 
type or kinase deficient EphB3 inhibition of integrin-mediated attachment was found 
to be kinase-dependent (Miao et al., 2005).
The decision as to whether signals downstream from Eph receptor/ephrin signalling 
result in an increase or decrease in cell-matrix attachment, seems to be mediated by 
the small GTPase R-Ras. Eph receptor activation of R-Ras, via p62DOK-mediated 
inhibition of RasGAP, increases integrin-mediated attachment via FAK and possibly 
PI3-kinase. In contrast, direct phosphorylation of R-Ras by Eph receptors inhibits 
FAK phosphorylation, and recruits SHP to dephosphorylate FAK, reducing integrin- 
mediated adhesion.
1.9.3 Other Eph receptor binding partners and influences
As detailed previously (1.3), Eph receptor-ligand binding results in receptor 
dimerisation and subsequent transphosphorylation by the kinase domains of the two 
receptors. Phosphorylation is known to occur on multiple tyrosine residues within the 
kinase domains of the receptor and these phosphorylated tyrosine residues serve as 
docking sites for the SH2 domain of many signalling proteins. Molecules known to 
bind to Eph receptors include the adaptors Grb7 (Han et al., 2002), GrblO (Stein et 
al., 1996), Nek and Crk (Hock et al., 1998a; Stein et al., 1998a), RasGAP, (Hock et 
al., 1998a; Holland et al., 1997), the Src family of non-receptor tyrosine kinases 
(Ellis et al., 1996; Zisch et al., 1998) and Abl (Yu and Bargmann, 2001). Work from 
our lab has recently implicated Abl family kinases in EphA receptor-mediated 
growth cone collapse (Harbott and Nobes, 2005). Abl is known to interact with other 
proteins implicated in Eph receptor signalling such as Src (Plattner et al., 1999), 
p62DOK and RasGAP (Yamanashi and Baltimore, 1997) and Crk (Feller et al., 
1994). In addition, many interactions with PDZ domain-containing proteins have
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been reported such as with AF6, TRK interacting protein, Pick I, Syntenin (Hock et 
al., 1998b). However, the physiological relevance of many of these interactions is 
unknown.
The role of Eph receptors and ephrins in blood vessel development has been 
discussed previously (see 1.4). Studies in endothelial cells have shed light on the 
downstream signalling pathways involved in the migration of endothelial cells. It is 
known that primary human microvascular endothelial cells, endogenously expressing 
EphB4, show a positive chemotactic response to ephrin-B2, and this response is 
blocked by inhibiting Src kinase activity (Steinle et al., 2002). Similarly, ephrin-B2 
stimulation of a cell line that endogenously expresses EphBl leads to a Src- 
dependent chemotactic response (Vindis et al., 2003). In both cell types Src becomes 
phosphorylated on tyrosine 416, which is indicative of Src tyrosine kinase activity 
(Kmiecik et al., 1988; Steinle et al., 2002; Vindis et al., 2003). EphBl and EphB2 
have been shown to interact with Src, and EphA4, EphA8 and EphB3 can all 
associate with the closely related tyrosine kinase Fyn (Choi and Park, 1999; Ellis et 
al., 1996; Hock et al., 1998a; Prevost et al., 2002). Cell migration mediated by 
EphB 1 and EphB2 in these systems was also shown to be dependent on the activities 
of MEK and PI-3 kinase respectively, and Src is required for activation of both of 
these pathways downstream of Eph receptor activation (Steinle et al., 2002; Vindis et 
al., 2003).
In addition to the regulation of Rho GTPases, Eph receptors and ephrins also regulate 
Ras family proteins (reviewed in Noren and Pasquale, 2004)). Both EphA and B 
receptors are known to negatively regulate H-Ras and its downstream MAP kinase 
pathway in a variety of cell types (Elowe et al., 2001; Miao et al., 2001; Nagashima 
et al., 2002). In addition, activation of MAP kinases occurs downstream from Eph 
receptors (Pratt and Kinch, 2003; Zisch et al., 2000). Activation of R-Ras and Rapl 
has also been shown as a result of Eph receptor activation (Nagashima et al., 2002; 
Zou et al., 1999).
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1.10 Regulation of repulsion versus adhesion
Evidence shows that Eph receptors can mediate both repulsion and adhesion, but the 
mechanisms by which this is possible are not well clarified. Eph/ephrin signalling 
can trigger both repulsive and adhesive responses in the same cells. Secondly, even 
though both Eph receptors and ephrins are membrane bound, and therefore require 
direct cell-cell contact for signalling to occur, they are able to mediate cell repulsion.
1.10.1 Endocytosis of EphB receptors and ephrin-Bs
EphB/ephrin-B signaling has been shown to result in cell repulsive events. An 
important question therefore was how two membrane-tethered proteins could result 
in cell-cell separation events, following high affinity binding of Eph receptor and 
ligand. Recent work from our lab has shown that Rac dependent trans-endocytosis of 
EphB-ephrin-B complexes is necessary for separation of cells following receptor- 
ligand interaction at sites of cell-cell contact (Marston et al., 2003). A recent study 
from Klein and colleagues has also proposed that bi-directional endocytosis of full- 
length Eph receptors and ephrins may be a mechanism allowing EphB/ephrinB 
dependent contact repulsion. They demonstrate that full-length receptors or ligands 
are transferred into the opposing cell and this removes the Eph/ephrin complex from 
the sites of cell-cell contact (Zimmer et al., 2003). It is possible that regulation of 
EphB receptor/ephrinB endocytosis will be an important modulator of Eph/ephrin 
attraction or repulsion.
1.10.2 Different splice forms of Eph receptors
One suggested explanation for the multiple signalling outcomes is that different 
splice forms of the receptor result in different effects. Different splice forms of 
EphA7 have been shown to ellicit different effects upon ephrin-A5 binding 
(Holmberg et al., 2000). In neuronal projections, ephrin-A5 null mice have revealed 
the importance of ephrin-A5 mediated repulsion for establishing the correct 
topography during neural development (Feldheim et al., 1998; Feng et al., 2000; 
Frisen et al., 1998; Vanderhaeghen et al., 2000). In addition, cells expressing ephrin-
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A5 induce a repulsive response to EphA7 (Holmberg et al., 2000). However, defects 
in cell adhesion were observed upon expression of an EphA7 splice variant lacking 
the tyrosine kinase domain, converting the response from a repulsive one into an 
adhesive one (Holmberg et al., 2000). Different splice forms of an Eph receptor can 
determine whether a cell responds to its ligand with repulsion or adhesion.
1.10.3 Cleavage of ephrin-As
A mechanism has recently been put forward to explain how membrane-tethered 
proteins can regulate cell-repulsion and axon withdrawal. It was found that EphA3 
stimulation of ephrin-A2 expressing neuroblastoma cells resulted in the shedding of 
the extracellular domain of ephrin-A2 into the medium (Hattori et al., 2000), and this 
cleavage was essential for cell-cell separation, and was mediated by the 
metalloprotease ADAMlO/kuzbanian (Hattori et al., 2000).
This finding, together with the discovery of a truncated isoform of ephrin-Al that 
inhibits cleavage of the full-length ephrin (Finne et al., 2004) suggests that regulation 
of ephrin-A cleavage may be important for switching between a repulsive and 
adhesive response. The constitutive association of ADAM 10 with ephrins raises the 
possibility that cleavage-independent receptor binding is also possible.
1.11 Aims
As described previously both Eph receptors and their ephrin ligands are membrane- 
bound. Therefore in order for signalling to occur direct cell-cell contact is required. It 
is well known that upon receptor-ligand binding a signal is generated through the 
receptor-bearing cell. However, more recently it has been shown that a signal can 
also be generated via the ligand-bearing cell, known as reverse signalling. Many 
downstream effects of both Eph and ephrin signalling have been described. 
However, much more is known about the signalling pathways downstream from the 
Eph receptors than their ligands the ephrins.
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Reverse signalling through ephrin-Bs has been described to play a role in many 
processes throughout development such as development of the blood (Heroult et al., 
2005) and lymphatic systems (Makinen et al., 2005), boundary formation (Mellitzer 
et al., 1999; Xu et al., 1999), and axon guidance in the visual system (Birgbauer et 
al., 2000; Birgbauer et al., 2001) and central nervous system (Henkemeyer et al., 
1996). The aim of this work was to investigate in vitro, using two model systems, 
(Swiss 3T3 fibroblasts exogenously expressing ephrin-B2, and HUAECs (Human 
Umbilical Arterial Cells) endogenously expressing ephrin-Bs), the morphological 
changes triggered as a result of ephrin-B activation by treatment with soluble pre­
clustered EphB receptors, and to dissect the signalling pathways involved 
downstream from the ephrin-B ligands. Since many of the effects observed as a 
result of EphB forward signalling are known to impinge directly on the actin 
cytoskeleton the role of ephrin-B signalling in actin cytoskeletal regulation and the 
potential involvement of the Rho family of GTPases, downstream from ephrin-B 
activation was investigated.
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Chapter 2
Materials and Methods
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2.1 Cell culture
2.1.1 Preparing glass coverslips
To ensure consistent results, glass coverslips were cleaned, to remove any residual 
detergent, and baked before use. 13mm diameter glass coverslips no. 1.5 (BDH) 
were washed in concentrated Nitric acid (BDH) in a 1L conical flask for lOmin, 
rinsed under running tap water for lOmin, then twice in distilled water and once in 
sterile water (Baxter). After a final wash in methanol (BDH), that prevents the 
coverslips sticking together during baking, coverslips were transferred to a glass petri 
dish and baked at 120°C for 4h to sterilise. For microinjection, coverslips were 
marked with a cross at their centre using a diamond pen prior to acid washing and 
baking. This facilitates the localisation of injected cells after staining. Swiss 3T3 
cells were plated directly onto glass coverslips. Unless otherwise indicated, HUAECs 
were seeded onto gelatin-coated coverslips (see 2.1.3).
2.1.2 Swiss 3T3 fibroblasts
2.1.2.1 Thawing cells
Swiss 3T3 fibroblasts were thawed from P7 stocks stored under liquid nitrogen. 15ml 
warmed Dulbecco’s modified Eagle’s medium (DMEM; Gibco), supplemented with 
10% Foetal Calf Serum (FCS; PAA Laboratories) plus penicillin (lOOU/ml) and 
streptomycin (lOOpg/ml) (Penicillin-Streptomycin liquid; Gibco) was added drop- 
wise to the defrosted cell suspension in an 80cm tissue culture flask (Nunc). Cells 
were incubated at 37°C, 10% CO2 for a minimum of 2h, medium changed to fresh 
DMEM/10% FCS to remove DMSO, and incubated as above until 80-90% 
confluent. If necessary cells were medium changed after 3-4 days.
2.1.2.2 Culture and passaging
Swiss 3T3 fibroblasts were grown in DMEM/10% FCS and passaged once the cells 
reached 80-90% confluency (3-4 days). Medium was aspirated and cells were
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washed twice with 3ml trypsin-EDTA (Gibco) then incubated with 0.5ml trypsin- 
EDTA for l-2min at room temperature. Following trypsinisation, 9.5ml warmed 
DMEM/10% FCS was added to inhibit trypsin and cells were dislodged by gentle 
tapping. Cells were re-plated at a 1:5 dilution onto 80cm2 flasks in DMEM/10% FCS 
and incubated at 37°C, 10% CO2 . Cells from passages 8-13 were used for 
experiments. Swiss 3T3 fibroblasts cultured beyond passage 13 increasingly showed 
signs of transformed colonies and were therefore not used for experiments.
2.1.2.3 Preparation of confluent, quiescent Swiss 3T3 fibroblasts
Cell number was estimated using a haemocytometer and cells were seeded on 13mm 
glass coverslips at high density, (5xl04 cells per well), in 4-well multiwell dishes 
(Nunc) with 1ml DMEM/4% FCS. Cells were incubated at 37°C, 10% CO2 for 7-10 
days without medium change, during which time they became confluent and 
quiescent. Quiescent cells characteristically form a confluent monolayer with 
adherens junctions, evenly spaced nuclei and no evidence of cell division. These 
cells retain some residual actin stress fibres (see Fig. 3.1).
For some experiments quiescent Swiss 3T3 cells were serum-starved overnight 
(16h). 50(uil of conditioned medium was removed from each well, centrifuged to 
remove dead cells and kept to one side. The remaining medium was replaced with 
950pl serum free medium (SFM; see 2.12) plus 50pl conditioned medium. Cells 
were incubated at 37°C, 10% CO2 . Serum-starved Swiss 3T3 fibroblasts display few, 
if any, actin stress fibres and a thin band of cortical actin around their periphery (see 
Fig. 3.9a).
2.1.3 Human Umbilical Arterial Endothelial Cells (HUAECs)
2.1.3.1 Thawing cells
HUAECs (TCS Cellworks) were supplied as frozen PI stocks, and stored under 
liquid nitrogen. One 80cm flask was coated with 5ml 1% gelatin (2% gelatin diluted 
50:50 with sterile H2O; Sigma) or 5ml attachment factor (gelatin based; TCS
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Cellworks) at room temperature for 2h. 30min prior to thawing cells the solution of 
gelatin/attachment factor was aspirated, and replaced with 19ml full medium made 
up of human endothelial serum free medium (Gibco), supplemented with 2% FCS, 
EGF (as manufacturers instructions), FGF (3p,g/ml) and an antibiotic supplement 
comprising Gentamicin (25p,g/ml) and Amphotericin (50p,g/ml) (large vessel 
endothelial cell growth supplement; TCS Cellworks). The medium was then 
equilibrated at 37°C, 5% CO2 . HUAECs were thawed in a 37°C water bath, added 
drop-wise to the equilibrated medium and incubated overnight. The following day, 
cells were medium changed to fresh full medium and left for 5 days, with a medium 
change to fresh full medium every 48h. PI cells were grown up, passaged to expand 
and re-frozen as P3 stocks (as described in 2.1.3.3).
2.1.3.2 Culture and passaging
HUAECs were cultured in full medium and passaged when cells reached 80-90% 
confluency (3-4 days). Medium was aspirated and cells rinsed once in 5ml buffered 
saline rinsing solution (TCS Cellworks), incubated with 3ml trypsin-EDTA (TCS 
Cellworks) for l-2min at room temperature to allow cells to detach and resuspended 
in 5ml trypsin blocking solution (TCS Cellworks). The cell suspension was then 
spun in a swinging rotor centrifuge at 1500rpm for 5min at 4°C. Supernatant was 
removed and cells resuspended in 10ml full medium. Cells were plated at a 1:4 
dilution onto gelatin/attachment factor coated 80cm flasks containing equilibrated 
medium, and medium changed every 48h. Alternatively cells were resuspended in 
10ml full medium as described for Swiss 3T3 fibroblasts (see 2.1.2.2) and plated as 
described above. HUAECs from passages 3-6 were used for experiments. After P6 
cells showed increasing signs of becoming senescent, indicated by increased size, 
flat morphology and multiple nuclei per cell (see Fig. 4.2).
For biochemistry 1.5-2.5ml HUAECs cell suspension, (approx 4.5-7.5 xlO5 cells), 
was plated onto 90mm dishes (Nunc) that had been coated with 4ml attachment 
factor for 2h at room temperature. Cells were incubated for 2-5 days at 37°C, 5% 
CO2 until the required cell density was reached. Cells were medium changed with 
full medium every 48h.
79
For cell biology, 60mm dishes (Nunc) containing 8 glass coverslips were coated with 
2.5ml 1% gelatin or attachment factor for 2h at room temperature. Cells were seeded 
at low density to obtain sub-confluent cells (1.25 x 105 cells per dish for use in 24h; 
0.625 x 105 cells for use in 48h) and at higher density (3 xlO5 cells per dish for use in 
48h) for confluent cultures. Cells were medium changed with fresh full medium 
every 24h.
It was necessary to serum-starve HUAECs for some experiments. HUAECs grown 
on coverslips and 90mm dishes were serum-starved overnight (16h). Medium was 
replaced with human endothelial SFM in the absence of growth factors and serum.
2.1.3.3 Freezing down cells
HUAECs were frozen down at passage 3. One 90% confluent 80cm2 flask gave 4 x 
lm l frozen stocks. Cells were trypsinised and resuspended in 4ml DMEM 
supplemented with 50% FCS at 4°C. Dimethyl sulfoxide (DMSO; Sigma) was added 
drop-wise to 10% on ice with gentle mixing and lml suspension aliquoted per 
cryotube (Nunc). Cryotubes were frozen upright at -20°C overnight and transferred 
to -80°C for up to one week, with long-term storage in liquid nitrogen.
2.2 Cell microinjection
Typically expression plasmids (see Table 2.1) were microinjected at a concentration 
of 200pg/ml. DNA (prepared using Qiagen maxi-prep protocol) was diluted in sterile 
filtered PBS-A and injected together with dextran as a marker, (generally biotin 
dextran [2mg/ml; Molecular Probes]). Solutions to be injected were spun down at 
13,000rpm for 5min in order to pellet any debris.
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Table 2.1 Expression plasmids used for microiniection
Expression Plasmid Source
pRK5
ephrin-B2
Truncated ephrin-B2 
5Y-F ephrin-B2 
ephrin-B2AV 
dn Grb4 
C3 Transferase
Nobes Lab
Ralf Adams (CRUK, London, UK)
Ralf Adams (CRUK, London, UK)
Tony Pawson (Toronto, Canada)
Ralf Adams (CRUK, London, UK)
Mark Henkemeyer (UT South Western, Texas) 
Nobes Lab
For microinjection, cells grown on coverslips were placed in the centre of a 60mm 
dish containing 4ml equilibrated medium, placed on the heated stage of an inverted 
microscope (Axiovert 200M; Zeiss) and viewed with 5x, 20x and 40x phase contrast 
air objectives. Cells were maintained at 37°C in an enriched CO2 environment. Boro- 
silicate needles (Harvard apparatus) were pulled with a horizontal needle puller 
(Suter P-97) and DNA was injected under constant pressure, typically 50-200hPa. 
Cultures were replaced in a humidified tissue culture incubator at 37°C, 5%-10% 
CO2 (cell type dependent) for 2-2.5h, to allow for expression of the injected plasmid. 
Injections were carried out using the 40x air objective. The cross in the centre of the 
coverslip can be used to help re-locate the cells after staining, (see Fig. 2.1 for an 
overview of the microinjection apparatus).
Swiss 3T3 cells were microinjected in 4ml serum free medium at 37°C, 10% CO2 . 
Typically each coverslip would be injected for 15min allowing 100-150 cells to be 
injected. HUAECs were microinjected in 4ml full medium at 37°C, 5% CO2 , for a 
maximum of lOmin per coverslip, after which cell morphology changes occurred. 
This allowed 50-70 cells per coverslip to be injected.
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Figure 2.1 M icroinjection A pparatus
A Incubator on top of a heated stage
B Zeiss Inverted Microscope
C Micro-manipulator
D Femtojet pump
E CO2 Controller Box
F Temperature Controller Box 
G Injector Arm
c -F
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2.3 Immunocytochemistry
Coverslips were removed from their wells, washed in PBS-A, and placed on 
pedestals (plastic tube tops) glued to plastic 90mm tissue culture dishes. Cells were 
fixed for lOmin with 4% formaldehyde (TAAB) in cytoskeletal buffer (see 2.12). In 
some cases 0.2% gluteraldehyde (Sigma) was included if antibody staining 
permitted. For staining of intracellular proteins, cells were incubated with 0.2% 
Triton X-100 (Sigma) for 5min. Free formaldehyde and aldehydes were quenched by 
addition of 0.5mg/ml sodium borohydride (Sigma). Cells were incubated with 
primary antibodies for 45min-lh and binding detected by incubation with fluorescent 
secondary antibodies for 30-45min. F-actin in retraction fibres and stress fibres was 
visualised using FITC- or TRITC-conjugated phalloidin alone or included with 
secondary antibodies. Coverslips were mounted onto glass slides using Mowiol 
containing phenylenediamine as an anti-fade agent (see 2.12). Cells were washed in 
between each stage with PBS-A and all dilutions were carried out in PBS-A unless 
otherwise stated. All incubations were at room temperature. See 2.13 for details of 
antibodies, suppliers and dilutions.
2.3.1 Concanavalin A staining
Concanavalin A (Con A) is a lectin that binds to carbohydrate moieties on the 
surface of cells. Con A binding was used as an alternative to fluorescent phalloidin, 
to detect retraction fibres that are revealed more clearly with a membrane marker 
than with an F-actin marker. Cells were fixed as above, in 4% formaldehyde with 
0.2% gluteraldehyde that preserves cell processes better than formaldehyde alone, in 
cytoskeletal buffer for lOmin. This was followed by incubation with biotinylated 
succinylated Con A (20p,g/ml; Vector Labs) for lh. Cells were then incubated with 
Vectastain solution (prepared according to manufacturers instructions; Vector labs) 
for 30min. This solution consists of an avidin and biotinylated horseradish 
peroxidase macromolecular complex (ABC) that binds to biotinylated Con A, and 
due to the extraordinarily high affinity of avidin for biotin is essentially irreversible. 
Horseradish peroxidase is then visualised by the development of a peroxidase 
substrate (in this case DAB; 3,3’-diaminobenzidine) that produces a colour. Cells
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were transferred to 4-well multiwell dishes containing at least 500pl of filtered DAB 
solution (prepared according to manufacturer’s instructions; Vector Labs). DAB 
undergoes an oxidation reaction in the presence of hydrogen peroxide, producing a 
brown colour reaction. Cells were incubated in the dark until they turned grey-black 
(achieved by adding nickel chloride when the DAB solution is prepared), which was 
typically up to lh, and mounted as above in Mowiol. Cells were washed with PBS-A 
after each stage.
2.4 Swiss 3T3 loss of cell-cell contact assay
Cells were seeded onto glass coverslips in DMEM/4%FCS as described. Post­
microinjection cells were left to express ephrin-B2 or mutant constructs (see Table 
2.1) for 2h before treatment with pre-clustered EphB2-Fc (R&D). Receptor bodies 
were pre-clustered at 37°C with anti-human IgG (R&D) at a 1:10 ratio (1 jxg of 
EphB2-Fc and 10p,g of IgG per ml) for 20min before treatment. Cells were incubated 
with pre-clustered receptor bodies for up to 2h, fixed and stained for ephrin-B2 and 
F-actin. For some experiments cells were pre-treated with bFGF. In this instance, 
cells were serum-starved 16h prior to microinjection (2.1.2.3). 1.5h post-injection 
cells were treated with 20ng/ml bFGF (R&D), left for 30min and stimulated with 
pre-clustered EphB2-Fc (lp,g/ml) as described. After stimulation, cells were fixed 
and stained to detect injection marker, ephrin-B2 and F-actin (see 2.3). The number 
of expressing cells losing contact with their neighbours within the monolayer was 
then analysed. A cell was scored to have lost cell-cell contact if more than 40% of 
the cell circumference had lost contact with the cell monolayer.
2.5 HUAEC retraction assay
Sub-confluent HUAECs grown on coverslips were removed from 60mm dishes, 
transferred to 4-well multi well dishes and left for a minimum of 30min. For some 
experiments cells were serum-starved (16h) prior to stimulation (2.1.3.2). Cells were 
stimulated with pre-clustered EphB4-Fc (5jig/ml; R&D) for up to 30min. EphB4-Fc 
was pre-clustered with anti-human IgG (1.78pg/ml) at a 2:1 molar ratio of EphB4- 
Fc:IgG at 37°C for 20min prior to stimulation. Cells treated with EphB4-Fc were
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fixed and stained for F-actin or Concanavalin A (see 2.3). Retracted cells were then 
counted. Retracted cells were defined as those displaying retraction fibres, those that 
had rounded and those with surface blebs The proportion of retracted cells displaying 
membrane blebbing was also counted separately. For some experiments cells were 
microinjected with mutant ephrin-B2 constructs, or other expression constructs (see 
Table 2.1) before EphB4-Fc stimulation.
2.6 Statistical Analysis
All error bars represent ± the standard error of the mean for that data set. Data was 
analysed using the software package GraphPad Instat (GraphPad Software Inc., CA, 
USA). Where only two data sets were compared to each other the students two-tailed 
T-test for unequal variance was used, represented as a P  value. In order to test 
whether multiple conditions were significantly different from each other it was not 
appropriate to use the students T-test since multiple tests on the same data would 
have been necessary, which increases random error. Therefore a one-way analysis of 
variance (ANOVA) was performed where more than two groups were compared 
(result shown as an ANOVA P  value). This allowed comparisons across groups of 
data and was followed by the Tukey-Kramer multiple comparisons test which was 
used to determine significant differences between individual groups of data, (result 
shown as a P  value). P  values of less than 0.05 were considered to be significant. 
Asterisks on graphs were used to denote the following: * P  < 0.05; **P < 0.01; ***p 
< 0.001; ns = not significant
2.7 Pharmacological inhibitors
Both the Swiss 3T3 loss of cell-cell contact assay and the HUAECs retraction assay 
were manipulated using a range of pharmacological inhibitors to help dissect the 
signalling pathways involved. Inhibitors were also used during phase time-lapse 
microscopy (see 2.11.1). Table 2.2 details the inhibitors used.
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Table 2.2 Range of pharmacological inhibitors used
Inhibitor Blocks Supplier Diluted in Final conc.
Y27632
Biebbistatin
SP600125
U0126
PP2
SU6656
Rho kinase 
Myosin II ATPase 
JNK
MAP kinase kinase (MEK1 & MEK2) 
Src family kinases 
Src family kinases
Welfide Corp. 
Tocris 
Tocris 
Tocris 
Calbiochem 
Calbiochem
Water
DMSO
DMSO
DMSO
DMSO
DMSO
20pM
lOOpM
30pM
20pM
lOpM
5uM
2.8 Stripe assay
The stripe assay is a choice assay. It was originally developed to test the repulsive or 
attractive effects of axon guidance molecules such as the ephrins in the retinotectal 
system (Vielmetter et al., 1990; Walter et al., 1987). Cells are given the option of two 
substrates over which to migrate (or adhere). The substrates are laid down in stripes 
using specially developed silicon matrices containing flow channels; upon injection 
of fluid into these lanes, non-specific adsorption of proteins to the glass coverslip 
occurs. Where the coverslip is apposed to the matrix adsorption cannot occur. Once 
the coverslip is removed from the matrix, a second solution is applied to coat those 
areas previously hidden and create the second stripe. The first stripe formed is 50pm 
in width; the second stripe is 40pm wide. A variation of a published protocol 
(Eickholt et al., 1999) was used to prepare the stripes for HUAEC migration 
experiments and the protocol was developed and carried out by Iwan Evans 
(laboratory of Dr. Catherine Nobes). Stripes were patterned onto acid-washed glass 
coverslips (the protocol is summarised in Table 2.3), and HUAECs required no 
additional extracellular matrix adsorption. Pre-clustered EphB4-Fc (lOpg/ml) was 
injected into the channels and the coverslip incubated at 37°C for 45min, followed by 
a blocking step with BSA (2mg/ml) and incubation at 37°C for 15min. A more dilute 
(1:5) pre-clustered Fc solution was then applied to the whole coverslip to form the 
second (narrower) set of stripes followed by incubation at 37°C for lh. More dilute 
solutions are applied to the coverslips in an attempt to equalise adsorption in the first 
and second sets of stripes (smaller volumes of solution come into contact with the 
first set of stripes). This is followed by a second blocking step with BSA (2mg/ml) 
and incubation at 37°C for 15min. In order to make control stripes the pre-clustered 
EphB4-Fc solution is replaced with pre-clustered Fc solution. The first stripes
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(50nm) were imaged via staining for the antibody clustering EphB4-Fc (Eph/Fc 
stripes) or Fc (Fc/Fc stripes).
Table 2.3 Method used to prepare stripes
Method Stripes for HUAECs
Step 1 
1st injection 
(1st stripes - 50pm )
50pl of PBS containing 10 pg/ml EphB4-Fc 
pre-clustered in a ratio of 2:1 of 
EphB4-Fc dimers:Rabbit anti Human IgG 
45 min, 37°C
Step 2 (2nd injection) lOOpl BSA block (2mg/ml in PBS) 15min 37°C
Step 3 (3rd injection) lOOpl PBS flush
Step 4 remove from matrix
Step 5 PBS wash x2 (lOOpl)
Step 6 
1st Treatment 
(2nd stripes - 40pm)
pre-clustered Fc at same molarity 
as lOpg/ml EphB4 - clustered with 
Goat anti Human IgG, then diluted 1:5 (lOOul) lh 37°C
Step 7 PBS wash x2 (lOOul)
Step 8 (2nd treatment) BSA block (2mg/ml in PBS) 15min 37°C
Step 8 PBS wash x2 (lOOpl) then left 30' with 
media in incubator before cells plated
Detection Goat anti Rabbit cy3
Reference modified from Eickholt et. al., 1999
HUAECs were plated onto the striped coverslips following trypsinisation as 
described previously and left overnight to adhere and migrate. The following day the 
coverslips were fixed and stained to detect the stripes, as described, and F-actin of 
HUAECs using FITC-conjugated phalloidin. The percentage of cells adhering to the 
coverslip on and off the red (50pm) stripes was then calculated.
2.9 Molecular biology techniques
2.9.1 Transformation and purification of DNA expression constructs
For bacterial transformation l-3pl DNA was added to 50pl DH5a competent cells 
(Gibco), and the tube gently tapped to mix. Cells were incubated on ice for 30min, 
heat shocked at 37°C for 20sec and then placed on ice for 2min. 950pl SOC medium 
(Gibco) was added and cells incubated at 37°C with shaking for lh. After
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expression, a range of dilutions were plated onto LB agar plates containing the 
relevant antibiotic supplement and incubated at 37°C overnight.
5ml LB Broth with the relevant antibiotic selection was inoculated with a single 
transformed colony and incubated overnight at 37°C with shaking. The culture was 
then taken through the Qiagen mini-prep protocol as per the manufacturer’s 
instructions to purify DNA.
In order to purify a larger quantity of plasmid DNA, 100ml LB Broth with the 
relevant antibiotic selection, was inoculated with lOOpl of the relevant mini-prep (or 
starter culture if no mini-prep was done) and incubated overnight at 37°C with 
shaking. The culture was then taken through the Qiagen maxi-prep protocol as per 
the manufacturer’s instructions. Constructs were verified by restriction enzyme 
digest and the OD at 260nm measured to give the DNA concentration.
For Rho pull downs 2p,l GST-RBD DNA (Rhotekin Rho binding domain in the 
pGEX-2T vector; 1 mg/ml stock; a kind gift from Dr. Harry Mellor) was added to 
200p,l pLysBL21 competent cells (a kind gift from Dr. Harry Mellor). Cells were 
incubated on ice for 30min, heat shocked at 42°C for 45sec and placed on ice for 
2min. 0.5ml LB was added and cells incubated at 37°C for 45min with shaking. 
300^1 cells were plated onto an LB agar plate and a 1:10 dilution plated onto a 
second plate. Ampicillin (100p,g/ml; Sigma) and Chloramphenicol (34p,g/ml; Sigma) 
selection was used and the plates incubated at 37°C overnight.
2.10 Biochemical techniques
2.10.1 Cell lysis
2.10.1.1 Swiss 3T3 fibroblasts
Cells were washed in cold Tris buffered saline (TBS; see 2.12) and lysed in RIP A 
buffer (see 2.12) on ice. Cells were dislodged with a cell scraper (Falcon) and the
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lysates were transferred to 1.5ml eppendorfs, and spun down at 13,000rpm for lOmin 
at 4°C, to pellet any cell debris. The supernatant was transferred to a new tube and 
passed through a 19G needle 4 times. 20pl lysate was removed for protein estimation 
(carried out using the Bio-rad Dc protein assay system; as per the manufacturers 
instructions). An equal volume of 2 x Laemelli sample buffer (Sigma) was added to 
the remaining supernatant and boiled for 5min at 100°C. For the best results samples 
were used immediately, although it was possible to store samples at -20°C for use at 
a later date.
2.10.1.2 HUAECs
For ephrin-B, MYPT1 and ROCK blots, HUAECs were lysed directly into 0.5-lml 
warm lxNupage non-reducing sample buffer (Invitrogen) plus 40mM DTT 
(dithiothreitol; Sigma). Following scraping cell lysates were transferred to 1.5ml 
eppendorfs. The lysates were very viscous and were passed through a 19G needle 4 
times, followed by centrifugation at 13,000rpm for lOmin. The supernatant was then 
transferred to a new 1.5ml eppendorf and boiled for 5min at 100°C. Samples were 
run on SDS-PAGE gels immediately but could be stored at -20°C for use at a later 
date.
For Rho pull downs cells were lysed in 800pl lysis buffer (see 2.12). After cell 
scraping, lysates were transferred to 1.5ml eppendorfs and put through a 19G needle 
4 times, then centrifuged at 13,000rpm for lOmin at 4°C. Supernatants were removed 
to fresh tubes and a 20pl aliquot taken for a total Rho protein determination by 
western blotting. 40pl lxNupage non-reducing sample buffer + 40mM DTT was 
added and the samples heated to 100°C for lOmin before being stored on ice until 
loaded. The remaining 780\i\ was kept on ice to be used for Rho-GTP determination 
(see 2.10.3.3).
2.10.2 SDS-PAGE and western blotting
SDS-polyacrylamide gels (see 2.12) were poured by hand. The percentage gel varied 
with the molecular weight of the protein of interest: high molecular weight proteins
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(such as MYPT1) required an 8% gel; mid-range molecular weight proteins, (such as 
ephrin-Bs) required a 10 or 12% gel; low molecular weight proteins (such as Rho) 
required a 15% gel. Proteins were run in running buffer (see 2.12) in the Mini- 
PROTEAN 3 system (Bio-Rad). Typically protein was run through the stacking 
portion of the gel at 100V and the voltage then increased to 150V for l-1.5h until an 
adequate separation of rainbow markers (Amersham) was seen. Protein was then 
transferred to a methanol-pre-treated PVDF membrane (Amersham) at 100V for 2h 
in transfer buffer (see 2.12) using Mini Trans-Blot Electrophoretic Transfer Cells 
(Bio-Rad).
PVDF membranes were blocked overnight at 4°C (or lh at room temperature) in 
Superblock (Perbio). 5% BSA (Sigma) was used as a blocking agent specifically 
when detecting phosphoMYPTl Thr850 and Thr696. Primary antibodies were 
diluted in TBS-Tween (see 2.12) with Superblock or 5% BSA added at a dilution of 
1:5. The filter was incubated for 60-90min at room temperature in primary antibody 
and washed in TBS-Tween (3xl5min washes). HRP-conjugated secondary 
antibodies, diluted in TBS-Tween with Superblock or 5% BSA added at a dilution of 
1:10, were then applied for 45min at room temperature. After 3xl5min TBS-Tween 
washes the protein bands were revealed using SuperSignal W est Pico 
Chemiluminescent Substrate (Pierce) to detect bound HRP. Luminescence was 
detected using CL-Xposurefilm (Pierce). For details of antibodies and dilutions see 
2.13.
PVDF membrane could be stripped to enable re-probing. This involved 2x25min 
washes with ImmunoPure IgG elution buffer (Pierce). Following stripping the filter 
must be washed in TBS-Tween and re-blocked as described above before re-probing 
can be done.
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2.10.3 Rho GTPase pull down assay
2.10.3.1 Purification of GST-RBD
100ml LB Broth (100p,g/ml Ampicillin; 34pg/ml Chloramphenicol) was inoculated 
with a single colony of GST-RBD and incubated overnight at 37°C with shaking. 
The bacterial culture was then diluted 1:20 in fresh LB Broth (100p,g/ml Ampicillin) 
and grown to OD600=0.7 (about 1.75h). Protein expression was induced with IPTG 
(isopropyl-p-D-thiogalactopyranoside; Calbiochem) at a final concentration of 
0.5mM and the culture incubated for a further 2h at 30°C with shaking. Cultures 
were collected by centrifugation at 3000rpm in 50ml tubes (Falcon), the supernatant 
was discarded and the pellets stored at -80°C until the next phase of the assay was 
undertaken.
Pellets from 300ml (6 x 50ml falcons) of culture were used per experiment, enough 
for 8 samples. All six pellets were resuspended in 4.5ml ice-cold STE buffer (see 
2.12) with ImM PMSF (phenylmethylsulphonyl fluoride; Amersham) and 
homogenised with a 19G needle (~8 passes). lOO^ig/ml lysozyme (Sigma), dissolved 
in 500pl STE buffer prior to use, was added and the suspension mixed (rocked by 
hand 6-7 times), and incubated on ice for 15min. 5mM DTT was then added and the 
suspension mixed (rocked by hand 6-7 times). Tween-20 (Amersham) to a final 
concentration of 1% and SDS (Sigma) to a final concentration of 0.03% were then 
added and the suspension mixed (rocked by hand 8-10 times). The suspension was 
aliquoted into 1.5ml eppendorfs and centrifuged at 14,000rpm for 30min at 4°C. 
Supernatant was transferred to a clean 15ml tube and 150pl prewashed (with cold 
STE buffer) glutathione sepharose beads (Amersham) were added to bind GST- 
RBD, followed by incubation for lOmin at room temperature with gentle rocking. 
The suspension was then centrifuged at 2000rpm for 3min at 4°C to pellet the beads. 
Beads were washed with ice-cold STE buffer 3 times (spun at 2000rpm for 2min at 
4°C), and resuspended in 120jxl STE buffer (total volume about 200p,l). For 
determination of protein loading on beads, lOpl of beads were removed and an equal 
volume of 1 x Nupage non-reducing sample buffer + 40mM DTT added. This was 
used to estimate the amount of protein loaded on the beads by coomassie staining
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(see 2.10.3.2). The bead preparation was stored on ice until cell lysates were 
prepared (typically lh).
2.10.3.2 Coomassie staining for protein
Samples of bacterial culture pre- and post-IPTG induction, together with a sample of 
the GST-RBD bead preparation and BSA protein standards, were run on a 15% SDS- 
PAGE gel for lh 15min at 150V. The gel was then incubated with 15ml filtered 
coomassie stain (see 2.12). Incubation ranged from a couple of hours to overnight 
with rocking. After staining the gel was washed in coomassie de-stain (see 2.12) 
until all protein bands were clearly visible. The gel could now be dried in a gel 
drying system (Sigma). The gel was incubated in equilibration buffer (see 2.12) for a 
minimum of 30min with rocking, placed between two sheets of cellophane in the gel 
drying apparatus (Sigma) and left overnight until free of moisture. The amount of 
protein on the beads and the extent of IPTG induction were estimated by comparing 
to the known BSA standards (see Fig. 5.6).
2.10.3.3 Rho Pull down
In order to determine changes in the amount of cellular Rho-GTP during pre­
clustered EphB4-Fc induced retraction of HUAECs the Rho pull down assay was 
used (method modified from Ren and Schwartz, 2000). Approximately 25pi (30- 
40pg) GST-RBD beads were added to each cleared lysate and samples rotated at 4°C 
for 45 min. The beads were then washed four times (in a microfuge at 5000rpm for 
20sec at 4°C) with 600pl cold Tris buffer (see 2.12). After the last wash the Tris 
buffer was removed carefully, 30pl hot 1 x Nupage non-reducing sample buffer + 
40mM DTT added to elute and all samples heated to 100°C for lOmin. The entire 
volume of Rho-GTP beads was loaded (samples were spun briefly before loading to 
ensure accuracy). Samples were then run alongside a 15pl aliquot of the 20pl sample 
mixed with sample buffer taken prior to the pull down (see 2.10.1.2). This was 
loaded as a measure of total Rho levels, (although volumes of lysates were measured 
after lysis and loading adjusted accordingly), on a 15% SDS-PAGE gel as described 
in 2.10.2. For antibody details see 2.13.
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2.11 Image acquisition
2.11.1 Phase time-lapse microscopy
A coverslip of sub-confluent HUAECs was placed in a 35mm glass-bottomed dish 
(World Precision Instruments) containing 1.5ml full medium ± inhibitors (such as 
Y27632 or SP600125) on the heated stage of an inverted microscope (Axiovert 
200M; Zeiss) and viewed using either 20x or 40x objectives. Cells were stimulated 
by the addition of 500pl medium containing appropriate stimulant to the dish. Cells 
were maintained at 37°C, 5% CO2 throughout. Time-lapse images were collected 
using a Hamamatsu camera and Openlab software (Improvision). Movies were 
collected one frame every 15sec and generally recorded over a period of lh.
2.11.2 Confocal microscopy
Fluorescent images were obtained using either a Leica upright microscope or a Leica 
DMIRE2 inverted microscope, and images acquired using a Leica AOBS SP2 
confocal imaging system. Images were taken with the 40x and 60x oil immersion 
objectives. Lasers used: Argon for FITC; Krypton-Argon for TRITC, Cy3 and Texas 
Red; Ultra violet for Alexa-350. Images were processed using the Leica confocal 
software and Adobe Photoshop.
2.11.3 Wide-fleld microscopy
Images were acquired using a Zeiss Axioplan II microscope with a Hamamatsu 
(ORCA-ER) camera. Oil immersion 40X Plan-Neofluar (NA 1,3) objective or an oil 
immersion 63X Plan Neofluar (NA 1,25) objective were used. For the stripes 
however a 10X Acroplan (NA0,25) air objective was used.
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2.12 Media and Solutions
Serum Free Medium
DMEM Powder 
Sodium Bicarbonate 
Pen/Strep 
Sodium Pyruvate
3.34g
0.5g
2.5ml
2.5ml
Make up to 250ml with distilled water and filter sterilise. 
Store in incubator at 37°C with the lid loose.
Cytoskeletal Buffer
MES (pH 6.1)
KC1
MgCl
EGTA
Sucrose
lOmM
125mM
2mM
2mM
10%
For Fix:
Formaldehyde
Gluteraldehyde
4%
0.2% (optional)
Mowiol
Glycerol
Mowiol
Tris HCL pH 8.5-8.8 
Phenylenediamine
25%
10%
0.1M
2 crystals per 5ml aliquot
Store in 50pl aliquots at -80°C 
Light sensitive
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RIPA Buffer (Lysis buffer)
Tris, pH 7.4 
NaCl
Triton X-100
Sodium Deoxycholate
SDS
Glycerol
EDTA
NaF
NaV03
Complete Protease Inhibitor tablet 
PMSF*
Make up fresh for every experiment. 
* Add immediately prior to lysis.
TBS
Tris pH 7.4 
NaCl
Make up to 1L with water 
Store at 4°C
TBS-Tween
20mM Tris pH 7.4 
150mM NaCl 
Tween 20
Make up to 1L with water 
Store at 4°C
20mM
125mM
1%
0.5%
0 . 1%
10%
5mM
50mM
0.5mM
1 tablet per 100ml 
lOOpg/ml
20mM
150mM
20mM
150mM
0 . 1%
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Polyacrylamide Gels
Resolving gel 05m l)
8% 10% 12% 15%
30% acrylamide mix 4000ul 5000ul 6000ul 7500ul
1.5M Tris pH 8.8 3800ul 3800ul 3800ul 3800ul
10% SDS 150ul 150ul 150ul 150ul
10 % APS 150ul 150ul 150ul 150ul
TEMED 9ul 6ul 6ul 6ul
UP Water 6900ul 5900ul 4900ul 3400ul
Stacking gel (4ml)
30% acrylamide mix 670ul
1.5M Tris pH 6.8 500ul
10% SDS 40ul
10 % APS 40ul
TEMED 4ul
UP Water 2700ul
Running Buffer (lOx)
250mM Tris 250mM
1.92M Glycine 1.92M
1% SDS 1%
Make up to 1L in Water
For lx dilute 1 in 10 in water
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Transfer Buffer (lOx)
480mM Tris 480mM
390mM Glycine 390mM
0.37% SDS 0.37%
Make up to 1L in water
For lx use 100ml lOx plus 200ml methanol plus 700ml water 
Coomassie Stain
Methanol 40%
Acetic acid 7%
Coomassie Blue 0.25%
Distilled Water 52.75%
Coomassie De-stain
Methanol 10%
Acetic Acid 10%
Distilled Water 80%
Equilibration Buffer
Ethanol 20%
Glycerol 10%
Distilled Water 70%
STE Buffer:
Tris, Ph 8.0 lOmM
NaCl 150mM
EDTA ImM
Make up in distilled water
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Lysis Buffer (Rho Pull Down)
Tris pH 7.2 50mM
Triton X-100 1%
SDS 0.1%
NaCl 500mM
MgC12 lOmM
Aprotinin lOug/ml
Leupeptin lOug/ml
PMSF ImM
Make up in distilled water
Tris Buffer (Rho Pull Down)
Tris pH 7.2 50mM
Triton X-100 1%
NaCl 150mM
MgC12 lOmM
Aprotinin lOug/ml
Leupeptin lOug/ml
PMSF ImM
Make up in distilled water
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2.13 Antibodies
2.13.1 Primary Antibodies
Primary antibody Species Supplier ICC* dilution WB* dilution
ephrin-B 1 Rabbit Zymed 1:100 1:1000
ephrin-B2 Goat R & D 1:150 1:1000
ephrin-B2 Rabbit Aviva 1:100 1:1500
ephrin-B3 Rabbit Zymed 1:100 1:1000
Myosin Phosphatase Rabbit Covance N/A 1:2000
Phospho MYPT1 Thr 696 Rabbit Upstate N/A 1:1500
Phospho MYPT1 Thr 850 Rabbit Upstate N/A 1:1500
RhoA Mouse Santa Cruz N/A 1:1000
ROCK I Mouse BD Transduction Labs N/A 1:250
ROCK II Mouse BD Transduction Labs N/A 1:1000
13-catenin Mouse BD Transduction Labs 1:100 N/A
Myc Mouse Serotec 1:200 N/A
Paxillin Mouse Zymed 1:50 N/A
N.B. EphB-Fcs were used as primary antibodies to ephrin-B ligands in fixed cells at a dilution of 
1:100 (stock = 200ug/ml)
* ICC = Immunocytochemistry 
WB = Western Blot
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2.13.2 Secondary Antibodies
species antibody fluorophore supplier diluted in dilution
donkey anti goat Cy3 Stratech PBS-A 1 300
donkey anti goat FITC Stratech PBS-A 1 200
donkey anti goat Texas Red Stratech PBS-A 1 200
donkey anti human FITC Stratech PBS-A 1 200
goat anti human Cy3 Stratech PBS-A 1 300
donkey anti mouse FITC Stratech PBS-A 1 200
donkey anti mouse Cy3 Stratech PBS-A 1 200
goat anti mouse FITC Stratech PBS-A 1 200
donkey anti mouse FITC Stratech PBS-A 1 200
donkey anti rabbit FITC Stratech PBS-A 1 200
donkey anti rabbit Texas Red Stratech PBS-A 1 200
donkey anti rabbit TRITC Stratech PBS-A 1 200
donkey anti rabbit HRP Stratech PBS-A 1:30,000
donkey anti goat HRP Stratech PBS-A 1:30,000
goat anti mouse HRP Stratech PBS-A 1:30,000
streptavidin (binds biotin) Alexa350 Molecular Probes PBS-A 1:200
phalloidin (binds F-actin) FITC Sigma PBS-A 1:200
phalloidin (binds F-actin) TRITC Sigma PBS-A 1:500
DAPI (binds DNA) / Sigma Water 1:10,000
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Chapter 3
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Clustering of ephrin-B2 
expressed in Swiss 3T3 
fibroblasts causes loss of 
cell-cell contact
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3.1 Introduction
Eph receptor/ephrin signalling has been shown to mediate both repulsive and 
attractive cell migrations in developing and adult tissues, and due to the membrane 
bound nature of both receptors and ligands, Eph receptor/ephrin activation requires 
direct cell-cell contact between receptor and ligand expressing cells. Signalling is bi­
directional; both Eph receptors and ephrin ligands are capable of sending and 
receiving a signal.
Eph/ephrin signalling has been shown to influence many developmental processes 
including neural crest cell migration, tissue boundary formation, axon guidance and 
angiogenesis. For example, segmental expression of ephrins in the somites is thought 
to guide early trunk neural crest cell migration (Krull et al., 1997; Wang and 
Anderson, 1997). In addition, Eph/ephrin signalling is responsible for the restriction 
of cell intermingling during hindbrain segmentation (Mellitzer et al., 1999; Xu et al., 
1999), and, more recently, has been implicated in the migration and adhesion of cells 
involved in the septation of the urorectal region (Dravis et al., 2004). Signals 
mediated by Eph receptors and ephrins also plays many roles throughout axon 
guidance. One of the most widely used models to study this is the projection of 
retinal axons to the midbrain. Eph receptors and ephrins have been shown to function 
as guidance molecules, vital for correct topographic mapping to occur (reviewed in 
Flanagan and Vanderhaeghen, 1998; Huber et al., 2003; O'Leary and Wilkinson, 
1999). Furthermore, Eph receptors and ephrins also function to regulate blood vessel 
development throughout angiogenesis (reviewed in Adams and Klein, 2000; Cheng 
et al., 2002a). For example, EphB4 and ephrin-B2 play a role during the specification 
of arteries and veins (Wang et al., 1998). Ephrin-B signalling is known to regulate 
the actin cytoskeleton and cell adhesion (Cowan and Henkemeyer, 2001; Huynh-Do 
et al., 2002; Xu et al., 2003), but the signalling pathways involved have not yet been 
fully characterised.
Ephrin-B ligands become phosphorylated on tyrosine upon stimulation with soluble 
pre-clustered EphB-Fc fusion proteins (Bruckner et al., 1997; Holland et al., 1996) 
and co-culturing cells expressing ephrin-Bs with EphB receptor expressing cells
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results in tyrosine phosphorylation of both receptors and ligands (Holland et al., 
1996). Ephrins do not possess a catalytic domain, but tyrosine phosphorylation of 
ephrin-Bs has been shown to occur via Src family kinases (Bruckner et al., 1997; 
Holland et al., 1996; Palmer et al., 2002), and is necessary for some reverse 
signalling events. For example, sprouting angiogenesis of endothelial cells triggered 
by EphB4-Fc is inhibited upon treatment with the Src family kinase inhibitor PP2 
(Palmer et al., 2002). In addition, other receptor tyrosine kinase pathways have been 
implicated in ephrin-B activation. Platelet-derived growth factor (PDGF) stimulation 
of ephrin-B expressing cells can result in tyrosine phosphorylation of the ligand 
(Bruckner et al., 1997; Palmer et al., 2002), and serum-triggered phosphorylation of 
ephrin-Bs in endothelial cells has been shown to be unaffected by inhibitors of Src 
family kinases, indicating other kinases are responsible for this induction (Palmer et 
al., 2002). The Tie-2 receptor tyrosine kinase has also been shown to phosphorylate 
ephrin-B2 in vitro (Adams et al., 1999). In addition, activated fibroblast growth 
factor receptor (FGFR) can induce tyrosine phosphorylation of endogenous ephrin- 
Bs in chick primary retina in vivo (Chong et al., 2000), and expressed ephrin-B 1 in 
Xenopus oocytes (Bong et al., 2004).
Ephrin-B proteins have well-conserved cytoplasmic domains, particularly the C- 
terminal 33 amino acids, which show nearly 100% identity among the three known 
ephrin-B ligands. Within these last 33 amino acids are five tyrosine residues, and a 
potential PDZ binding motif (Song et al., 2002). In avian ephrin-B 1, tyrosine 
residues at positions 312, 317 and 331 (corresponding to 311, 316 and 330 in mouse) 
are phosphorylated upon Eph receptor engagement in vivo (Kalo et al., 2001). Tyr- 
331 is within the PDZ binding domain at the C-terminus of ephrin-Bs and has been 
shown to be the major in vivo phosphorylation site of ephrin-B 1 in the ephrin- 
Bl/EphB2 complex. It is postulated that this residue plays a role in the 
multimerisation of ephrin-B molecules (Kalo et al., 2001). Interestingly, it has 
recently been shown that murine Tyr-304 is crucial for Grb4 binding via its SH2 
domain (Su et al., 2004), as is the equivalent residue (Tyr-298) in Xenopus (Bong et 
al., 2004). This residue is not reported as an in vivo phosphorylation site, but it is 
possible that phosphorylation of Tyr at positions 311 and 316 could induce a 
conformational change that positions Tyr-304 to interact with Grb4 (Su et al., 2004).
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Ephrin-B signalling is not entirely phosphorylation dependent. Various signalling 
molecules have been shown to bind via the C-terminal PDZ binding motif present in 
all known ephrin-Bs. These include the adaptor proteins GRIP-1, GRIP-2 and 
syntenin, the protein kinase C-interacting protein Pickl, the protein tyrosine 
phosphatase PTP-BL and the GTPase activating protein (GAP) for heterotrimeric G- 
proteins, PDZ-RGS3 (Bruckner et al., 1999; Lin et al., 1999; Lu et al., 2001; Palmer 
et al., 2002; Torres et al., 1998). The significance of many of these interactions is not 
clear. However, PDZ proteins have been widely implicated in forming submembrane 
scaffolds that cluster molecules at the cell surface (Craven and Bredt, 1998; Gamer 
et al., 2000; Sheng and Pak, 2000). Interaction between ephrin-B 1 and PDZ-RGS3 
was found to be necessary for ephrin-B 1 mediated cell dissociation in the Xenopus 
embryo (Lu et al., 2001), and activation of reverse signalling inhibited the 
chemoattraction of cerebellar granule cells induced by the chemokine SDF-1. This 
inhibition was found to depend on cross-talk between ephrin-B 1 signalling and G- 
protein coupled receptor signalling via PDZ-RGS3 (Lu et al., 2001). Binding of PTP- 
BL (a protein tyrosine phosphatase) to ephrin-B 1, with delayed kinetics via its PDZ 
domain, results in ephrin-B 1 dephosphorylation and phosphotyrosine dependent 
signalling is subsequently switched off (Palmer et al., 2002). Ephrin-B signalling is 
also responsible for a dramatic cell rounding response in HEK 293 cells which 
requires the MAP kinase JNK (c-jun amino terminal kinase) and is phosphorylation 
independent (Xu et al., 2003).
Regulation of the actin cytoskeleton is essential for guiding cell movements. Cell 
surface receptors can transmit signals in response to external cues that give rise to 
actin cytoskeletal changes, leading to the regulation of cell adhesion and motility 
(Cowan and Henkemeyer, 2001; Huynh-Do et al., 2002; Xu et al., 2003). Ephrin-Bs 
have been linked to downstream signalling partners involved in the regulation of 
cytoskeletal dynamics, cell migration and adhesion events. The SH2/SH3 domain 
protein Grb4 binds to ephrin-B 1 via its SH2 domain in a phosphotyrosine dependent 
manner and, through its SH3 domains, links ephrin-B 1 to many proteins with roles in 
cytoskeletal regulation (Cowan and Henkemeyer, 2001). In response to ephrin-B 1 
activation, a redistribution of paxillin away from focal adhesions to the cytoplasm 
occurs, as well as increased phosphorylation of focal adhesion kinase (FAK) at 
Tyr397 (Cowan and Henkemeyer, 2001). In addition, the recruitment of many other
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downstream proteins via the SH3 domains of Grb4 is possible (Cowan and 
Henkemeyer, 2001), such as cyclase associated protein (CAP), which has been 
proposed to regulate actin stress fibres and focal adhesions (Ribon et al., 1998), and 
hnRNPK which has been shown to interact with Vav, an exchange factor for Rac 
(Bustelo et al., 1995; Hobert et al., 1994).
In order to understand how ephrins and Eph receptors are involved in cell migration, 
it is necessary to understand the cellular responses that are triggered upon ephrin 
activation by Eph receptors, and the signalling pathways that underlie these 
responses. Swiss 3T3 cells are a fibroblast cell line that has been used extensively for 
the investigation of actin cytoskeletal rearrangements triggered by growth factor 
receptors (Rankin and Rozengurt, 1994; Ridley, 1995; Ridley and Hall, 1992; 
Seufferlein and Rozengurt, 1994). Swiss 3T3 fibroblasts have been well 
characterised and are flat well-spread cells in culture, therefore an ideal cell type for 
microinjection.
A reasonable amount of information is known about the biochemical ‘forward’ 
signals transduced by Eph receptors. However, little is known about the signalling 
pathways and events triggered by ephrin-B ‘reverse’ signalling. It has previously 
been shown that BHK (Baby Hamster Kidney) fibroblast cells transfected with 
ephrin-B 1 show a loss of actin stress fibres and cell rounding when stimulated with 
EphB2 (Cowan and Henkemeyer, 2001). In order to look at the cytoskeletal changes 
that occur upon activation of another ephrin ligand, ephrin-B2,1 expressed ephrin-B2 
in confluent, quiescent Swiss 3T3 fibroblasts. The downstream signalling events 
triggered after ephrin-B2 clustering by soluble Eph receptors were then analysed.
In this chapter, I have shown that stimulation of Swiss 3T3 cells, exogenously 
expressing ephrin-B2, with soluble pre-clustered EphB2-Fc triggers a loss of cell-cell 
contact, resulting in the ephrin-B2 expressing cells withdrawing from their 
neighbours within the cell monolayer. I have shown that this response requires the 
presence of serum factors or fibroblast growth factor (FGF). A truncated form of 
ephrin-B2, missing the entire cytoplasmic domain, does not trigger loss of cell-cell 
contact, demonstrating a dependence on the intracellular domain of the ligand. In 
addition, I have shown that Src family kinases, and the SH2/SH3 domain adaptor
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protein Grb4, are critical for loss of cell-cell contact to occur. However, PDZ domain 
protein interactions are not necessary and the response is not sensitive to pre­
treatment with the ROCK inhibitor, Y27632, or blebbistatin, an inhibitor of myosin 
II ATPase.
3.2 Results
3.2.1 Characterisation of Swiss 3T3 Fibroblasts
Confluent Swiss 3T3 fibroblasts were prepared as described in chapter 2. When 
plated at high density and grown to confluency, without medium change, cells 
become quiescent after 7-10 days in culture. Cells within the monolayer are closely 
juxtaposed (Fig. 3.1a) and have adherens junctions between cells as shown by p- 
catenin staining (Fig. 3.1b). The cells are flat, well-spread and without serum- 
starvation display some actin stress fibres (Fig. 3.1c).
Endogenous ephrin-B expression in Swiss 3T3 fibroblasts can be demonstrated by 
staining cells using an “Eph receptor body” (Gale and Yancopoulos, 1997), a 
chimeric protein composed of the extracellular ligand-binding domain of an Eph 
receptor, in this case EphB2, which has selective binding affinity for ephrin-Bs, 
fused to the Fc fragment of the heavy chain of human IgG (EphB2-Fc). Generally, 
EphB receptors bind ephrin-B ligands and EphA receptors bind ephrin-A ligands, 
and binding within subclasses is fairly promiscuous (Davis et al., 1994; Gale et al., 
1996b; Gale and Yancopoulos, 1997). Binding of EphB2-Fc (pre-clustered with anti­
human IgG; 20min stimulation) to endogenous ephrin-Bs was visualised after 
fixation with a fluorescently tagged secondary antibody. Clusters of ephrin-B are 
revealed evenly distributed across the fibroblast, extending to the edge of the 
lamellae (Fig 3.2a & red in c). Cells fixed prior to EphB2-Fc treatment, display a 
diffuse, rather than puncate, ephrin-B stain (data not shown), indicating that 
stimulation of ephrin-Bs in these cells triggers clustering of endogenous ligands. 
Panels d-f are controls for non-specific antibody binding; cells were treated with the 
isolated Fc portion of human IgG pre-clustered with anti-human IgG, and show no 
staining pattern (Fig. 3.2d).
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Figure 3.1 Q uiescent Swiss 3T3 Fibroblasts
Phase Contrast p-catenin F-actin
Quiescent Swiss 3T3 fibroblasts are well spread and form a monolayer as shown by 
phase contrast microscopy (a). The cells have adherens junctions, illustrated by p- 
catenin staining using an anti-p-catenin antibody (b). Phalloidin staining o f  
filamentous actin (F-actin) reveals that these cells, without serum-starvation, display 
some actin stress fibres (c). Scale bar 20pm.
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Immunocytochemistry using an “Eph receptor body” does not distinguish between 
the 3 ephrin-B family members due to the promiscuous binding of EphB receptors to 
multiple ephrin-Bs (Gale et al., 1996b). Western blot analysis was used to determine 
which ephrin-B family members Swiss 3T3 cells endogenously express. Figure 3.2i 
shows that Swiss 3T3 cells express ephrin-B3 (molecular weight of ephrin-Bs is 
approximately 45kDa (Bruckner et al., 1999; Lin et al., 1999). No expression of 
ephrin-Bl or ephrin-B2 was detected (Fig. 3.2g&h), although mouse ephrin-B 1-Fc 
and mouse ephrin-B2 Fc were detected using these antibodies. Ephrin-B-Fcs are 
chimeric proteins composed of the extracellular domain of one of the three ephrin-B 
ligands fused to the Fc fragment of the heavy chain of human IgG and have a 
calculated molecular weight of 49.2 kDa but as a result of glycosylation the 
recombinant protein migrates at 60 kDa under reducing conditions. I have 
demonstrated using western blotting that Swiss 3T3 fibroblasts endogenously 
express ephrin-B3 but not ephrin-Bl or ephrin-B2.
3.2.2 Detection of expressed ephrin-B2 in Swiss 3T3 fibroblasts
Stimulation of confluent Swiss 3T3 fibroblasts with EphB2-Fc resulted in no 
detectable changes to the actin cytoskeleton or cell morphology (results not shown). 
The levels of endogenous ephrin-B3 expression may not be sufficient to elicit a 
morphological response upon stimulation. Alternatively, ephrin-B3 may not trigger a 
morphological/actin cytoskeletal response, unlike ephrin-Bl (Cowan and 
Henkemeyer, 2001). These cells therefore present an ideal model system for looking 
at changes to the actin cytoskeleton and cell morphology triggered by activation of 
exogenous ephrin-B2. Ephrin-B2 was expressed by microinjection of pRK5-ephrin- 
B2 (200pg/ml), plus FITC dextran (5mg/ml) as an injection marker. Post-injection 
cells were incubated at 37°C/10%CO2 for various times to allow for surface 
expression of ephrin-B2, after which they were fixed and stained, without 
permeabilisation, for surface ephrin-B2 using a commercially available antibody. 
30min post-injection nuclear FITC dextran is clearly visible indicating injected cells 
(Fig. 3.3a & green in c), but no surface ephrin-B2 expression was detected (Fig. 
3.3b). lh post-injection, injected cells are again clearly identified (Fig. 3.3d & green 
in f), together with a low level of surface ephrin-B2 staining (Fig. 3.3e & red in f).
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Figure 3.2 Endogenous ephrin-B expression in Swiss 3T3 fibroblasts 
Ephrin-B F-actin Merge
Swiss ephrin-Bl 
Lysate Fc
Swiss ephrin-B2 
Lysate Fc
Swiss
Lysate
66kDa
45kDa
Cells were stimulated for 20min with pre-clustered EphB2-Fc and stained for F-actin 
with FITC-phallodin (green) and ephrin-Bs, (by detecting anti-human IgG used to 
cluster the bound “Eph receptor body”), with a Cy3 conjugated secondary antibody 
(red). Swiss 3T3 cells endogenously express ephrin-Bs (a & red in c). No staining 
was seen upon treatment o f  cells with pre-clustered Fc alone (d & f). W estern 
blotting analysis using commercially available antibodies to the individual ephrin-Bs 
revealed endogenous expression o f only ephrin-B3, which has a molecular weight o f 
approximately 45kDa (i). No expression o f ephrin-Bl or ephrin-B2 was detected, 
although the antibodies do recognise mouse ephrin-Bl Fc and mouse ephrin-B2-Fc 
(g&h), which have a calculated molecular weight o f 49.2kDa but as a result o f  
glycosylation migrate at 60kDa under reducing conditions. Scale bar 10pm.
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Figure 3.3 Surface expression o f ephrin-B2 post-m icroiniection
Injection Marker ephrin-B2 Merge
1 BB
Swiss 3T3 fibroblasts were microinjected with pRK5-ephrin-B2 (200pg/m l) and 
incubated at 37°C/10% CO2 for various times to allow for protein expression. FITC 
dextran (5mg/ml) was co-injected as an injection marker (green). Cells were fixed 
and not permeabilised so that only surface ephrin-B2 was detected using an anti- 
ephrin-B2 antibody (red). Surface ephrin-B2 expression was not detected 30min 
post-injection (a-c). lh  after injection a weak signal was detected in many, but not 
all, injected cells (d-f). After 2h all injected cells displayed a uniform diffuse ephrin- 
B2 stain (g-i). Scale bar 20pm.
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After 2h, the injected cells (Fig. 3.3g & green in i) clearly show an elevated diffuse 
surface expression of ephrin-B2 (Fig. 3.3h & red in i). Therefore, cells were 
routinely incubated for 2-2.5h post-microinjection to allow for sufficient surface 
expression of ephrin-B2 constructs.
3.2.3 EphB receptor stimulation of ephrin-B2 induces clustering of 
ephrin-B2 and loss of cell-cell contact
In order to investigate the effect of EphB2-Fc stimulation on cells expressing 
exogenous ephrin-B2, Swiss 3T3 fibroblasts were microinjected with pRK5-ephrin- 
B2 (200pg/ml) plus biotin dextran (2mg/ml) and left for 2h to express. To activate 
ephrin-B2 signalling, cells were exposed to lpg/ml EphB2-Fc pre-clustered with 
anti-human IgG at a ratio of lpg:10pg. Ephrin-B2 expressing cells were stimulated 
for between 10 and 60min after which time the cells were fixed and stained to 
visualise actin filaments and ephrin-B2 expression.
Unstimulated ephrin-B2 expressing cells show uniform diffuse ephrin-B2 staining 
(Fig. 3.4b and red in c), and display no loss of cell-cell contact compared with 
expression of empty vector alone (Fig. 3.4k). Ephrin-B2 expressing cells stimulated 
with pre-clustered EphB2-Fc initially show clustering of ephrin-B2 into spots at 
lOmin (data not shown), and larger patches at later times (30 and 60min; Fig. 
3.4e&h; red in f&i). Clustering of ephrin-B2 causes expressing cells to lose cell-cell 
contact and withdraw from their neighbours (Fig. 3.4d-g; arrows in f&i). Loss of 
cell-cell contact was defined as an expressing cell where more than 40% of its 
circumference had lost contact with the surrounding monolayer. A rise in the number 
of ephrin-B2 expressing cells exhibiting loss of cell-cell contact was observed after 
lOmin pre-clustered EphB2-Fc stimulation (P < 0.001; Fig 3.4k) and increased over 
time, a higher proportion of cells responding after 60min stimulation compared with 
lOmin (P < 0.01; Fig. 3.4k). Injection of empty vector alone prior to pre-clustered 
EphB2-Fc stimulation does not cause the injected cells to lose cell-cell contact (Fig. 
3.4j&k) indicating the response is specific to ephrin-B2 clustering. Notably, every 
ephrin-B2 expressing cell does not lose cell-cell contact as a consequence of
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Figure 3.4 C lustering o f ephrin-B 2 in Sw iss 3T3 fibrob lasts triggers
loss o f cell-cell contact
F-actin ephrin-B2 Merge
60min E pRKS (Empty Vector) I Full I rnuth cphrin-B2
*  *  *
l . r n u ih  o f  t r e a t m e n t  w i th  p r e - c lu s t e r e d  F p h R 2 - F c  ( m in i
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stimulation by EphB2-Fc, nor is the extent the same. This is most likely due to 
variation in the expression levels of ephrin-B2 achieved through microinjection. A 
certain threshold of expression may need to be reached in order for signalling to 
occur.
For the experiments described above, EphB2-Fc was pre-clustered prior to 
stimulation. However, Eph receptor activation by ephrin ligands is known to trigger 
different signalling pathways, depending on the level of clustering of the ephrin 
ligand. For example, human renal microvascular endothelial cells endogenously 
expressing EphBl, exhibit a decrease in cell attachment to fibronectin and receptor 
phosphorylation, when stimulated with ephrin-B 1-Fc dimers. However, activation of 
EphBl by stimulation with ephrin-B 1-Fc pre-clustered into higher order aggregates 
causes cell attachment and capillary tube formation (Stein et al., 1998b). In order to 
see if this also applies to ephrin-B2 signalling, cells were stimulated with unclustered 
EphB2-Fc (lpg/ml) dimers. Interestingly, under these conditions there is no increase 
in loss of cell-cell contact compared with unstimulated cells (Fig. 3.5). It is therefore 
necessary to cluster the ligand into higher order aggregates using anti-human IgG in 
order to trigger loss of cell-cell contact.
The loss of cell-cell contact response I observe is not specific to EphB2 stimulation. 
Ephrin-B2 expressing Swiss 3T3 cells stimulated with pre-clustered EphB4-Fc 
(1 (iig/ml), respond in a similar manner. The result is less dramatic than that seen upon 
EphB2-Fc stimulation, but there is an increased loss of cell-cell contact across the 
time course (Fig. 3.6). A significant proportion (>25%) of ephrin-B2 expressing cells 
have lost cell-cell contact after 30min stimulation (P <0.01; Fig. 3.6) rising to >30% 
after 60min stimulation (P <0.001; Fig.3.6). EphB4 is a known binding partner of 
ephrin-B2, and ephrin-B2 is in fact the only known ligand for EphB4 (Flanagan and 
Vanderhaeghen, 1998). Therefore, it is not surprising that EphB4 stimulation of 
ephrin-B2 induces a morphological response.
114
Figure 3.5 Stimulation of Swiss 3T3 cells expressing ephrin-B2 with
un-clustered EphB2-Fc does not cause loss of cell-cell contact
Length of treatment with un-clustered EphB2-Fc (min)
Treatment with dimeric EphB2-Fc (lpg/ml) does not trigger ephrin-B2 expressing 
Swiss 3T3 cells to lose cell-cell contact compared with unstimulated cells. The 
experiment was repeated a minimum of 3 times with between 300-400 cells counted 
in total per time-point.
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Figure 3.6 Stimulation of Swiss 3T3 fibroblasts expressing ephrin-B2
with pre-clustered EphB4-Fc results in loss of cell-cell contact
Length of treatm ent with pre-clustered EphB4-Fc (min)
Ephrin-B2 expressing cells lose cell-cell contact upon treatment with pre-clustered 
EphB4-Fc (lp,g/ml). Loss of cell-cell contact increases over time (ANOVA P  = 
0.0009) A significant proportion (26.9%) of ephrin-B2 expressing cells have lost 
cell-cell contact after 30min stimulation (P < 0.01). >30% cells have responded after 
60min stimulation. The experiment was repeated a minimum of 3 times with 
between 300-400 cells counted in total per time point. (Asterisks denote statistical 
significance with respect to control).
3.2.4 Neither ROCK or JNK activity is required for loss of cell-cell 
contact induced by ephrin-B2 signalling
The Rho effector kinase, ROCK, and c-Jun amino terminal kinase (JNK) have both 
been implicated, independently, as signalling intermediates involved in a repulsive 
response to ephrin-Bl activation (Tanaka et al., 2003; Xu et al., 2003). In order to 
determine whether these signalling molecules are necessary for ephrin-B2 regulated 
loss of cell-cell contact, Swiss 3T3 fibroblasts were pre-treated with inhibitors to 
ROCK or JNK and the effect on loss of cell-cell contact investigated.
Treatment of ephrin-B2 expressing cells with the ROCK inhibitor Y27632 (20pM) 
for 30min caused confluent quiescent cells to lose actin stress fibres while remaining 
spread and in contact with their neighbours in the monolayer (data not shown). 
Y27632 did not inhibit EphB2-Fc triggered loss of cell-cell contact (Fig. 3.7) 
demonstrating that ROCK activity is not necessary for loss of cell-cell contact 
triggered as a result of ephrin-B2 clustering. Treatment of ephrin-B2 expressing cells 
with the JNK inhibitor SP600125 (30p,M) for lh had no visible affect on cell 
morphology, cells did not lose their actin stress fibres and remained well-spread and 
closely juxtaposed within the monolayer (data not shown). SP600125 did not inhibit 
loss of cell-cell contact triggered by EphB2-Fc (Fig. 3.7) therefore it is unlikely that 
JNK is involved in the loss of cell-cell contact observed after ephrin-B2 clustering in 
these cells.
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Figure 3.7 Ephrin-B2 triggered loss o f cell-cell contact does not 
require ROCK activity and is not blocked by the JNK  inhibitor  
SP600125
I Unstimulated
160min pre-clustered EphB2-Fc
pRK5-ephrin-B2 pRK5-ephrin-B2 + Y27632 
Condition
pRK5-ephrin-B2 + SP600125
Swiss 3T3 cells exogenously expressing ephrin-B2 were untreated or pre-treated 
with the ROCK inhibitor Y27632 (20pM) or the JNK inhibitor SP600125 (30p,M) 
prior to stimulation with pre-clustered EphB2-Fc (lp,g/ml) for lh. No significant 
difference in loss of cell-cell contact was observed compared to stimulation in the 
absence of these inhibitors. The experiment was repeated a minimum of 3 times, and 
between 300-400 cells were counted in total for each condition.
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3.2.5 The cytop lasm ic dom ain o f ephrin-B 2, tyrosin e  
phosphorylation, Grb4 and serum factors are necessary for loss of 
cell-cell contact induced by ephrin-B2 clustering
In order to test whether loss of cell-cell contact is dependent upon the cytoplasmic 
domain of ephrin-B2, a truncated form of ephrin-B2 (200p,g/ml) was expressed in 
Swiss 3T3 cells. Truncated ephrin-B2, (comprising residues 1-253), lacks the entire 
intracellular domain including the functionally important tyrosine residues (Bong et 
al., 2004; Kalo et al., 2001; Su et al., 2004), and the PDZ binding motif. As expected, 
stimulation of truncated ephrin-B2 did not trigger loss of cell-cell contact (Fig. 3.8) 
and cells remained juxtaposed with their neighbours (data not shown). This data 
confirms that the cytoplasmic domain of ephrin-B2 is required for the observed loss 
of cell-cell contact to occur.
The adaptor protein Grb4 has been shown to bind to activated ephrin-B 1 through its 
phosphorylated tyrosine residues and is necessary for the loss of actin stress fibres 
and cell rounding observed after stimulation with Eph receptors (Cowan and 
Henkemeyer, 2001). In order to test whether Grb4 is an important component of 
ephrin-B2 signalling, dominant negative Grb4 (myc tagged; 200p,g/ml) was co­
expressed with ephrin-B2 (200p,g/ml) in Swiss 3T3 fibroblasts and expression of 
dnGrb4 and ephrin-B2 detected using anti-myc and anti-ephrin-B2 antibodies 
respectively (data not shown). Dominant negative Grb4, comprising the isolated SH2 
domain, can bind to tyrosine-phosphorylated ephrin-B2, which would prevent 
endogenous Grb4 from binding. Since this construct lacks SH3 domains it would 
inhibit downstream signalling by preventing the recruitment of other proteins 
implicated in reverse signalling (Cowan and Henkemeyer, 2001). Upon stimulation 
of cells co-expressing dnGrb4 and ephrin-B2 with pre-clustered EphB2-Fc, loss of 
cell-cell contact was inhibited to levels similar to those seen for unstimulated ephrin- 
B2 expressing cells (P < 0.001), demonstrating a requirement for Grb4 in signalling 
mediated by clustered ephrin-B2 (Fig. 3.8).
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Figure 3.8 Loss of cell-cell contact exhibited by ephrin-B2 expressing  
cells under various conditions after 60min EphB2-Fc stimulation
* * *
* * *
Unstimulated ephrin-B2 Truncated 5Y-F ephrin- ephrin-B2 + ephrinB2 - 
ephrin-B2 ephrin-B2 B2 dnGrb4 serum
Construct Injected
Swiss 3T3 fibroblasts exogenously expressing ephrin-B2 lose cell-cell contact in 
response to stimulation with pre-clustered EphB2-Fc for 60min (P <0.001). 
Expression of truncated ephrin-B2 (lacking the intracellular region) does not trigger 
loss of cell-cell contact and co-expression of dominant negative Grb4 inhibits the 
response. Serum-starvation renders cells unable to lose contact in response to EphB2 
stimulation. Expression of 5Y-F ephrin-B2 triggers only a weak loss of cell-cell 
contact response compared to full-length ephrin-B2 (P <0.001) but there is a 
significant increase with respect to control fP<0.01). Each experiment was repeated 
a minimum of 4 times, with between 500-600 cells counted in total for each 
condition. (* describes statistical difference with respect to unstimulated cells; * 
describes statistical difference with respect to full-length ephrin-B2 expressing cells).
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In order to determine if phosphorylation of ephrin-B2 is important for loss of cell­
cell contact a mutant ephrin-B2 construct, where all five tyrosine residues in the last 
33 amino acids of the cytoplasmic tail have been mutated to phenylalanine, (5Y-F 
ephrinB2; 200pg/ml), was expressed in Swiss 3T3 fibroblasts. 5Y-F ephrin-B2 
triggered a reduced loss of cell-cell contact response in comparison to that observed 
after stimulation of full-length ephrin-B2 (P < 0.001; Fig. 3.8). However, there was 
still an effect with respect to unstimulated cells (P < 0.01; Fig. 3.8). Therefore, 
phosphorylation of ephrin-B2 does have a role to play, but other factors may be 
involved since inhibition is not complete.
In the experiments presented above, Swiss 3T3 cells were stimulated with Eph 
receptors in the presence of serum in the culture medium. To determine whether 
serum factors are required for loss of cell-cell contact, cells were serum depleted 
overnight, which leads to a complete loss of actin stress fibres (Fig 3.9a & green in
c). In the absence of serum factors loss of cell-cell contact is not triggered by pre­
clustered EphB2-Fc (P <0.001; Fig. 3.8). No loss of cell-cell contact was observed 
compared with unstimulated cells (Fig. 3.8). These data suggest that a component(s) 
of serum is necessary for EphB2 triggered loss of cell-cell contact.
3.2.6 FGF is required for ephrin-B2 regulated loss of cell-cell contact 
in serum-starved cells
Since serum is important for loss of cell-cell contact triggered by ephrin-B2 
clustering, I wanted to determine which factors in serum may be required for this 
ephrin-mediated response. An obvious candidate is the growth factor FGF, since it 
has previously been shown in Xenopus that FGFR can bind to and phosphorylate 
ephrin-Bl and regulate cell adhesion. An FGFR interaction with ephrin-Bl has also 
been shown to occur during cell migration into the eye field in Xenopus (Chong et 
al., 2000; Moore et al., 2004). To test the involvement of FGF, serum-starved 
confluent Swiss 3T3 cells were injected with an expression construct for ephrin-B2 
(200p,g/ml) and incubated at 37°C/10% CO2 for 2h to allow for ephrin-B2 
expression. After 1.5h cells were treated with 20ng/ml bFGF for 30min, followed by 
stimulation with pre-clustered EphB2-Fc (lpg/ml).
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Under starved conditions pre-clustered EphB2-Fc stimulation of ephrin-B2 
expressing Swiss 3T3 fibroblasts does not trigger loss of cell-cell contact (Fig. 3.8 & 
3.9a-c). Treatment of ephrin-B2 expressing cells with bFGF in the absence of pre­
clustered EphB2-Fc causes membrane ruffling (Ridley, 1995) but ephrin-B2 
expressing cells do not lose cell-cell contact (Fig. 3.9d-f). However, upon treatment 
with bFGF followed by stimulation with pre-clustered receptor, ephrin-B2 
expressing cells show a dramatic loss of cell-cell contact phenotype, with cell body 
rounding and the presence of long retraction fibres that remain in contact with non- 
ephrin-B2 expressing cells (Fig. 3.9g-i). There is a significant increase in loss of cell­
cell contact across the time course (Fig. 3.10). Less than 10% of cells lose cell-cell 
contact without pre-clustered EphB2-Fc stimulation (time 0). After lOmin treatment 
with pre-clustered EphB2-Fc 34% of expressing cells have lost cell-cell contact (P < 
0.05; Fig. 3.10). This rises to more than 40% after 60min (P < 0.001; Fig. 3.10). 
Therefore, serum-starved cells require FGF treatment in order to round up in 
response to pre-clustered EphB2-Fc.
3.2.7 Loss of cell-cell contact triggered by ephrin-B2 clustering in the 
presence of FGF is dependent on Src tyrosine kinase activity, 
tyrosine phosphorylation of ephrin-B2 and Grb4 function
Src family kinases have been shown to mediate ephrin-B phosphorylation in primary 
endothelial cells and cortical neurons (Palmer et al., 2002). In order to determine if 
Src is involved in the loss of cell-cell contact I observe in response to ephrin-B2 
clustering, ephrin-B2 expressing cells were serum-starved, treated with bFGF as 
described previously and pre-treated with the Src inhibitor PP2 (10|iM) for 30min 
followed by stimulation with soluble pre-clustered EphB2-Fc. Inhibition of Src, 
using this pharmacological inhibitor, dramatically inhibits loss of cell-cell contact (P 
< 0.001; Fig. 3.11), indicating a requirement for Src family kinases in this EphB2 
triggered loss of cell-cell contact.
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F igure 3 .9  FG F is requ ired  for E p h B 2-F c  ind u ced  ep h r in -B 2
signalling and subsequent loss of cell-cell contact
F-actin ephrin-B2 Merge
Cells were labelled for F-actin with FITC-phalloidin (green) and ephrin-B2 using an 
anti-ephrin-B2 antibody (red). Stimulation of serum-starved Swiss 3T3 cells 
expressing ephrin-B2 with pre-clustered EphB2-Fc alone (lpg/ml) for 60min caused 
clustering of ephrin-B2 into patches (b & red in c) but no loss of cell-cell contact (a 
& green in c). Treatment with bFGF (20ng/ml) alone for 30min caused 
reorganisation of actin into ruffles but no loss of cell-cell contact (d-f). Treatment 
with bFGF (20ng/ml) for 30min followed by pre-clustered EphB2-Fc stimulation for 
60min caused clustering of ephrin-B2 into patches (h & red in i) and dramatic loss of 
cell-cell contact and cell rounding (g & green in i). The experiment was carried out 
four times with a minimum of 400 cells counted in total per time point. Scale bar 
10pm.
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Figure 3.10 Serum -starved  ephrin-B2 expressing cells , in the  
presence o f  FGF, lose cell-cell contact in response to EphB 2  
stimulation
pRK5 (E m pty vector) 
pRK5-ephrin-B2
Length of treatm ent with pre-clustered EphB2-Fc (m in )
Swiss 3T3 fibroblasts exogenously expressing ephrin-B2 and subsequently treated 
with 20ng/m l bFGF lose cell-cell contact in response to stim ulation w ith p re­
clustered EphB2-Fc (ANOVA P = 0.0003). After lOmin stim ulation a significant 
proportion o f  ephrin-B2 expressing cells (34%) lose cell-cell contact (P <0.05), 
rising to 46% after lh  (P <0.001). Injection o f pRK5 alone does not result in loss o f 
cell-cell contact. The experiment was carried out a minimum o f 3 times and between 
300-500 cells were counted in total for each time point. (Asterisks denote statistical 
significance with respect to unstimulated cells).
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As detailed previously (3.2.5) the cytoplasmic domain of ephrin-B2 is required for 
loss of cell-cell contact induced by ephrin-B2 clustering in the presence of serum. In 
order to test whether this is also true for serum-starved cells treated with FGF, 
mutant ephrin-B2 constructs were expressed as already described (3.2.5), followed 
by FGF treatment and pre-clustered EphB2-Fc stimulation. As expected, the 
cytoplasmic domain of ephrin-B2 and the adaptor protein Grb4 are required for loss 
of cell-cell contact to occur (Fig. 3.11) and tyrosine phosphorylation of ephrin-B2 is 
necessary for a full response (Fig. 3.11).
In order to test whether the C-terminal PDZ binding domain functions to regulate 
loss of cell-cell contact, I expressed an ephrin-B2 construct lacking the C-terminal 
valine within the PDZ interaction site (ephrin-B2AV; a kind gift from Rudiger 
Klein). This is expected to abolish or strongly reduce binding of PDZ proteins to 
ephrin-B2. Expression of ephrin-B2AV (200|ig/ml) successfully triggered loss of 
cell-cell contact (Fig. 3.11). The percentage of cells rounding was not significantly 
different to that found upon stimulation of full-length ephrin-B2. This indicates that 
recruitment of downstream molecules via the PDZ binding domain is not necessary 
for loss of cell-cell contact triggered by Eph receptor binding.
Therefore, the cytoplasmic domain of ephrin-B2, tyrosine phosphorylation, Src 
tyrosine kinase activity and Grb4 are all required for loss of cell-cell contact in 
response to ephrin-B2 clustering, in the presence of FGF after serum-starvation (Fig. 
3.11). These findings agree with those found upon stimulation of non-starved Swiss 
3T3 cells with pre-clustered EphB2-Fc indicating that the same pathway is involved. 
PDZ protein interactions are not required for loss of cell-cell contact to occur.
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Figure 3.11 Loss o f  cell-cell contact exh ib ited  by seru m -sta rv ed
ephrin-B2 expressing cells, in the presence of FGF, after 60min  
EphB2-Fc stimulation under various conditions
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Unstimulated ephrin-B2 Truncated 5Y-F ephrin- ephrin-B2 + ephrin-B2AV ephrin-B2 + 
ephrin-B2 ephrin-B2 B2 dnGrb4 PP2
Construct injected
Pre-treatm ent o f ephrin-B2 expressing cells w ith 20ng/m l bFGF follow ed by 
stim ulation with pre-clustered EphB2-Fc for lh  causes dramatic loss o f  cell-cell 
contact (P < 0.001). Expression o f truncated ephrin-B2 does not trigger loss o f  cell­
cell contact. Co-expression o f dnGrb4 or pre-treatment with PP2, an inhibitor o f  Src 
family kinases, inhibits the loss o f  cell-cell contact. Expression o f 5Y-F ephrin-B2 
triggered a reduced loss o f  cell-cell contact response (P < 0.001), but there is an 
effect with respect to control (P < 0.05). Expression o f ephrin-B2 containing a 
mutation in the PDZ binding domain does not significantly affect the loss o f  cell-cell 
contact response. Each experiment was repeated a minimum o f 3 times and 300-500 
cells counted in total for each condition. (* describes statistical significance with 
respect to unstimulated cells; * describes statistical significance w ith respect to full- 
length ephrin-B2 expressing cells).
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3.3 Discussion
In this chapter, I have examined the response of confluent, quiescent Swiss 3T3 cells 
exogenously expressing ephrin-B2, to stimulation with soluble pre-clustered EphB2- 
Fc. Taken together the results demonstrate a loss of cell-cell contact response to 
ephrin-B2 clustering consistent with previous reports of a repulsive role for ephrin-B 
signalling.
In the presence of serum, clustering of ephrin-B2 expressed in Swiss 3T3 fibroblasts 
stimulates the formation of ephrin-B2 clusters in distinct membrane patches and 
triggers loss of cell-cell contact (Fig. 3.4). The cytoplasmic domain of the ligand, and 
the adaptor protein Grb4 are necessary for EphB2 triggered loss of cell-cell contact, 
and tyrosine phosphorylation is required for a full response (Fig. 3.8). ROCK activity 
is not necessary for loss of cell-cell contact and JNK is not involved (Fig. 3.7). In the 
absence of serum, pre-clustered EphB2-Fc stimulation does not trigger loss of cell­
cell contact, but in the presence of bFGF, the loss of cell-cell contact phenotype is 
evident (Fig. 3.9). Cells have begun to lose cell-cell contact after lOmin EphB2 
treatment, but the maximum effect was not reached until lh (Fig. 3.10). The response 
does not appear to be transient. The cytoplasmic domain of the ligand is again 
required for loss of cell-cell contact (Figs 3.8 & 3.11) as well as Src family kinases, 
Grb4 and tyrosine phosphorylation (Fig. 3.8 & 3.11). Recruitment of PDZ containing 
proteins (Fig. 3.11) is not necessary for loss of cell-cell contact triggered by ephrin- 
B2 clustering.
No morphological changes occur upon EphB2 stimulation of un-injected Swiss 3T3 
fibroblasts, which I have shown to endogenously express ephrin-B3. One explanation 
for this is that the expression levels are not sufficient to induce a morphological 
response. Alternatively, ephrin-B3 activation may not trigger an actin 
cytoskeletal/morphological response, unlike ephrin-B 1 (Cowan and Henkemeyer, 
2001; Xu et al., 2003) and ephrin-B2 (described in this chapter).
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3.3.1 Serum factors or FGF is necessary for loss of cell-cell contact 
triggered by ephrin-B2 clustering
Eph receptors and ephrins, as well as FGF receptor families and their activating 
ligands, have been shown to coordinate cell adhesion and migration during 
development (DeVore et al., 1995; Huynh-Do et al., 2002; Meyer et al., 2005; 
Osterhout et al., 1997). Ephrin-B ligands can become phosphorylated on tyrosine by 
both growth factor and EphB receptor treatment. Stimulation with the soluble 
ectodomain of Eph receptors has been shown to induce tyrosine phosphorylation of 
ephrin-Bs. For example, exogenously expressed ephrin-B 1 in BHK cells becomes 
tyrosine phosphorylated upon treatment with EphB2 (Cowan and Henkemeyer,
2001), and endogenous ephrin-B in primary neurons or endothelial cells undergoes 
tyrosine phosphorylation upon treatment with EphB-Fc (Palmer et al., 2002). The 
FGF receptor has been shown to directly bind to and phosphorylate transmembrane 
ephrin-Bs and modulate their effect on cell adhesion. In Xenopus embryos, FGF 
receptor activation can inhibit the dissociative effects of x-ephrin-Bl (Chong et al., 
2000). Also during retinal development in Xenopus, FGF modulation of ephrin-B 
reverse signalling is required to regulate the positioning of retinal progenitors within 
the eye (Moore et al., 2004). Platelet-derived growth factor (PDGF) is also capable 
of phosphorylating ephrin-Bs. Stimulation of the endogenous PDGF receptor in 
NIH3T3 fibroblasts ectopically expressing ephrin-B 1 results in rapid ephrin-B 1 
phosphorylation. It is thought that ephrin-B 1 could be an in vivo target for the PDGF 
receptor (Bruckner et al., 1997). Recent work has demonstrated a role for Eph/ephrin 
signalling in angiogenesis (reviewed in Heroult et al., 2005), and Tie-2, a member of 
a family of receptor tyrosine kinases known to function throughout angiogenesis, can 
phosphorylate ephrin-B 1 in vitro (Adams et al., 1999). FGF signalling is also thought 
to play a role in the development of the vasculature (Wilkie et al., 1995). It is thought 
that cross-talk may exist between signalling pathways triggered by growth factors 
such as FGF and ephrin-B proteins. The data presented here support a role for cross­
talk between FGF and ephrin-B signalling to regulate cell-cell contact.
There is currently no evidence for FGF involvement in ephrin-B signalling in 
mammals. However, the results in this chapter show that serum-starved Swiss 3T3
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fibroblasts, exogenously expressing ephrin-B2, do not lose cell-cell contact in 
response to pre-clustered EphB2-Fc stimulation, unlike those in the presence of 
serum or FGF (Figs 3.8 & 3.9). Similarly, treatment with FGF alone does not cause 
ephrin-B2 expressing cells to lose cell-cell contact (Fig. 3.9). These results indicate 
FGF has a contributory effect to the loss of cell-cell contact observed, corroborating 
a role for FGFR and ephrin-B cross-talk to mediate cell-cell contact.
3.3.2 Src dependent phosphorylation of ephrin-B2 is required for 
EphB2 triggered loss of cell-cell contact in Swiss 3T3 fibroblasts
Ephrin-B ligands do not possess a catalytic domain, but phosphorylation of ephrin- 
Bs on tyrosine can be mediated by other kinases, such as the FGFR and Src (Chong 
et al., 2000; Palmer et al., 2002). For example, ephrin-B 1 has been shown to be 
phosphorylated by Src in vitro upon Eph receptor engagement (Bruckner et al., 1997; 
Palmer et al., 2002). Ephrin-Bs are localised within lipid rafts (Bruckner et al., 1999) 
and Src family kinases and ephrin-B ligands co-localise in discrete signalling centres 
within lipid rafts after Eph receptor induced clustering (Palmer et al., 2002). Pre­
treatment of Swiss 3T3 fibroblasts with PP2, a pharmacological inhibitor of Src 
family kinases, inhibits the loss of cell-cell contact I observe in response to ephrin- 
B2 clustering (Fig. 3.11). These data suggest the involvement of Src family kinases 
in the loss of cell-cell contact response. The pyrazolopyrimidine PP2 was developed 
as an inhibitor of the Src family and was first used to look at the effects of T cell 
receptor induced T cell activation, where the activity of the Src kinases Lck and 
FynT have been shown to be important (Hanke et al., 1996). Recently however, PP1 
and PP2, although fairly selective, have been shown to inhibit other protein kinases 
as well, although less potently (Bain et al., 2003). This should be considered when 
interpreting the results as the involvement of Src family kinases has only been tested 
by pre-treatment with PP2. However, their involvement would corroborate the 
current literature.
Phosphorylation of ephrin-Bs on tyrosine is known to occur at specific tyrosine 
residues situated within the C-terminal 33 residues of the cytoplasmic tail, both in 
vivo and in vitro (Bruckner et al., 1997; Holland et al., 1996; Kalo et al., 2001). It
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has been shown that this phosphorylation can occur both as a result of Eph receptor 
binding (Bruckner et al., 1997; Cowan and Henkemeyer, 2001) and through 
interactions with other receptor tyrosine kinases (Bruckner et al., 1997). Surprisingly, 
using a commercially available phospho-ephrin-B antibody or generic 
phosphotyrosine antibodies I was unable to detect phosphorylation of ephrin-B2 after 
Eph receptor treatment (results not shown). However, I did obtain evidence that 
suggests a requirement for tyrosine phosphorylation of ephrin-B2. 5Y-F ephrin-B2 is 
a construct that has all five tyrosine residues in the last 33 amino acids of the 
carboxy-terminal tail mutated to phenylalanine. Several studies have demonstrated 
the functional relevance of at least four out of five of the tyrosine residues found 
within the C-terminal 33 amino acids of B-ephrins. Tyr-312, Tyr-317 and Tyr-331 
are phosphorylated upon Eph receptor engagement in vivo (Kalo et al., 2001) and 
Tyr-304 has been shown to be important for Grb4 binding via its SH2 domain (Su et 
al., 2004). Pre-clustered EphB2-Fc stimulation of expressed 5Y-F ephrin-B2 
produced a much weaker loss of cell-cell contact response compared to stimulation 
of the full-length protein (Figs 3.8 & 3.11). This indicates that tyrosine 
phosphorylation is necessary for the full response to occur.
3.3.3 The adaptor protein Grb4 is required for ephrin-B2 regulated 
loss of cell-cell contact
It has been previously demonstrated in BHK cells that the SH2/SH3 domain adaptor 
protein Grb4 binds to the cytoplasmic domain of expressed ephrin-B 1 in a 
phosphotyrosine dependent manner and this leads to cell rounding and actin 
cytoskeletal modifications (Cowan and Henkemeyer, 2001). However, cell rounding 
has also been demonstrated to occur independently of both tyrosine phosphorylation 
and Grb4 and in this instance was mediated by JNK (Xu et al., 2003). The results 
presented here would agree that Grb4 is necessary for loss of cell-cell contact in 
response to ephrin-B2 clustering. Co-expression of dnGrb4 together with ephrin-B2 
reduced loss of cell-cell contact to control levels (Figs 3.8 & 3.11). This dominant 
negative construct retains the ability to bind to ephrin-B2 as it consists of the isolated 
SH2 domain. However, the ability to recruit downstream signalling molecules is 
impaired due to a lack of the functional SH3 domains. Grb4 is known to bind to
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many proteins that have been implicated in the regulation of the cytoskeleton 
(Cowan and Henkemeyer, 2001). I have shown that Grb4 is necessary to initiate the 
recruitment of signalling molecules necessary for modifying the actin cytoskeleton 
enabling loss of cell-cell contact to occur in response to ephrin-B2 clustering in this 
system.
Although SFKs have been shown to phosphorylate ephrin-Bs, it is not known 
whether tyrosine phosphorylation by SFKs can modulate the binding of SH2 
containing adaptor proteins such as Grb4. Interestingly, a recent study had shown 
that Grb4 binding in Xenopus embryos is dependent on activated FGF receptor 
(FGFR) (Bong et al., 2004). It has been shown that activated FGFR induces ephrin- 
B1 tyrosine phosphorylation (Bong et al., 2004; Chong et al., 2000), and promotes 
the formation of a complex between ephrin-B 1 and Grb4 (Bong et al., 2004). 
Binding of Grb4 to ephrin-B 1 is phosphorylation dependent (Bong et al., 2004; 
Cowan and Henkemeyer, 2001), and is unable to occur in the presence of a kinase 
inactive FGFR (Bong et al., 2004). This would suggest that the requirement for FGF 
in this system is to facilitate Grb4 binding.
3.3.4 PDZ domain interactions are not required for loss of cell-cell 
contact triggered by ephrin-B2 activation
Numerous studies have demonstrated a functional role for the cytoplasmic domain in 
the propagation of the reverse signal (Cowan and Henkemeyer, 2001; Lin et al., 
1999; Song et al., 2002; Xu et al., 2003). As described previously the last 33 amino 
acids of the C-terminal region of ephrin-Bs contain functionally important tyrosine 
residues, and at the extreme carboxy terminus a PDZ binding domain. Numerous 
PDZ domain interactions have been demonstrated to occur upon ephrin-B activation, 
although their function remains unclear (Bruckner et al., 1999; Lu et al., 2001; 
Palmer et al., 2002). As expected, loss of cell-cell contact in response to ephrin-B2 
clustering is attributable to the cytoplasmic domain of the ligand (Figs 3.8 & 3.11). 
However, there was no significant reduction in loss of cell-cell contact observed 
when an ephrin-B2 construct lacking the C-terminal valine within the PDZ binding
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motif was expressed (ephrin-B2AV; Fig. 3.11) indicating that PDZ binding domain 
interactions are not required for EphB2 triggered loss of cell-cell contact.
3.3.5 Rho Kinase and c-Jun amino terminal kinase are not required 
for loss of cell-cell contact.
The small GTPase Rho and the MAP kinase JNK have both been implicated in 
separate publications as regulators of cell rounding responses triggered by ephrin-B 
reverse signalling (Tanaka et al., 2003; Xu et al., 2003). JNK has been shown to be 
phosphorylated when both the forward and reverse signalling pathways are activated 
(Huynh-Do et al., 2002; Stein et al., 1998a) and overexpression of ephrin-B 1 in 
human embryonic kidney (HEK) 293T cells dramatically increases the activity of 
JNK leading to a cell rounding response that is dependent on JNK activity (Xu et al., 
2003). In Xenopus, the cytoplasmic protein Dishevelled (Xdsh) has been shown to 
mediate reverse signalling by EphB2 stimulated ephrin-B 1 leading to the activation 
of RhoA and ROCK (Tanaka et al., 2003). However, the loss of cell-cell contact I 
observe here is not affected by treatment with inhibitors to either JNK or ROCK 
(Fig. 3.7) indicating that this loss of cell-cell contact is not a Rho kinase/acto-myosin 
driven contraction event and is not dependent on JNK activity.
3.3.6 Loss of cell-cell contact triggered by ephrin-B2 signalling 
requires EphB2 receptor clustering
The binding of ephrins to Eph receptors occurs at sites of cell-cell contact, and is 
known to cause clustering of both the ligands and receptors, which triggers signalling 
in both the receptor and ligand expressing cells (Kullander and Klein, 2002). In 
support of a requirement for clustering, ephrins were found to be inactive in soluble 
form, despite being able to activate receptors when presented on the surface of cells 
(Davis et al., 1994), suggesting that membrane attachment may facilitate ligand 
dimerisation or clustering, which may then promote receptor clustering. In support of 
this, artificial clustering enabled previously inactive soluble ligands to effectively 
tyrosine phosphorylate their cognate Eph receptors (Davis et al., 1994).
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Stimulation of ephrin-B2 expressing cells with unclustered EphB2-Fc dimers did not 
cause loss of cell-cell contact to occur (Fig. 3.5). The extent of clustering required 
for ephrin ligands to activate their binding partners varies between receptor-ligand 
pairs, although it is thought that EphB receptors may have a higher requirement for 
aggregation beyond the dimerisation stage to become activated than EphAs (Gale 
and Yancopoulos, 1997). Since different levels of ligand clustering is known to 
affect receptor signalling, resulting in different cellular responses depending whether 
the ligand is presented as a dimer or higher order aggregate (Stein et al., 1998b), it is 
not surprising that the level of Eph receptor clustering affects signalling from the 
ephrins. Activation of ephrins and Eph receptors leads to the multimerisation of both 
molecules into plasma membrane clusters (Davis et al., 1994). The formation of 
clusters is thought to be necessary to initiate conformational changes that allow the 
subsequent phosphorylation and binding of signalling partners (Himanen et al., 2001; 
Song, 2003; Toth et al., 2001). Interactions between ephrins and Eph receptors occur 
at sites of cell-cell contact in vivo where assembly in lipid rafts is believed to occur 
as a consequence of cell-cell contact. Artificially clustering the receptor is simply 
further mimicking the in vivo process.
3.3.7 Conclusion
In response to EphB2-Fc stimulation of expressed ephrin-B2 in Swiss 3T3 
fibroblasts, I observe a loss of cell-cell contact response requiring the presence of 
serum factors or FGF, the adaptor protein Grb4, Src family kinases and tyrosine 
phosphorylation of ephrin-B2. PDZ domain protein interactions are not required, the 
response is not dependent on ROCK activity, and does not involve JNK.
Cell rounding has been demonstrated to occur as a result of ephrin-B 1 activation by 
two independent groups (Cowan and Henkemeyer, 2001; Xu et al., 2003). In one 
instance cell rounding is dependent on tyrosine phosphorylation and Grb4 binding 
(Cowan and Henkemeyer, 2001), in the other cell rounding can occur independently 
of Grb4, tyrosine phosphorylation and PDZ protein interactions, yet requires JNK 
activity (Xu et al., 2003). Taken together, the results presented here corroborate those 
of Cowan and Henkemeyer (Cowan and Henkemeyer, 2001). The loss of cell-cell
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contact response I observe to ephrin-B2 clustering is dependent on Grb4 and tyrosine 
phosphorylation and does not require JNK activity.
However, there are key differences. I have demonstrated a novel loss of cell-cell 
contact phenotype as a result of ephrin-B2 clustering. In addition, I have provided 
evidence of a requirement for serum factors in order for loss of cell-cell contact in 
response to EphB2-Fc stimulation, where as cell rounding occurred after ephrin-B 1 
activation in serum-starved BHK cells. However, serum-starving BHK cells does not 
cause a complete loss of actin stress fibres, which is the case in Swiss 3T3 cells, and 
there is a low level of tyrosine phosphorylation seen in the unstimulated cells, 
indicating these cells may not be truly growth factor free. There is also a marked 
difference in the time course of events. The cell rounding response to expressed 
ephrin-B 1 activation in BHK cells occurs over a time period of up to 6h. However, 
the loss of cell-cell contact response I observe in Swiss 3T3 cells upon clustering of 
expressed ephrin-B2 occurs after lOmin reaching a maximum within lh. This could 
be due to the expression levels of protein achieved, since ephrin-B 1 was expressed in 
BHK cells by transfection, and microinjection was used to express ephrin-B2 in 
Swiss 3T3 fibroblasts. Alternatively the response may be cell type dependent. In 
addition, I have shown that PDZ domain protein interactions, which were not 
investigated by Cowan and Henkemeyer (Cowan and Henkemeyer, 2001), are not 
required for loss of cell-cell contact in response to ephrin-B2 clustering. This finding 
corroborates Xu and colleagues, who showed that the cell rounding response to 
ephrin-B 1 activation in HEK 293 cells was independent of PDZ protein interactions 
(Xu et al., 2003). It is apparent that cell rounding as a consequence of ephrin-B 
clustering, can be mediated by two independent pathways.
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Chapter 4
Ephrin-B2 signalling in 
endothelial cells results in 
membrane retraction and 
blebbing
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4.1 Introduction
In chapter 3, I showed that loss of cell-cell contact occurred in response to 
stimulation of Swiss 3T3 fibroblasts, expressing exogenous ephrin-B2, with soluble 
pre-clustered EphB receptors. Having characterised the effects of ephrin-B2 
signalling in this model system and the effects of receptor stimulation of various 
mutant ephrin-B2 constructs, I have now investigated the response of human 
endothelial cells, that endogenously express ephrin-B ligands, to EphB treatment.
Human Umbilical Arterial Endothelial Cells (HUAECs), endogenously expressing 
ephrin-Bs, have been used as a primary cell line to study reverse signalling in a 
physiologically relevant cell type. The aim was to provide an insight into how 
ephrin-B reverse signalling contributes to the regulation of cell movements necessary 
for the correct migration of endothelial cells throughout development.
Blood vessel development occurs via a number of different processes. Initially, 
through a process called vasculogenesis, endothelial cells differentiate and 
proliferate, merging to form a tubular network. This is followed by angiogenesis, 
which is the process of remodelling the primary vascular plexus to form the mature 
vascular network. This involves sprouting of new blood vessels as well as splitting 
and pruning of existing vessels to generate a larger branched network (Risau, 1997).
Angiogenesis requires the accurate migration of endothelial cells to specific target 
sites. There are many critical growth factors required for the regulation of blood 
vessel formation and several studies have implicated Eph receptors and ephrins 
(reviewed in Adams, 2002; Cheng et al., 2002a). In vivo, venous endothelial cells, 
expressing EphB4, and arterial endothelial cells expressing ephrin-B2, make contact 
in fine capillary beds during development. It is thought that the EphB4-ephrin-B2 
interaction inhibits intermingling of the venous and arterial endothelial cells, and in 
this way maintains arterial-venous distinction, presumably via repulsive signals 
establishing and maintaining boundaries between the vessels (Wang et al., 1998). 
Deletion of ephrin-B2 or EphB4 results in identical defects in angiogenic 
remodelling and the phenotype is embryonic lethal (Adams et al., 1999; Gerety et al.,
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1999; Wang et al., 1998). Ephrin-B reverse signalling, and not simply forward 
signalling from the receptors, was confirmed to be required when expression of a 
truncated form of ephrin-B2, lacking the cytoplasmic domain, failed to rescue the 
angiogenesis defects associated with loss of ephrin-B2 (Adams et al., 2001). 
However, this observation was challenged in a later transgenic mouse study where 
the cytoplasmic domain of ephrin-B2 was replaced by B-galactosidase and no 
angiogenesis defects were observed (Cowan et al., 2004), demonstrating that the C- 
terminal domain of ephrin-B2 was not required during early vascular development. 
The differences between these two studies may simply be due to the type of 
mutations used leading to altered protein localisation, or possibly affecting their 
ability to cluster and function. Interestingly, mice with the B-galactosidase insertion 
in place of the cytoplasmic domain die from cardiac defects postnatally, indicating a 
potential role for ephrin-B2 in heart development (Cowan et al., 2004).
Ephrin-B2 continues to selectively mark arteries during later embryonic development 
as well as in the adult, although expression extends to the surrounding arterial 
smooth muscle (Gale et al., 2001; Shin et al., 2001a). Therefore, ephrin-B2 is 
apparently not only required during the earliest stages o f arterial/venous 
determination, but may be important during the development of arteries, perhaps by 
regulating interactions between endothelial smooth muscle cells involved in the 
formation of arterial walls (Yancopoulos et al., 2000). During angiogenesis in the 
adult, such as tumours or the female reproductive tract, the endothelium of new 
vessels re-expresses ephrin-B2 suggesting that ephrin-B2 may be important in these 
angiogenic settings (Yancopoulos et al., 2000).
In contrast to the repulsive signalling described above, ephrin-B2 can also induce 
capillary sprouting (Adams et al., 1999; Fuller et al., 2003; Palmer et al., 2002). For 
example, in vivo, ephrin-B2 deficient embryos show defective vascularisation of the 
nervous system, which would normally occur via angiogenic sprouting from the 
perineural vascular plexus (Adams et al., 1999). In vitro, ephrin-B2 has been shown 
to play a role in endothelial cell sprouting (Fuller et al., 2003).
Ephrin-B2 signalling has recently been implicated, not only in the development of 
blood vessels but also the lymphatic system (Makinen et al., 2005). The major roles
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of the lymphatic system are to maintain tissue fluid balance, provide a route for fat 
absorption in the gut and immune surveillance. Lymphatic vessels appear to originate 
from a subset of venous endothelial cells and like the blood vasculature the 
lymphatic system undergoes remodelling. However, the development of the 
lymphatic vasculature is less understood. Makinen and colleagues, using knock-in 
mice, demonstrated a requirement in vivo for the PDZ binding motif at the C- 
terminal end of ephrin-B2 in order for correct lymphangiogenic remodelling 
(Makinen et al., 2005). Two knock-in mice were generated; Ephrin-B2AV mice 
expressed ephrin-B2 lacking the C-terminal valine in the PDZ binding site and 
ephrin-B25F expressed ephrin-B2 with all 5 conserved tyrosine residues mutated to 
phenylalanine. Homozygous mutant mice survived the requirement for ephrin-B2 in 
the vascular system, however, ephrin-B2AV exhibited major lymphatic defects 
(Makinen et al., 2005). Interaction with PDZ proteins, but not tyrosine 
phosphorylation, was found to be required for lymphatic remodelling.
Despite the lack of a catalytic domain, ephrin-Bs are capable of transducing a signal 
(reverse signalling). There is in vitro evidence that this ephrin-B signalling requires 
the cytoplasmic domain of the ligand (Adams et al., 2001; Xu et al., 2003). Ephrin-B 
ligands become phosphorylated on tyrosine upon Eph receptor engagement (Bong et 
al., 2004; Bruckner et al., 1997; Cowan and Henkemeyer, 2001; Holland et al., 1996; 
Kalo and Pasquale, 1999a; Su et al., 2004), and binding of the adaptor protein Grb4 
has been shown to occur in a phosphotyrosine-dependent manner, linking ephrin-Bs 
to a range of molecules involved in actin cytoskeletal regulation, via its SH3 domains 
(Bong et al., 2004; Cowan and Henkemeyer, 2001; Su et al., 2004). Src family 
kinases have been shown to be responsible for tyrosine phosphorylation of the ligand 
upon Eph receptor binding (Bruckner et al., 1997; Holland et al., 1996; Palmer et al.,
2002). In addition, tyrosine phosphorylation of ephrin-B 1 can be induced 
independently of EphB receptor binding by PDGF and FGF (Bong et al., 2004; 
Bruckner et al., 1997; Chong et al., 2000; Palmer et al., 2002). The PDZ binding 
domain present in the cytoplasmic tail of all known ephrin-Bs has also been shown to 
mediate PDZ protein interactions in vitro (Lin et al., 1999; Lu et al., 2001; Torres et 
al., 1998).
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In this chapter, I show that EphB4-Fc stimulation of HUAECs triggers cell 
contraction, cell rounding and, in a proportion of the retracting cells, dynamic 
membrane blebbing. This response is transient, with cells recovering to a spread state 
within 30min, despite the continued presence of EphB4-Fc in the culture medium. 
Retraction requires the cytoplasmic domain of the ligand, but does not require the 
SH2/SH3 domain adaptor protein Grb4.
4.2 Results
4.2.1 Characterisation of HUAECs
Cultured arterial endothelial cells (HUAECs) have a flat morphology and form a 
monolayer, when grown to confluency on glass coverslips or plastic culture dishes 
(Fig. 4.1a), with adherens junctions between cells (Fig. 4.1b). Signalling from 
ephrin-B2 and its cognate receptor EphB4 has been implicated in regulating the 
formation and patterning of blood vessels throughout embryonic development 
(Adams et al., 1999; Gale et al., 2001; Gerety et al., 1999; Shin et al., 2001a; Wang 
et al., 1998). Using immunocytochemistry, I have confirmed that HUAECs 
endogenously express ephrin-B2 (Fig. 4.1c & red in e). HUAECs in culture were 
treated with pre-clustered EphB4-Fc that binds endogenous ephrin-B2, since this is 
the only known ligand for EphB4 (Kim et al., 2002). The cells were fixed after 
20min pre-clustered EphB4-Fc stimulation and bound receptor was detected with 
fluorescent secondary antibodies. Punctate ephrin-B2 staining was observed, 
extending to the edge of the lamellae (Fig. 4.1c & red in e). Panels f-h are controls 
for non-specific antibody binding. Cells treated with the isolated Fc portion of 
human IgG pre-clustered with anti-human IgG, show no visible staining (Fig. 4 .If). 
Ephrin-B2 expression was confirmed by western blotting of cell lysates, using 
commercially available antibodies raised against the individual ephrin-Bs. HUAECs 
were found to endogenously express all 3 members of the ephrin-B family: ephrin- 
B l, ephrin-B2 and ephrin-B3 (Fig. 4.1i). But as noted above, stimulation of 
HUAECs with EphB4-Fc should activate only ephrin-B2 (Kim et al., 2002).
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Figure 4.1 HUAECs express ephrin-B l, ephrin-B2 and ephrin-B3
ephrin-Bl ephrin-B3
jj-1 cell lysate loaded
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HUAECs were obtained as passage 1 stocks from TCS cellworks and cells between 
passages 3 and 6 were used for experiments, since those cultured beyond P6 showed 
signs of senescence. At passage 3 cells were well-spread (Fig. 4.2a), and displayed 
numerous actin stress fibres and membrane ruffles, demonstrated by staining for 
filamentous actin using TRITC-conjugated phalloidin (Fig. 4.2c). By passage 7/8 
cells are larger and flatter (Fig. 4.2b&d) and their growth rate has slowed as 
demonstrated by the increased time between passaging. Higher passage cells 
displayed an increased incidence of multiple nuclei per cell (Fig. 4.2d&e). At 
passage 3, 6% of cells had double nuclei, whereas >15% of cells at passage 7 were 
bi-nucleate (P < 0.001; Fig. 4.2e). For consistent, reliable results cells were therefore 
used before the onset of senescence.
4.2.2 Stimulation of HUAECs with EphB4-Fc triggers a dramatic 
cell retraction response
In order to characterise the response of HUAECs to ephrin-B2 signalling, sub- 
confluent cells were stimulated with pre-clustered EphB4-Fc (5pg/ml; 2:1 molar 
ratio of EphB4-Fc:anti-human IgG) and the dynamic responses observed were 
recorded by time-lapse phase microscopy (Supplementary Material: Movies 4.1 & 
4.2).
HUAECs in culture have dynamic ruffling lamellae (Fig. 4.3a). Upon EphB4-Fc 
stimulation (Fig. 4.3b) cells retract, withdrawing their margins (Fig. 4.3c) and 
leaving behind long retraction fibres (Fig. 4.3 arrows in d). Within 20min, in the 
continued presence of EphB4-Fc, this response is reversed and cells re-spread their 
lamellae along the retraction fibres they left behind (Fig. 4.3f). An increase in 
ruffling appeared to occur upon recovery (Supplementary Material: Movie 4.1), but 
further analysis would be needed to confirm this observation. A proportion of the 
retracting cells round up and display dynamic membrane blebbing (Fig. 4.4; 
Supplementary Material: Movie 4.2) characteristic of apoptotic cells. These cells also 
rapidly recover to a fully spread state within 20-40min (Fig 4.4; Supplementary 
Material: Movie 4.2).
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Figure 4.2 After passage 6 increasing num bers o f  H U A E C s appear
senescent
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Cells were stained with TRITC-phalloidin to detect F-actin (red) and DAPI to detect 
cell nuclei (blue). Passage 3 HUAECs in culture have a well-spread, flat morphology 
(a) and display actin stress fibres (c). After passage 6 cells became larger, flatter (b) 
and appeared to display fewer actin stress fibres (d). >15% cells contain double 
nuclei after passage 6 compared with only 5% at passage 3 (P < 0.001; e). (Asterisks 
refer to the increase in double nuclei compared with P3 cells).
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Figure 4.3 H U A EC s stimulated with pre-clustered EphB 4-Fc retract
then rapidly re-spread 
x40 magnification (retraction)
f  +15.5min
Phase tim e-lapse stills o f  HUA ECs stim ulated w ith pre-clustered EphB 4-Fc 
(5pg/m l). U nstim ulated H UAECs are w ell-spread and ruffling (a) Follow ing 
stimulation cells retract (c-e), and leave behind long retraction fibres (c-e; arrows in
d). Within 20min cell retraction is rapidly reversed and cells recover to display large 
membrane ruffles (f). Scale bar 15pm. (See Supplementary Material: Movie 4.1).
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Figure 4.4 HUAECs stimulated with pre-clustered EphB4-Fc retract
and a subset o f cells undergo membrane blebbing, followed by rapid 
recovery 
x20 Magnification (Blebbing)
Phase time-lapse stills of HUAECs stimulated with pre-clustered EphB4-Fc 
(5pg/ml). Unstimulated HUAECs are well-spread with ruffling lamella (a). 
Following EphB4-Fc stimulation cells retract and a proportion exhibit membrane 
blebbing (arrows in c&d). The effect is transient, after 20min EphB4-Fc stimulation 
cells recover and re-spread lamellae (e&f). Scale bar 30p,m. (See Supplementary 
Material: Movie 4.2).
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Using phase time-lapse microscopy of HUAECs in culture I have therefore revealed 
a transient cell retraction response to stimulation with pre-clustered EphB4-Fc. A 
series of distinct cellular events are observed. Initially cells round up, withdrawing 
their margins, leaving behind long retraction fibres, and a subset of cells undergo 
membrane blebbing. Retraction and blebbing are followed by rapid recovery to a 
fully spread state, despite the continued presence of EphB4-Fc.
To confirm that the repulsive response I observe is due to ephrin-B2 stimualtion by 
EphB4 receptors, HUAECs were stimulated with pre-clustered Fc molecules. This is 
the Fc portion of IgG alone, and allows a duplicate assay to be carried out in the 
absence of the EphB4 moiety. Upon addition of pre-clustered Fc no retraction or 
membrane blebbing was observed (Fig. 4.5; Supplementary Material: Movie 4.3). 
Even after 40min stimulation cells remained well spread and continued to ruffle (Fig. 
4.5f).
4.2.3 Analysis of m orphological changes seen in response to 
stimulation of HUAECs with pre-clustered EphB4-Fc
I have shown using phase time-lapse microscopy that HUAECs undergo a repulsive 
cell retraction response to treatment with soluble pre-clustered EphB4-Fc (4.2.2). In 
order to analyse the cellular changes that take place after pre-clustered EphB4-Fc 
treatment, cells were fixed and stained with the cell membrane marker Concanavalin 
A (Con A) to investigate cell shape changes, and with fluorescently tagged 
phalloidin to look at actin cytoskeletal rearrangements.
Con A is a lectin that binds to carbohydrate moieties on the surface of cells 
(specifically A-linked mannose). HUAECs, fixed with formaldehyde, were treated 
with biotinylated succinylated Con A (20pg/ml), which binds to the cell surface and 
can then be detected using the vectastain system (see 2.3.1). This method highlights 
clearly the retraction fibres left behind after cell rounding, allowing quantification of 
the extent of retraction taken place. As shown in Fig. 4.6 and seen from the time- 
lapse studies, (Fig. 4.3 & 4.4 together with movies 4.1 & 4.2), unstimulated 
HUAECs are flat with spread lamellae (Fig. 4.6a). After lOmin pre-clustered EphB4-
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Figure 4.5 H UAECs stimulated with pre-clustered Fc do not retract
b Omin
v f-
Phase time-lapse stills showing HUAECs treated with pre-clustered Fc alone 
(5p,g/ml). Unstimulated cells are well-spread and ruffling (a). Upon stimulation cells 
remained well-spread (b), continued to ruffle and showed no signs of retraction even 
after 40min stimulation (c-f). Scale bar 15p,m. (See Supplementary Material: Movie 
4.3).
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Fc stimulation dramatic cell retraction occurs, characterised by the appearance of 
long retraction fibres and withdrawal of cell margins (Fig. 4.6 arrows in b). After 
30min stimulation with pre-clustered EphB4-Fc, cells recover, re-form lamellae and 
re-spread (Fig. 4.6c).
Quantification of the response reveals that the majority of cells undergo retraction in 
response to EphB4-Fc stimulation (Fig. 4.9d). Retracting cells were counted as those 
displaying long retraction fibres or membrane blebbing. A small proportion of 
unstimulated cells exhibited retraction but this could be due to endogenous Eph 
receptor expression by the surrounding cells (data not shown) causing a low level of 
ephrin-B signalling to occur. Cell retraction peaks after lOmin with >65% cells 
retracting (P < 0.001) and >20% of these blebbing (P < 0.001; Fig. 4.6d). Phase 
time-lapse studies show that the timing of cell retraction and recovery, together with 
the extent of the response, can vary from cell to cell. This could be due to varying 
expression levels of ephrin-B2. Cells with a higher ephrin-B2 expression may exhibit 
a more dramatic response. It is known from immunocytochemistry that expression 
varies between cells and across a cell monolayer (data not shown). After 20-30min 
the extent of retraction has reduced to levels similar to those in unstimulated cells 
(Fig. 4.6d).
In order to further characterise the morphological changes taking place, F-actin 
staining using fluorescently labelled phalloidin was used, which allows a detailed 
look at the actin cytoskeleton throughout the time course of retraction. Unstimulated 
cells display actin-rich membrane ruffles and contain numerous actin stress fibres 
(Fig.4.7a). By lOmin cells have retracted leaving behind long actin-rich retraction 
fibres (Fig. 4.7 arrows in b), and a proportion of cells undergo the more exaggerated 
response of membrane blebbing (Fig. 4.7c). As the cells retract there appears to be a 
re-arrangement of actin stress fibres (Fig. 4.7b). By 20min the majority of cells have 
recovered, displaying large lamellae and strikingly very few, if any, actin stress 
fibres (Fig. 4.7d). A rearrangement of the actin cytoskeleton occurs as a consequence 
of EphB4-Fc triggered ephrin-B2 signalling.
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F ig u re  4 .6  Q u a n tif ic a t io n  o f  re tra ct io n  and b le b b in g  a fter
stimulation o f  H U A EC s with pre-clustered EphB4-Fc
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Staining for Concanavalin A highlights the dramatic retraction seen upon treatment 
with pre-clustered EphB4-Fc (5pg/m l). Unstimulated cells are well-spread (a). After 
lOmin EphB4-Fc stim ulation retraction  was observed, characterised by the 
appearance o f  long retraction fibres (arrows in b), and by 30min the cells have re­
spread (c). Quantification shows that a transient increase in both retraction (ANOVA 
P < 0.0001) and blebbing (ANOVA P < 0.0001) occurs over time. After lOmin pre­
clustered EphB4-Fc stimulation, >65% o f cells had retracted (P < 0.001; d) and 20% 
o f these exhibited membrane blebbing (P < 0.001; d). The cells quickly recover from 
these shape changes. By 20m in post-stim ulation retraction and blebbing have 
reduced to near control levels (d). The experiment was repeated >10 times with a 
minimum of 1000 cells counted in total per time point. (Asterisks denote statistical 
difference compared with unstimulated cells). Scale bar 15pm.
149
Figure 4.7 Actin changes seen upon treatm ent o f H U A EC s with  
EphB4
HUAECs were stained for F-actin w ith TRITC-phalloidin. Unstimulated HUAECs 
contain numerous actin stress fibres and are well-spread with ruffling lamella (a). 
After stimulation with pre-clustered EphB4-Fc (5pg/m l) for lOmin cells retract (b) 
leaving behind actin-rich retraction fibres (arrows in b). Blebbing occurred in >20% 
o f cells (c). Despite the continued presence o f EphB4-Fc these shape changes were 
rapidly reversed. After 20min the majority o f  cells are well-spread, but strikingly 
lack actin stress fibres (d). Scale bar 15pm.
150
4.2.6 Substrate bound EphB4 is repulsive to ephrin-B2 expressing 
HUAECs
As stated previously both Eph receptors and ephrins are membrane-tethered proteins. 
Therefore in order for signalling to occur in vivo, cell-cell contact is crucial. One 
assay that replicates this more fully than stimulation with soluble receptor bodies is 
the stripe assay. Pre-clustered EphB4-Fc was immobilised on coverslips in 
alternating stripes consisting of pre-clustered EphB4-Fc versus Fc alone (EphB4/Fc). 
HUAECs were then plated onto these EphB4/Fc striped coverslips, thus 
encountering the receptor in a more physiologically relevant manner. As a control, 
HUAECs were also plated onto coverslips patterned with alternating stripes of pre­
clustered Fc alone (Fc/Fc). After 24h the cultures were fixed and migrating HUAECs 
were detected using FITC-conjugated phalloidin to detect F-actin (green). EphB4-Fc 
(or Fc in the control) was localised with antibodies that recognise the anti-human 
IgG used for clustering (visualising the red stripes).
When offered the choice between EphB4-Fc versus Fc alone, HUAECs exhibit a 
preference for migration on the black, non-receptor stripes (Fig. 4.8a-c), displaying a 
repulsive response to substrate bound EphB4. 77.6% of cells migrated onto the Fc 
stripes with only 22.4% of cells on the EphB4 stripes (P <0.01; Fig. 4.8g). If 
distribution of cells is truly random, 55% of cells would lie on the red stripes 
(EphB4-Fc) and 45% on the black stripes (Fc), due to the width of the red stripes 
being 50pm and the black stripes 40pm. In the control situation where HUAECs 
were plated onto substrata consisting of alternating stripes of pre-clustered Fc, 
HUAECs showed no preference in their migratory behaviour (Fig. 4.8d-f). 53.9% of 
cells adhered to the wider red stripes and 46.1% to the black stripes as expected (Fig. 
4.8g). It is also noted that cells plated onto the EphB4-Fc/Fc patterned coverslip 
undergo morphological changes. The cells no longer appear flat and well-spread 
(Fig. 4.8e & green in f), but become elongated in appearance (Fig. 4.8b & green in 
c). This allows the cells to lie in between the EphB4-Fc stripes (Fig. 4.8c). These 
findings corroborate the repulsive retraction response seen in response to soluble pre­
clustered EphB4-Fc stimulation during phase time-lapse microscopy, and by 
immunocytochemistry.
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Figure 4.8 H UAECs display a repulsive response to substrate-bound
EphB4-Fc
OFF RED STRIPES
HUAECs were cultured on alternating stripes o f pre-clustered EphB4-Fc/Fc versus 
Fc/Fc. Stripes were visualised by detection o f the IgG used for clustering (red). 
HUAECs were visualised by FITC-phalloidin used to detect F- (green). HUAECs 
avoid stripes containing EphB4-Fc and become elongated in appearance (b & c). 
Cells migrate randomly over the Fc stripes and remained well-spread (e & f). If  
distribution was random 55% o f cells would lie on red stripes and 45% off, due to 
the slightly larger w idth o f  red stripes. This was true for cells on the Fc striped 
coverslip (g). However, >75% o f cells avoided the EphB4-Fc stripes (P < 0.01; g). 
The experiment was repeated 3 times and a minimum o f 200 cells counted per 
experiment. Scale bar 62.5p.m.
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4.2.7 Removal of serum factors does not affect cell retraction 
triggered by EphB4
In chapter 3, I observed that Swiss 3T3 cells exogenously expressing ephrin-B2 
undergo a loss of cell-cell contact response to EphB receptor stimulation. This effect 
was shown to be dependent on the presence of serum factors or FGF. In order to 
determine if HUAEC retraction requires serum factors, cells were depleted of serum 
and growth factors for 16h before EphB4-Fc stimulation. Unlike Swiss 3T3 cells, 
which lose their actin stress fibres upon starvation, HUAECs exhibited no obvious 
changes to their morphology or actin cytoskeleton (Fig. 4.9a&b). Upon pre-clustered 
EphB4-Fc stimulation, cells retracted their margins and exhibited long retraction 
fibres (Fig. 4.9c&d). Serum-starvation resulted in no difference in the levels of 
retraction or blebbing observed compared with non-starved cells. Therefore serum 
appears not to be a contributory factor to EphB4-Fc induced cell retraction in 
HUAECs. However, it is possible that growth factors are adsorbed by the gelatin 
matrix, and can then be utilised by cells upon serum-starvation, rendering it 
ineffective. This is suggested by the fact that actin-stress fibres remain after the 
removal of serum and growth factors from the culture medium.
4.2.8 The cytoplasmic domain of ephrin-B2 is required for EphB4 
triggered retraction in HUAECS, but Grb4 is not required
In order to attempt to determine the mechanism of signalling underlying EphB4 
triggered cell retraction, I have expressed various ephrin-B2 mutant constructs by 
microinjection. The effects of these mutations were then analysed and a clearer 
picture of the signalling domains necessary for retraction obtained. To confirm that 
microinjection did not result in adverse effects for the injected HUAECs, empty 
vector alone (pRK5; 200pg/ml), plus biotin dextran (2mg/ml) as an injection marker, 
was microinjected into sub-confluent cells. As expected, a normal retraction response 
was seen, with just over 60% pRK5-injected cells retracting (Fig. 4.10d). Over­
expression of full-length ephrin-B2 (200pg/ml) prior to treatment with pre-clustered 
EphB4-Fc caused a dramatic shift towards cell rounding and produced an
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Figure 4.9 The effect o f  serum  starvation on EphB 4-Fc induced  cell
retraction and mem brane blebbing
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F-actin was detected using TRITC-phalloidin. Unstimulated HUAECs are well- 
spread, flat cells rich in actin stress fibres (a). Serum-starvation does not affect cell 
morphology and cells retained their actin stress fibres (b). Serum-starvation did not 
affect the retraction response to EphB4-Fc stimulation (b-f). The levels of retraction 
and blebbing observed under serum-starved conditions were not different to those 
exhibited by non-starved cells (e & f). The experiment was repeated 3 times with a 
minimum of 300 cells counted in total per condition. Scale bar 15pm.
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exaggerated cell retraction response (Fig. 4.10a-c), with 91% of cells retracting 
compared to only 62% of pRK5-injected cells (P <0.01; Fig. 4.10d).
Numerous studies have described the functional importance of the cytoplasmic 
domain of ephrin-Bs, in particular the last 33 amino acids (Adams et al., 2001; 
Cowan and Henkemeyer, 2001; Tanaka et al., 2005; Xu et al., 2000). Truncated 
ephrin-B2, (comprising residues 1-253), lacks the entire intracellular domain 
including the functionally important tyrosine residues (Bong et al., 2004; Kalo et al., 
2001; Su et al., 2004), and the PDZ binding domain. Expression of truncated ephrin- 
B2 (200fig/ml) in HUAECs, prior to pre-clustered EphB4-Fc stimulation, triggered a 
weaker retraction response than over-expression of full-length ephrin-B2 (P < 
0.001), equal to that observed for pRK5-injected cells (Fig. 4.10g-h). This suggests 
that the ephrin-B2 cytoplasmic domain is necessary for retraction, since the enhanced 
response seen after over-expression of full-length ephrin-B2 does not occur.
Expression of a mutant construct where all 5 functionally important tyrosine 
phosphorylation sites have been mutated to phenylalanine (5Y-F ephrin-B2; 
200pg/ml), prior to pre-clustered EphB4-Fc stimulation, triggered a level of 
retraction between endogenous signalling and over-expressed full-length ephrin-B2 
(Fig 4.10g). The same was true when a construct with a mutation in the PDZ binding 
domain (ephrin-B2AV; 200pg/ml) was expressed. Due to the endogenous expression 
of ephrin-B2 by HUAECs, mutant ephrin-B2 constructs cannot act as non-functional 
proteins. The endogenous ephrin-B signalling is able to compensate for the mutations 
introduced. As a result, introduction of mutant constructs in this way is not as 
informative as a system where no basal level of signalling is present.
The SH2/SH3 domain adaptor protein Grb4 has been shown to bind to ephrin-B 1 in a 
phosphotyrosine dependent manner and initiate actin cytoskeletal changes (Cowan 
and Henkemeyer, 2001). I have shown that the loss of cell-cell contact response seen 
in Swiss 3T3 cells, upon EphB2 stimulation of exogenous ephrin-B2, is Grb4 
dependent (see chapter 3). In order to discover whether the retraction response seen 
upon initiation of ephrin-B2 signalling in HUAECs is also Grb4 dependent, a 
dominant negative Grb4 construct was expressed in HUAECs prior to pre-clustered 
EphB4-Fc stimulation. Unlike the mutant ephrin-B2 constructs introduced via
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microinjection, this construct can act as a dominant negative. The construct 
comprises the Grb4 SH2 domain alone and therefore retains the ability to bind to 
endogenous ephrin-Bs but is unable to initiate downstream signalling events due to 
the lack of SH3 domains, which are known binding sites for many downstream 
signalling molecules. Expression of dnGrb4 (200pg/ml) resulted in no inhibition of 
either retraction or blebbing compared with control injection o f pRK5 (Fig. 
4.11a&b). Therefore, unlike the loss of cell-cell contact observed in response to 
clutsering of exogenous ephrin-B2 in Swiss 3T3 cells, Grb4 is not necessary for 
retraction and blebbing as a result o f ephrin-B2 signalling in HUAECs, suggesting 
that a different signalling pathway is used to generate this repulsive response.
Cells microinjected with ephrin-B2 or other mutant constructs were also stimulated 
with pre-clustered Fc for lOmin to confirm that the effects seen were specific to 
EphB4 stimulation. No difference in the level of retraction was observed regardless 
of the construct injected (Fig. 4.10d&e; Fig. 4.11).
4.3 Discussion
In this chapter, I have described the repulsive response of HUAECs to ephrin-B2 
signalling after both soluble Eph receptor treatment and interaction with substrate 
bound Eph receptor. Stimulation of sub-confluent HUAECs in culture, which 
endogenously express ephrin-Bs, with pre-clustered EphB4-Fc, results in rapid cell 
retraction characterised by the withdrawal of cell margins, and the appearance of 
long actin-rich retraction fibres; a proportion of the cells round up and undergo 
membrane blebbing (Figs 4.6 & 4.7). Retraction peaks lOmin after Eph receptor 
addition (Fig. 4.6). The response is transient, the majority of cells having recovered 
and re-spread lamellae within 30min (Fig. 4.6), concomitant with a loss of actin 
stress fibres (Fig. 4.7). The retraction response occurs independently of serum 
factors, (Fig. 4.9), and Grb4, (Fig. 4.11).
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Figure 4.10 The im portance of the cytoplasm ic domain o f ephrin-B2  
for EphB4 triggered cell retraction
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HUAECs were microinjected with various mutant ephrin-B2 constructs (200jxg/ml) 
together with biotin dextran (2mg/ml) as an injection marker (blue), and the effect on 
the EphB4-triggered retraction response was investigated. F-actin was detected using 
TRITC-phalloidin (red). Expression of pRK5 alone resulted in 61% cells retracting 
(d). Over-expression of full-length ephrin-B2 caused a dramatic shift in the response 
towards cell rounding (a-c) and an enhanced retraction response, with 91% injected 
cells retracted (P < 0.01; d). Truncated ephrin-B2, lacking the entire cytoplasmic 
domain did not trigger an increased retraction response (d). Over-expression of 5Y- 
F ephrin-B2, where all the tyrosine residues have been mutated to phenylalanine and 
ephrin-B2 with a mutation in the PDZ binding domain (ephrin-B2AV) did not cause 
an inhibition of retraction (d). No retraction above control levels was observed upon 
stimulation of expressed constructs with pre-clustered Fc for lOmin (d). Each 
experiment was carried out a minimum of 5 times with at least 250 cells counted in 
total per condition. (Red asterisks denote statistical significance compared to full- 
length ephrin-B2. Black asterisks refer to pRK5-injected cells). Scale bar 15p,m.
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Figure 4.11 Grb4 is not required for the retraction response
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HUAECs were microinjected with a dominant negative Grb4 construct (200pg/m l), 
comprising the isolated SH2 domain o f  Grb4, plus biotin dextran (2mg/ml). Upon 
stimulation with pre-clustered EphB4-Fc (5pg/m l) for lOmin no difference in the 
level o f  retraction (a) and blebbing (b) was observed, com pared w ith control 
injections o f pRK5 (200pg/m l) plus biotin dextran (2mg/ml). Cells expressing 
dnGrb4 stim ulated w ith pre-clustered Fc for lOmin do not exhibit retraction or 
blebbing (a&b). The experim ent was carried out 5 times with a m inim um  o f  250 
cells counted in total per condition.
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4.3.1 Ephrin-B2 signalling triggers a cell retraction response in 
HUAECs independently of serum factors and Grb4
In chapter 3 ,1 described a loss of cell-cell contact response to pre-clustered EphB2- 
Fc stimulation by ephrin-B2 expressing Swiss 3T3 fibroblasts, that required the 
presence of serum factors or FGF and binding of the adaptor protein Grb4. FGF has 
previously been shown to phosphorylate ephrin-B ligands. The activated fibroblast 
growth factor receptor (FGFR) can induce tyrosine phosphorylation of ephrin-Bs in 
chick primary retina in vivo (Chong et al., 2000), and in Xenopus oocytes (Bong et 
al., 2004). Grb4 is able to bind to ephrin-Bs in a phosphotyrosine dependent manner 
and, via its SH3 domains, can recruit various signalling molecules involved in 
regulating the actin cytoskeleton such as cyclase associated protein (CAP) (Cowan 
and Henkemeyer, 2001). However, the response described in HUAECs, as a result of 
pre-clustered EphB4-Fc stimulation, is regulated by a different signalling pathway. 
Retraction and blebbing are not dependent on serum factors and the response does 
not require Grb4.
Serum-starvation of HUAECs, together with removal of growth factors, did not 
affect the level of retraction and blebbing observed upon pre-clustered EphB4-Fc 
treatment. This finding supports the results of Cowan and Henkemeyer who 
demonstrated EphB2-triggered cell rounding of ephrin-B 1 expressing Baby Hamster 
Kidney (BHK) cells, that happened to be serum-starved (Cowan and Henkemeyer, 
2001), but differs from results I described in chapter 3, where serum factors were 
required for loss of cell-cell contact in response to ephrin-B2 clustering. However, it 
should be noted that unlike Swiss 3T3 cells, that lose actin-stress fibres upon serum 
depletion, this is not the case for HUAECs or BHKs, indicating they may not be truly 
growth factor free. HUAECs are plated onto a gelatin substrate and this may bind 
serum factors (growth factors, serum lipids) that may remain available after serum- 
starvation, rendering it less effective.
The results presented in this chapter describe a repulsive retraction response to 
ephrin-B2 signalling, that is not dependent on Grb4, as demonstrated by the failure 
of dominant negative Grb4 to inhibit cell retraction. However, this finding does not
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corroborate those of Cowan and Henkmeyer, who describe cell rounding in response 
to pre-clustered EphB2-Fc stimulation of ephrin-B 1 expressing BHK cells, which is 
dependent on Grb4 binding to ephrin-B 1 in a phosphotyrosine dependent manner 
(Cowan and Henkemeyer, 2001). In addition, the lack of a requirement for Grb4 does 
not corroborate the results presented in chapter 3, describing a loss of cell-cell 
contact response to ephrin-B2 clustering in Swiss 3T3 fibroblasts that is dependent 
on Grb4. However, In 2003 Xu and colleagues highlighted another example of cell 
rounding in response to ephrin-B 1 activation. Over-expression of ephrin-B 1 in HEK 
293 cells led to cell rounding which occurred independently of Grb4 binding (Xu et 
al., 2003) and would therefore agree with the Grb4 independent cell retraction 
phenotype observed in HUAECs. Interestingly, data from the Nobes laboratory has 
recently shown Grb4 to be important for the re-spreading event that follows cell 
retraction in response to ephrin-B2 signalling. However, the importance of Grb4 in 
order that cells can recover to re-spread lamellae remains to be determined.
4.3.2 Development of the vasculature
Genetic experiments carried out by many groups have unequivocally demonstrated 
the importance of bi-directional Eph/ephrin signalling during vascular development 
(reviewed in Davy and Soriano, 2005). However, such studies have provided limited 
information about the cellular consequences of activation of EphB receptors and 
ephrin-B ligands. The findings at this stage appear contradictory. EphB receptor 
activation has been demonstrated to increase the migration, adhesion and 
proliferation of endothelial cells (Adams et al., 1999; Maekawa et al., 2003; Stein et 
al., 1998b; Steinle et al., 2002), and can promote endothelial sprouting (Adams et al., 
1999; Stein et al., 1998b). In contrast activation of EphBs has also been shown to 
inhibit endothelial cell migration, proliferation and sprouting (Fuller et al., 2003; 
Hamada et al., 2003; Kim et al., 2002; Sturz et al., 2004). Similarly, ephrin-B2 
activation has been shown to increase endothelial cell migration, adhesion, sprouting 
and proliferation (Fuller et al., 2003; Hamada et al., 2003; Huynh-Do et al., 2002; 
Steinle et al., 2003), but also to decrease sprouting activity (Zhang et al., 2001). The 
reason for the observed differences in response is not known. It could be due to the 
different cell types used or, alternatively, a result of differing experimental
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conditions. For example, some studies investigated the effect on VEGF induced 
endothelial migration (Kim et al., 2002; Sturz et al., 2004), whereas in other systems 
the receptor/ligand alone was sufficient (Steinle et al., 2003).
The findings from this study would support a model for both endothelial cell 
repulsion and attraction in response to ephrin-B2 signalling. Cycles of endothelial 
cell retraction and recovery may be necessary for the correct migration of cells 
throughout blood vessel development and the specification of arteries and veins. 
However, more work is needed in order to investigate this further.
4.3.3 Significance of membrane blebbing
In this chapter, I have demonstrated that a subset of HUAECs can undergo 
membrane blebbing as a consequence of ephrin-B2 signalling. Membrane blebbing is 
defined as the protrusion and subsequent retraction of plasma membrane bound blebs 
on the surface of cells and is a morphological change characteristic of apoptotic cells. 
During apoptosis cells undergo a loss of matrix attachment and retraction followed 
by plasma-membrane blebbing, which is usually transient. Cell fragmentation and 
death then follow (Vermeulen et al., 2005). The Rho GTPase target ROCK I has 
been shown to be cleaved by caspases during apoptosis (Coleman et al., 2001) and 
ROCK I is known to stimulate actomyosin-based contractility. ROCK can activate 
myosin light chain kinase indirectly, by phosphorylating the myosin binding subunit 
of myosin light chain phosphatase. This renders it inactive and therefore prevents 
dephosphorylation of myosin light chain allowing actomyosin contractility (Amano 
et al., 1996; Kimura et al., 1996). In addition, ROCK can act directly, by 
phosphorylating myosin light chain kinase itself in some systems (Amano et al., 
1996).
Membrane blebbing in this instance, displayed in a proportion of HUAECs 
stimulated with pre-clustered EphB4-Fc, is not a sign of apoptosis. ROCK I is not 
cleaved (data not shown), and the cells are not dying, they rapidly recover to re­
spread lamellae, as demonstrated by phase time-lapse microscopy (Supplementary 
Material; Movie 4.1 & 4.2). Membrane blebbing could simply be a more dramatic
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retraction response. Those cells that undergo membrane blebbing may express higher 
levels of ephrin-Bs than those that simply retract their margins. Membrane blebbing 
is not a phenomenon restricted to apoptotic cells. Blebs have been observed at the 
leading edge of migrating cells, playing a role in cell locomotion (Grinnell, 1982; 
Keller et al., 1985; Trinkaus, 1973; Trinkaus, 1980) and blebbing has been seen to 
precede cell spreading after plating cells in tissue culture dishes (Bereiter-Hahn et al., 
1990; Cunningham, 1995; Hoglund, 1985).
Since ROCK has a role to play in actomyosin contractility, and the 
retraction/blebbing response to ephrin-B2 signalling followed by re-spreading is 
reminiscent of a contraction event, the role of ROCK in cell retraction as a result of 
ephrin-B2 signalling in HUAECs will be investigated in chapter 5.
4.3.4 The cytoplasmic domain of ephrin-B2 is im plicated in 
retraction triggered as a result of ephrin-B2 activation
Microinjection experiments introducing mutant ephrin-B2 constructs into HUAECs 
have proved to have a limited use. Swiss 3T3 fibroblasts, which do not express 
ephrin-B2, can be microinjected with mutant constructs to determine the effect of 
specific mutations on the loss of cell-cell contact observed as a result o f exogenous 
ephrin-B2 clustering. This is not the case in HUAECs. Endogenous ephrin-B2 
triggers a retraction response that is not blocked by over-expression of truncated or 
mutant ephrin-B2 constructs. However, an exaggerated response was observed upon 
injection of full-length ephrin-B2, with an increased number of cells responding and 
a much higher incidence of cell rounding. A requirement for the cytoplasmic domain 
of ephrin-B2 for these responses is therefore suggested by the reduction of retraction 
down to below endogenous levels, upon stimulation of truncated ephrin-B2, which 
lacks the entire intracellular domain.
Phosphorylation on tyrosine residues was the first reported indication of reverse 
signalling (Bruckner et al., 1997) and ephrin-Bs have been shown to become tyrosine 
phosphorylated in numerous studies (Cowan and Henkemeyer, 2001; Palmer et al., 
2002; Tanaka et al., 2005). However, expression of 5Y-F ephrin-B2, in which all five
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potential tyrosine phosphorylation sites in the carboxy-terminal tail have been 
mutated to phenylalanine, prior to pre-clustered EphB4-Fc stimulation, triggers a 
level of retraction in between that of full-length ephrin-B2 stimulation and 
endogenous signalling. A range of PDZ domain protein interactions with ephrin-Bs 
are known to occur (Bruckner et al., 1999; Lin et al., 1999; Lu et al., 2001; Palmer et 
al., 2002; Torres et al., 1998). For example, PDZ-RGS3 has been shown to be 
essential for ephrin-B mediated neuronal cell migration in vitro (Lu et al., 2001). In 
vivo the PDZ interaction site has recently been shown to be required for remodelling 
of the lymphatic vasculature (Makinen et al., 2005) and also for midline fusion 
events (Davy et al., 2004). PICK-1, PDZ-RGS3 and Dvl2 are all expressed in the 
lymphatic endothelium, and the localisation patterns of PDZ-RGS3 and Dvl2 were 
altered in mutant mice homozygous for a mutation in the C-terminal valine of the 
PDZ binding motif (ephrin-B2AV/AV) (Makinen et al., 2005) suggesting a direct 
interaction and a function as ephrin-B2 effectors in this tissue. In HUAECs over­
expression of ephrin-B2AV resulted in a level of retraction midway between that seen 
upon stimulation of expressed full-length ephrin-B2 and endogenous signalling. The 
results from both 5Y-F ephrin-B2 and ephrin-B2AV over-expression were therefore 
inconclusive. Interestingly, the cell rounding response to ephrin-B 1 activation 
described by Xu and colleagues was shown to be independent o f tyrosine 
phosphorylation and PDZ domain protein interactions, requiring residues in the 
cytoplasmic domain other than the last 33 amino acids (Xu et al., 2003). This 
phenotype was also independent of Grb4. Since EphB4 triggered retraction in 
HUAECs is independent of Grb4 it may suggest that the signalling pathway utilised 
here is also independent of tyrosine phosphorylation and PDZ domain protein 
interactions.
Src family kinases have been shown to be involved in tyrosine phosphorylation of 
ephrin-Bs (Palmer et al., 2002). In an attempt to determine whether a requirement for 
tyrosine phosphorylation does exist, the involvement of Src family kinases in the 
retraction response to ephrin-B2 signalling in HUAECs was investigated. Two 
pharmacological inhibitors were tested, PP2 and SU6656. However, results obtained 
from these experiments were inconclusive since pre-treatment caused cells to retract 
even in the control situation, without EphB4 stimulation.
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4.3.5 Conclusions
HUAECs endogenously expressing ephrin-B2 undergo a repulsive response to 
stimulation with both soluble and substrate bound EphB4-Fc. Treatment of HUAECs 
with soluble EphB4-Fc triggers a dramatic retraction response and, in a subset of 
cells, membrane blebbing. The response is transient, cells re-spread lamellae within 
30min, concomitant with a loss of actin stress fibres. Cell retraction and blebbing is 
independent of Grb4, since dominant negative Grb4 did not block the response.
Cell rounding as a consequence o f ephrin-B 1 activation has recently been 
demonstrated by two groups (Cowan and Henkemeyer, 2001; Xu et al., 2003). 
However, the signalling pathways mediating this response differ dramatically. Cell 
rounding can occur as a result of tyrosine phosphorylation-dependent Grb4 binding 
(Cowan and Henkemeyer, 2001), and also independently o f tyrosine 
phosphorylation, PDZ domain protein interactions and Grb4, but requiring c-jun 
amino terminal kinase (JNK) activity (Xu et al., 2003).
The retraction response described in HUAECs does not require Grb4, is rapid, 
peaking after lOmin pre-clustered EphB4-Fc stimulation, and transient with cells 
having re-spread their lamellae within 30min. In BHKs cell rounding and loss of 
actin stress fibres was observed much later, after 6h pre-clustered EphB2-Fc 
stimulation, and the response was not transient (Cowan and Henkemeyer, 2001). 
However, in HUAECs endogenous protein is activated, but in BHKs ephrin-B 1 was 
expressed by transfection. It is also possible that the responses could be cell-type 
dependent. Interstingly Cowan and Henkemeyer did report a loss of actin stress 
fibres concomitant with cell rounding and this finding is corroborated upon re­
spreading of EphB4 stimulated HUAECs.
The data presented in this chapter do corroborate that of Xu and colleagues, where 
ephrin-B 1 activation resulted in cell rounding independently of Grb4 as is the case 
here. In that study, JNK activity was found to be crucial for cell rounding (Xu et al., 
2003). In this study, cell rounding occurs as a result of ephrin-B2 signalling and a 
potential role for JNK in HUAEC retraction as a result of EphB4 stimulation will be
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investigated in chapter 5. In addition, since the small GTPase Rho is known to 
regulate actin stress fibre formation, and a loss of actin stress fibres is observed upon 
re-spreading, I have investigated the involvement of Rho in the retraction and 
subsequent recovery of HUAECs in response to pre-clustered EphB4-Fc stimulation.
In Swiss 3T3 cells, exogenous ephrin-B2 clustering resulted in a Grb4 dependent 
loss of cell-cell contact response (see chapter 3) reminiscent of the cell rounding seen 
after ephrin-B 1 activation in BHK cells (Cowan and Henkemeyer, 2001). However, 
stimulation of ephrin-B2 in HUAECs triggers a cell rounding event independently of 
Grb4, as described after ephrin-B 1 activation in HEK 293 cells (Xu et al., 2003). 
These data highlight the fact that there are two distinct pathways in operation 
regulating ephrin-B mediated cell adhesion.
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Chapter 5
Retraction and blebbing 
triggered by ephrin-B2 
signalling is mediated by 
Rho, ROCK and JNK 
activity
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5.1 Introduction
In chapter 4, I showed that stimulation of HUAECs, that endogenously express 
ephrin-Bs, with pre-clustered EphB4-Fc, triggered a dramatic cell retraction event 
characterised by cell rounding, the appearance of long retraction fibres and, in a 
proportion of cells, membrane blebbing. Retraction is not dependent on the presence 
of serum factors or Grb4, suggesting that it is not dependent on tyrosine 
phosphorylation of ephrin-B2, but requires the intracellular domain of the ligand.
Numerous signalling proteins and adaptor molecules capable of interacting with 
ephrin-Bs have been identified (see 1.8), and the importance of reverse signalling 
into the ephrin expressing cell, has been demonstrated by in vitro and genetic studies. 
However, the underlying mechanism of ephrin-B activation, and the downstream 
signal transduction pathways involved remain unclear. The cell rounding and 
subsequent re-spreading response to ephrin-B2 signalling that I described in chapter 
4 is reminiscent of a cell contraction event. Therefore, in an effort to elucidate further 
the signalling pathways downstream of ephrin-B2 in this retraction assay, a potential 
role for Rho family GTPases, the RhoA-associated kinase ROCK, and the MAP 
kinase c-Jun amino terminal kinase (JNK) were investigated.
Through its ability to promote both protrusion and contraction, the actin cytoskeleton 
is the driving force for cell migration. The molecular control of actin filament 
assembly and disassembly underlies cell motility, and the Rho family of small 
GTPases are particularly important for the actin reorganisations that take place 
during cell migration. Rho regulates stress fibre formation (Ridley and Hall, 1992), 
while Rac and Cdc42 regulate lamellipodia and filopodia respectively (Nobes and 
Hall, 1995; Ridley et al., 1992). Rho is known to induce stress fibre and focal 
adhesion formation by stimulating contractility and many cell types utilise contractile 
actin and myosin filaments to induce rapid, reversible changes in shape. A known 
down-stream target of Rho is the effector protein Rho kinase (ROCK). ROCK is 
known to stimulate actomyosin-based contractility by inducing the phosphorylation 
of the myosin regulatory light chain. This has been shown to occur both indirectly, 
via phosphorylation, and subsequent inactivation, of myosin light chain phosphatase
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(Kimura et al., 1996), or directly, by phosphorylating myosin light chain kinase 
(MLCK) itself in some cell systems (Amano et al., 1996). Due to the rapid 
contraction response displayed by HUAECs in response to receptor stimulation, Rho 
and ROCK activity could be necessary for retraction to occur. In addition, the 
response is transient, followed by re-spreading, and upon recovery cells have lost 
their actin stress fibres, as described in chapter 4 (Fig. 4.7). Investigation into how 
ephrin-B ligands can modulate the actin cytoskeleton, potentially through the family 
o f Rho GTPases, may shed light on the regulation of cell migration by ephrin-B 
reverse signalling.
A recent study highlighted a role for JNK activity in cell rounding induced by 
ephrin-B 1 activation (Xu et al., 2003). In addition, earlier studies have shown JNK to 
be phosphorylated when both the forward (via Eph receptor) and reverse (via ephrin 
ligand) signalling pathways are switched on (Huynh-Do et al., 2002; Stein et al., 
1998a). Accumulating evidence implicates the c-Jun amino terminal kinase (JNK) 
pathway in the regulation of cell migration, although the precise nature o f JNK 
involvement, and the signalling pathways downstream of JNK activation are unclear. 
For example, JNK activation correlates with an increase in cell migration in several 
cell types (Abassi and Vuori, 2002; Hauck et al., 2001; Huynh-Do et al., 2002). In 
addition, the signalling molecules that activate JNK are essential for cell migration 
(Shin et al., 2001b; Xia et al., 2000; Yujiri et al., 2000), and inhibition of JNK 
impairs cell migration rates in several cell types, such as smooth muscle cells and 
Schwann cells (Kavurma and Khachigian, 2003; Yamauchi et al., 2003). JNK has 
also been shown to play a role in the migration of fibroblasts in wound healing 
assays (Javelaud et al., 2003), and in some aspects of cytoskeletal reorganisation in 
both Drosophila (Kaltschmidt et al., 2002; Martin-Bianco et al., 2000), and 
mammalian cells (Zhang et al., 2003). Also, several cytoskeleteton-associated 
proteins as well as adaptor proteins have recently been identified as JNK substrates, 
such as the actin-binding protein Spir (Otto et al., 2000) and the focal adhesion 
adaptor protein paxillin (Huang et al., 2003). Taken together these findings clearly 
implicate JNK in the control of cell migration in a broad range of cell types and in 
several developmental processes.
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In this chapter, I have shown that EphB4 induced cell retraction in HUAECs is 
driven by actomyosin based contractility, and is dependent on both Rho and ROCK 
activity. JNK appears to be acting upstream of Rho-ROCK signalling. Interestingly, 
despite Rho being required for cell retraction to occur, Rho activity is dramatically 
down regulated at later times, coincident with a loss of actin-stress fibres seen during 
recovery and re-spreading of lamellipodia.
5.2 Results
5.2.1 Cell retraction induced by ephrin-B2 signalling is driven by 
acto-myosin contraction and dependent on Rho/ROCK signalling
The rapid cell retraction event I observe in response to pre-clustered EphB4-Fc 
stimulation of HUAECs could be driven by contraction of actin-myosin filaments 
leading to a cell contraction event. The Rho-ROCK pathway is known to be 
important for cell contractility to occur. Smooth muscle cell contraction and 
membrane blebbing during apoptosis are two examples of events mediated by the 
Rho-ROCK pathway (Coleman et al., 2001; Uehata et al., 1997). I therefore 
investigated a potential role for ROCK and acto-myosin contractility in this assay,
To determine the role of ROCK activity during the retraction response to ephrin-B2 
activation, the effect of Y27632 on cell behaviour was investigated. Y27632 is a 
specific inhibitor of ROCK activity, with a similar IC50 for both ROCK isoforms 
(Ishizaki et al., 2000; Uehata et al., 1997). As described in chapter 4, cells stimulated 
with pre-clustered EphB4-Fc for lOmin retracted and withdrew their cell margins (P 
< 0.001; Fig. 5.1a). Pre-treatment with the ROCK inhibitor Y27632 (20pM) for 
30min resulted in a loss of actin stress fibres (Fig. 5.1b), and upon stimulation with 
pre-clustered EphB4-Fc, the cells remained well-spread and did not undergo 
retraction or blebbing compared to treatment with pre-clustered Fc alone (Fig 5.1b 
and d-e).
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HUAECs were stained for F-actin using TRITC-phalloidin. Stimulation with pre- 
clustered EphB4-Fc (5pg/m l) for lOmin resulted in dramatic cell retraction (P < 
0.001; arrows in a). Pre-treatment with the Rho kinase inhibitor Y27632 (20pM ; b) 
or the myosin II ATPase inhibitor blebbistatin (lOOpM; c), caused a loss o f  actin 
stress fibres, and the cells rem ain w ell-spread after pre-clustered EphB4-Fc 
stim ulation (b & c). Quantification o f the percentage o f  cells retracting (d) and 
blebbing (e) demonstrates that both Y27632 and blebbistatin, inhibit retraction and 
blebbing down to control levels (b-e). Treatment with Fc alone does not cause 
retraction (d) or blebbing (e). Pre-treatm ent with DMSO prior to EphB4-Fc 
stimulation had no significant effect with respect to retraction and blebbing (d & e). 
Asterisks denote statistical difference with respect to control Fc stimulation. Scale 
bar 15 pm.
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The same was true if cells were pre-treated with blebbistatin, a small molecule 
inhibitor of both muscle and non-muscle myosin II. This molecule inhibits the 
ATPase activity of myosin II and therefore actin-myosin contraction (Kovacs et al., 
2004; Straight et al., 2003). Cells were pre-treated with blebbistatin (lOOpM) for 
30min prior to pre-clustered EphB4-Fc treatment. Cells lost their actin stress fibres 
upon blebbistatin treatment and during time-lapse microscopy it was observed that 
slight morphological changes occured as a result of blebbistatin treatment. Cells 
seemed to be very flat and have thin extensions from the cell body. This phenotype 
has previously been referred to as a “collapsed” morphology (Wilkinson et al., 
2005). The cells remained flat and the majority stayed well-spread after EphB4-Fc 
stimulation. A small proportion of cells showed a slight retraction phenotype, 
although this was not a dramatic response when compared with the effects of EphB4- 
Fc treatment on cells without Blebbistatin treatment. No blebbing was seen to occur 
(Fig. 5.1c). Quantification reveals an inhibition of retraction and blebbing to control 
levels, as observed after treatment with pre-clustered Fc alone (Fig 5 .Id & e). Since 
blebbistatin is diluted in dimethyl sulfoxide (DMSO) before use, the effects of 
DMSO stimulation were tested to confirm that the inhibition of retraction and 
blebbing was a direct consequence of the inhibitor being tested. DMSO had no 
significant effect on the levels o f retraction and blebbing seen upon EphB4-Fc 
stimulation (Fig. 5.Id & e).
These results indicate that cell retraction and membrane blebbing, in response to 
ephrin-B2 signalling, is dependent on both ROCK and actomyosin driven 
contractility. Phase time-lapse analysis was used to look for any dynamic effects of 
Y27632 and blebbistatin pre-treatment, after pre-clustered EphB4-Fc stimulation. 
Figures 5.2a and b show that cells are well-spread and ruffling prior to EphB4-Fc 
treatment. After stimulation with pre-clustered EphB4-Fc, cells pre-treated with 
Y27632 remained flat and continued to ruffle, with no retraction even after 45min 
stimulation (Fig. 5.2a; Supplementary material: Movie 5.1). Cells pre-treated with 
blebbistatin, prior to pre-clustered EphB4-Fc stimulation, remained well-spread, 
exhibiting no signs of retraction, even after 45min EphB4-Fc stimulation (Fig. 5.2b; 
Supplementary Material: Movie 5.2). These data can be compared favourably to the 
control pre-clustered Fc stimulation of HUAECs, which did not trigger retraction or 
blebbing (see Fig. 4.5; Supplementary material: Movie 4.3).
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Figure 5.2 Inhibitors of R O C K  and mvosin II ATPase com pletely
b lock  re tra c tio n  and  b leb b in g  trig g e red  by ep h rin -B 2  ac tiv a tio n  
a) Y27632
a - lOmin
c +10niin
Phase time-lapse stills showing HUAECs pre-treated with the ROCK inhibitor 
Y27632 (20^M) prior to pre-clustered EphB4-Fc (5ng/ml) stimulation. Unstimulated 
cells are well-spread and display membrane ruffling (a). Upon EphB4-Fc stimulation 
(b) no retraction or blebbing was observed (c-f). Even after 45min the cells remained 
well spread and continued to ruffle (f). Scale bar 15p.m. (See Supplementary 
Material: Movie 5.1).
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b) Blebbistatin
^  •
V*
e +30min
Phase time-lapse stills showing HUAECs pre-treated with Blebbistatin (lOOpM) 
prior to pre-clustered EphB4-Fc (5pg/ml) stimulation. Unstimulated cells have a 
well-spread, flat morphology (a). Treatment with pre-clustered EphB4-Fc (b) caused 
a small proportion of cells to retract slightly but did not induce any blebbing (b-f). 
Scale bar 15pm. (See Supplementary Material: Movie 5.2).
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5.2.2 A transient increase in ROCK activity occurs in response to 
ephrin-B2 signalling which is blocked by the ROCK inhibitor 
Y27632
The data above demonstrate that ROCK is necessary for EphB4-Fc induced cell 
retraction and blebbing. However, it was not known whether an increase in ROCK 
activity occurs across the time course of retraction. In order to investigate this a read 
out of ROCK activity was required. ROCK is known to phosphorylate MYPT1 
(Kimura et al., 1996), the 130kDa myosin phosphatase targeting subunit, which has 
previously been shown to be expressed by aortic endothelial cells (Hirano et al., 
1999). Phosphorylation of MYPT1 inactivates myosin phosphatase allowing 
increased phosphorylation of myosin light chain keeping it in an active conformation 
and allowing actomyosin contractility (Kimura et al., 1996). Therefore, in order 
detect an increase in ROCK activity, phosphorylation of the targeting subunit of 
myosin phosphatase (MYPT1) was investigated. ROCK can phosphorylate MYPT1 
at two sites: Thr696 and Thr850 (Feng et al., 1999a; Velasco et al., 2002). Western 
blotting was carried out at stages throughout the time course and the levels of 
MYPT1 phosphorylation investigated using commercially available antibodies to 
phosphorylated MYPT1 at Thr696 and Thr850. An antibody to total MYPT1 was 
used to determine correct protein loading.
Under normal culture conditions a transient increase in MYPT1 phosphorylation at 
Thr850 can be seen in response to EphB4-Fc stimulation (ANOVA P = 0.0151; Fig. 
5.3a). Phosphorylation increased 30sec after stimulation, peaking at 2-5min 
stimulation with a >2-fold increase (P < 0.05). Phosphorylation then declined 
towards control levels by 30min. Therefore, an increase in ROCK activity appears to 
occur prior to retraction, with levels decreasing back to basal to allow the cells to 
recover. This pattern is identical under serum-starved conditions (ANOVA P = 
0.0049; Fig. 5.3b). Once again phosphorylation peaked after 2-5min stimulation, 
with a >2.5-fold increase (P < 0.05), and declined to control levels by 30min.
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Figure 5.3 Activation of ephrin-B2 triggers a transient increase in 
phosphorvlated MYPT1 at Thr850
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HUAECs stimulated with pre-clustered EphB4-Fc (5pg/ml) as indicated, were lysed 
and analysed by western blot using antiMYPTl (115kDa) and anti-phosphoMYPTl 
Thr850 (130kDa) antibodies. Equal protein loading was obtained throughout, as 
demonstrated by total MYPT1 levels (a-c). Under normal culture conditions a 2.1- 
fold increase in activation was seen after 5min EphB4-Fc stimulation (P < 0.05; a). 
Under serum-starved conditions, a >2.5-fold increase in activation (P < 0.05; b) was 
observed. The increase was transient with levels reduced to basal by 30min (a & b). 
As a control HUAECs were stimulated with Fc alone. No increase in phosphorylated 
MYPT1 at Thr850 was seen under these conditions (c). Asterisks denote statistical 
significance compared with unstimulated cells.
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As shown in chapter 4, cells were still able to undergo retraction in the absence of 
serum and growth factors (see Fig. 4.9). This finding would corroborate that data, 
since phosphorylation of MYPT1 at Thr850 occurs with or without serum. This 
suggests that whereas the loss of cell-cell contact seen in Swiss 3T3 fibroblasts, as a 
result o f ephrin-B2 clustering (chapter 3), is dependent on serum yet independent of 
ROCK, the retraction response seen in HUAECs, upon pre-clustered EphB4-Fc 
stimulation, is not serum dependent, but does requires ROCK activity. The two 
responses look similar, in that they cause a cell rounding/loss of contact phenotype, 
but occur via different pathways. However, as mentioned previously (4.3.1) it is not 
known whether HUAECs are truly growth factor free after serum-depletion, since 
cells do not lose their actin stress fibres. It is possible that growth factors may be 
adsorbed by the gelatin matrix and subsequently utilised by HUAECs upon serum- 
starvation.
As a control, cells were treated with pre-clustered Fc prior to lysis. No increase in 
phosphorylation of MYPT1 at Thr850 is seen under these conditions (Fig. 5.3c). This 
indicates that the increase in MYPT1 phosphorylation, and therefore ROCK activity, 
is due to EphB4-Fc stimulation and subsequent ephrin-B2 signalling, and does not 
simply occur as a consequence of treatment.
The effect of Y27632 on MYPT1 phosphorylation was investigated to confirm the 
link between MYPT1 and ROCK. As illustrated in Figure 5.3, unstimulated cells 
have a basal level of MYPT1 phosphorylation at Thr850 (Fig. 5.4a). Treatment with 
pre-clustered Fc did not affect the level of phosphorylation (Fig. 5.4a), but treatment 
with pre-clustered EphB4-Fc resulted in an increase in phosphorylation at Thr850 
(Fig. 5.4a). However, upon pre-treatment with Y27632 (20pM) for 30min, followed 
by pre-clustered EphB4-Fc stimulation, phosphorylation of MYPT1 at Thr850 was 
completely diminished to levels below those seen in unstimulated cells (Fig. 5.4a). 
Interestingly, Y27632 was only found to block phosphorylation at Thr850 and not 
Thr696 (Fig. 5.4c) indicating that something else is phosphorylating ROCK at this 
site. It is known that MYPT1 can be phosphorylated by kinases other than ROCK, 
such as MRCK (myotonic dystrophy kinase-related Cdc42-binding kinase), a Cdc42 
effector kinase (Tan et al., 2001). Supporting this lack of inhibition it was found that 
pre-clustered EphB4-Fc stimulation did not induce an increase in MYPT1
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Figure 5.4 The R O C K  inhibitor Y27632 blocks phosphorylation  o f
MYPT1 at Thr850 but not at Thr696
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HUAECs stimulated as indicated, were lysed and protein levels analysed by western 
blot using antibodies to either: phosphoMYPTl Thr850 (130kDa), phosphoMYPTl 
Thr696 (130kDa), total MYPT1 (115kDa), ROCK I (160kDa), or ROCK II 
(180kDa). No increase in phosphoMYPTl at Thr850 above control levels was seen 
upon treatment with pre-clustered Fc (a). Treatment with pre-clustered EphB4-Fc 
(5pg/ml) caused an increase in phosphoMYPTl at Thr850 (a). Phosphorylation at 
Thr850 was inhibited if cells were pre-treated with the ROCK inhibitor Y27632 
(20|iM; a). There was no increase in MYPT1 phosphorylation at Thr696 upon 
stimulation with pre-clustered EphB4-Fc (b) and Y27632 did not block 
phosphorylation at this site (c). HUAECs express both ROCK I and ROCK II (d).
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phosphorylation at Thr696 (Fig. 5.4b). These results indicate that phosphorylation of 
MYPT1 at Thr696 is not required for cell retraction induced by ephrin-B2 signalling 
and suggests that phosphorylation of MYPT1 at Thr850 is sufficient for retraction 
and blebbing to occur.
Two isoforms of ROCK exist (Nakagawa et al., 1996) both of which are expressed 
by HUAECs (Fig. 5.4d). It is not known which isoform is required for retraction to 
occur in this instance, or if both are necessary, since Y27632 has been shown to 
inhibit both isoforms (Ishizaki et al., 2000).
5.2.3 The small GTPase RhoA mediates the repulsive retraction  
response triggered by ephrin-B2 signalling
Since I have shown that ROCK is required for the retraction response seen as a result 
o f EphB4-Fc stimulation, and is transiently activated across the time course, the most 
obvious candidate upstream of ROCK is the small GTPase RhoA. In order to assess 
the involvement of RhoA in this assay, cells were microinjected with a C3 
transferase expression construct. C3 ADP-ribosyltransferase (C3), derived from 
Clostridium botulinum, is an ADP ribosylase that selectively ribosylates Rho on 
Asparagine and renders all three Rho isoforms (RhoA, -B and -C ) inactive (Aktories 
et al., 1988; Wilde et al., 2000). Unstimulated cells contain numerous actin stress 
fibres (Fig. 5.5a). Upon injection of the C3 transferase expression construct, cells 
remain well-spread but lose all their actin stress fibres (Fig. 5.5b). It was found that 
cells injected with C3 transferase prior to pre-clustered EphB4-Fc stimulation do not 
undergo retraction above control levels (Fig. 5.5c). This indicates a requirement for 
Rho in the retraction process. Injection of this construct without EphB4-Fc 
stimulation did cause a slight increase in retraction (although not statistically 
significant) to occur compared to unstimulated cells without C3 expression. 
However, the levels remain constant upon EphB4 stimulation (Fig. 5.5c).
In order to look at cellular levels of active RhoA across the time course, and 
determine if RhoA is activated in response to pre-clustered EphB4-Fc stimulation, a 
technique known as a Rho pull down was carried out. This is an affinity precipitation
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Figure 5.5 Inhibition o f  Rho via injection o f  C3 transferase inhibits  
retraction and blebbing
U n stim u la te d  
b p h B 4  10 m in
Uninjected C 3 Injected
T reatm en t
Cells were stained for F-actin using TRITC-phalloidin (red). Unstimulated HUAECs 
are flat well-spread cells with numerous actin stress fibres and membrane ruffles (a). 
Pre-clustered EphB4-Fc stimulation results in cell retraction (P < 0.001; c). Upon 
injection of C3 transferase (20pg/ml) a small proportion of cells retracted but the 
majority remained spread and lost their actin stress fibres (b). Cells injected with C3 
transferase and subsequently stimulated with pre-clustered EphB4-Fc (5pg/ml) did 
not undergo retraction or blebbing at levels above those seen for unstimulated cells 
(c). Asterisks denote statistical significance with respect to unstimulated cells. Scale 
bar 15 pm.
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assay for endogenous GTP-loaded (active) Rho. Since Rho effectors only interact 
with GTP-bound Rho, the Rhotekin Rho binding domain (RBD) was used to pull 
down endogenous GTP-RhoA from HUAEC lysates. This domain should bind active 
RhoA and inhibit its conversion to the GDP form, therefore allowing an accurate 
measure of GTP-RhoA loading. HUAECs were stimulated for various lengths of 
time throughout the time course and the levels of GTP-Rho assessed.
In order to carry out this assay, I prepared glutathione sepharose beads with a fusion 
of the Rhotekin Rho binding domain (RBD) coupled to glutathione S-transferase 
(GST-RBD) bound to them. Bacteria were inoculated with GST-RBD and expression 
of the protein was induced with IPTG. Samples taken before and after addition of 
IPTG demonstrate efficient induction of the protein (Fig. 5.6a). The GST-RBD 
protein was then bound to glutathione sepharose beads as detailed in 2.9.3.1 and the 
amount of protein loaded on the beads was estimated using coomassie staining, 
comparing the level with BSA standards (Fig. 5.6a). As a positive control, serum- 
starved Swiss 3T3 fibroblasts with and without serum stimulation were used. It is 
documented that serum stimulation of starved Swiss 3T3 cells results in a substantial 
increase in GTP-bound Rho (Ren et al., 1999; Ren and Schwartz, 2000). Using Rho 
pull downs, I show that serum-starved Swiss 3T3 cells express a very low basal level 
of active RhoA, but upon stimulation with 10% FCS for 3min, a substantial increase 
in the level of GTP-RhoA is observed (>8 fold increase; Fig 5.6b). This is a 
reproducible increase, indicating the reliability of the assay.
However, throughout the time course of cell retraction, I did not observe an increase 
in the levels of active RhoA (Fig. 5.6c). There are a number of possible explanations 
for this. One possibility is that RhoA is not being activated despite mediating the 
response. Another is that there could be a small increase in GTP-RhoA, perhaps only 
a local activation, but the levels are too small to be detected here. Finally, activation 
may be extremely fast and I have missed it. Interestingly, at lOmin I observe a 
dramatic reduction in GTP-bound RhoA (P < 0.01; Fig. 5.6c). This is reproducible 
and appears to coincide with the onset of recovery and loss of actin stress fibres seen 
in re-spreading cells. This may suggest that RhoA activation is switched off in order 
to allow the cells to recover.
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Figure 5.6 Levels o f  active Rho decrease upon EphB4-Fc stimulation
preceding a loss o f  stress fibres and re-spreading
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A coomassie stained gel to show IPTG induction of the Rhotekin Rho binding 
domain (RBD) and the Rhotekin RBD bound to glutathione sepharose beads (a). 
RhoA was detected using an anti-RhoA (24kDa) antibody. As a positive control for 
the Rho pull down assay, serum-starved (SS) Swiss 3T3 fibroblasts were used, which 
contain very little if any GTP-bound Rho (a). Upon stimulation with 10% FCS for 
3min a >8-fold induction of GTP-bound Rho occurred (a). The levels of total Rho 
were equal in the two samples (a). Upon stimulation of HUAEC lysates with pre­
clustered EphB4-Fc (5pg/ml) no increase in Rho-GTP was observed. Interestingly, 
the levels of active Rho declined (c). The effect was most dramatic at lOmin 
resulting in a substantial decrease in GTP-bound Rho (c). This can be quantified,
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illustrating a 4-fold decrease with respect to control (P  <0.01; g). Asterisks denote 
statistical difference with respect to unstimulated cells.
5.2.4 The c-Jun amino terminal kinase (JNK) inhibitor SP600125 
blocks cell retraction triggered by ephrin-B2 signalling
The MAP kinase JNK has previously been implicated in an ephrin-B 1 -induced cell 
rounding response in HEK 293 cells (Xu et al., 2003). To determine the role of JNK 
in this assay the effect o f the anthrapyrazole SP600125 on cell retraction induced by 
pre-clustered EphB4-Fc stimulation was investigated. SP600125 is a small molecule 
inhibitor o f JNK activity (Bennett et al., 2001). Cells were pre-treated with 
SP600125 (30pM), or DMSO (as a vehicle control) for lh  prior to EphB4-Fc 
stimulation for lOmin. Cells without SP600125 pre-treatment underwent a retraction 
response upon pre-clustered EphB4-Fc stimulation, characterised by the appearance 
of long retraction fibres and withdrawal of cell margins {P < 0.001; Fig. 5.7a) as 
detailed in chapter 4. Cells pre-treated with SP600125 remained well spread 
displaying membrane ruffles and actin stress fibres (Fig. 5.7b), and did not undergo 
retraction. Quantification shows that pre-clustered EphB4-Fc stimulation did not 
trigger retraction or blebbing above control levels, as depicted by treatment with pre­
clustered Fc (Fig. 5.7c & d). This result confirms previous studies from Nancy Ip’s 
laboratory demonstrating that JNK is required for cell rounding in response to 
ephrin-B activation (Xu et al., 2003).
In order to test whether this inhibition is specific to the MAP kinase JNK, another 
MAP kinase inhibitor was also used. U0126 is a selective inhibitor of the mitogen 
activated protein kinase kinases MEK-1 and MEK-2 (Favata et al., 1998). Pre­
treatment with U0126 (20pM) for 30min prior to EphB4-Fc stimulation did not 
result in an inhibition of retraction and only slightly affected the levels o f blebbing 
(P <0.05; Fig. 5.7c & d). This suggests that the retraction response observed may be 
specific to the JNK pathway, although inhibitors to every MAP kinase were not 
tested. As a control, cells were pre-treated with DMSO alone prior to stimulation, 
since both inhibitors were diluted in DMSO and it was important to ascertain that the
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Figure 5.7 M em brane retraction and blebbing triggered by EphB4
treatment are blocked by the c-iun amino terminal kinase (JNK) 
inhibitor SP600125
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Cells were stained for F-actin using TRITC-phalloidin. HUAECs stimulated with 
pre-clustered EphB4-Fc (5p,g/ml) for lOmin retract their cell margins leaving behind 
long retraction fibres (arrows in a). Pre-treatment of cells with the JNK inhibitor 
SP600125 (30pM) blocked the retraction response. Cells remained flat and contained 
actin stress fibres (b) and cell retraction/blebbing was reduced to control levels, seen 
with pre-clustered Fc treatment alone (c & d). The MAP kinase inhibitor U0126 did 
not block retraction and did not inhibit blebbing to the same extent (c & d). EphB4- 
Fc stimulation was not effected by the presence of DMSO (c & d). Asterisks denote 
statistical difference with respect to EphB4 stimulation. Scale bar 15pm.
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carrier itself was not exerting any inhibitory effects on the process. No significant 
effects on the levels of retraction and blebbing were seen (Fig. 5.7c & d).
Phase time-lapse analysis confirms that cells pre-treated with SP600125 do not 
undergo retraction (Fig. 5.8 & Supplementary Material: Movie 5.3). Cells were flat 
with membrane ruffles prior to treatment. Upon stimulation the morphology of the 
cells was not altered, no differences in cell behaviour were noted even after 45min 
stimulation (Fig. 5.8 & Supplementary Material: Movie 5.3). This lack of retraction 
response can be compared favourably to that seen when cells are stimulated with pre­
clustered Fc as a control (Fig. 4.5; Supplementary Material: Movie 4.3).
5.2.5 JNK is acting upstream of Rho
In an attempt to determine where JNK lies in the signalling pathway the effect of the 
JNK inhibitor SP600125 on MYPT1 phosphorylation was investigated. Stimulation 
with pre-clustered EphB4-Fc resulted in an increase in phosphorylation as shown 
previously (Fig. 5.9; P < 0.05). However, cells pre-treated with SP600125 exhibited 
reduced levels of MYPT1 phosphorylation at Thr850 (Fig. 5.9). The effect was not 
as dramatic as that seen upon Y27632 pre-treatment where phosphorylation was 
almost entirely inhibited (Fig. 5.4a), but were reduced to the basal level seen in 
unstimulated cells. JNK appears to be acting upstream of Rho-ROCK in this system.
5.3 Discussion
In this chapter, I have described a requirement for Rho, ROCK and JNK activity, 
together with acto-myosin contractility, for the retraction seen upon ephrin-B2 
activation in HUAECs. Inhibiton of ROCK and myosin II ATPase prevents 
retraction and blebbing in response to pre-clustered EphB4-Fc stimulation. A 
transient increase in MYPT1 phosphorylation at Thr850 is seen across the time 
course of retraction, which can be blocked using the ROCK inhibitor Y27632. The 
small GTPase Rho is required for retraction to occur and there is a substantial down- 
regulation of active Rho coincident with re-spreading, suggesting active Rho is
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Figure 5.8 The JNK inhibitor SP600125 blocks EphB4 triggered cell 
retraction
b Omin
d + 20min
e + 30min
Phase time-lapse stills of HUAECs pre-treated with SP600125 (30^M) and 
stimulated with pre-clustered EphB4-Fc (5pg/ml). Unstimulated cells are flat, well- 
spread and display membrane ruffling (a). Stimulation with EphB4-Fc (b) did not 
induce membrane retraction (c-f). Prolonged stimulation with pre-clustered EphB4- 
Fc for >35min did not trigger a retraction response (f). Scale bar 15p,m. (See 
Supplementary Material: Movie 5.3).
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Figure 5.9 The JN K  inhibitor SP600125 inhibits EphB4 triggered
phosphorylation of MYPT1 at Thr850
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HUAECs were stimulated as indicated, lysed and analysed by western blot. 
Phosphorylated MYPT1 (130kDa) was detected using an anti-phosphoMYPTl 
Thr850 antibody. Equal protein loading was determined by probing for total MYPT1 
(115kDa). Stimulation with pre-clustered EphB4-Fc (5pg/ml) caused an increase in 
phosphoMYPTl at Thr850 (P < 0.05). Pre-treatment with the JNK inhibitor 
SP600125 (30pM) inhibited the phosphorylation seen in response to EphB4-Fc 
stimulation. Asterisks denote statistical difference with respect to unstimulated cells.
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switched off to allow cells to recover. JNK appears to be acting upstream of Rho- 
ROCK in this pathway.
5.3.1 Rho-ROCK signalling is required for the EphB4-induced  
retraction response
Although Eph receptors have been shown to signal through Rho GTPases, little is 
known about ephrin mediated signalling and the Rho family. However, during my 
PhD, Rho and ROCK activity have been implicated downstream of ephrin-B 1 
(Tanaka et al., 2003). Xenopus Dishevelled has been shown to form a complex with 
ephrin-B 1 via binding directly to the C-terminal region of ephrin-B 1, or indirectly 
through interaction with Grb4, upon tyrosine phosphorylation of ephrin-B 1 (Tanaka 
et al., 2003) and interaction with Dishevelled is required for ephrin-B 1-mediated cell 
sorting in Xenopus embryos, mediated by RhoA and ROCK activity. However, this 
study used exogenously expressed protein throughout. In addition ephrin-B 1 was the 
ligand involved and I have demonstrated a requirement for RhoA and ROCK activity 
downstream of endogenously expressed ephrin-B2 activation. Furthermore, 
Rho/ROCK activity was only demonstrated to increase when ephrin-B 1 was 
activated via co-culture with EphB2 expressing cells and presumed to become 
tyrosine phosphorylated resulting in Grb4 binding, leading the authors to suggest 
Grb4 is involved. However, I have demonstrated cell rounding independently of 
Grb4 as a consequence of ephrin-B2 signalling. Very recently a second paper has 
implicated RhoA downstream of ephrin-B 1 (Lee et al., 2006). Ephrin-B 1 was shown 
to act through the PCP pathway via Dishevelled during Xenopus development to 
control the migration of cells into the eye field. Both studies were carried out in 
Xenopus. It remains to be seen whether Dishevelled mediates Rho/ROCK activation 
downstream of ephrin-B2 in mammalian cells. Daam-1, a formin homology protein 
which forms a complex with Dvl (the mammalian homologue of Dishevelled) and 
Rho in mammalian cells could be a potential candidate (Habas et al., 2001).
I have demonstrated a requirement for Rho to enable HUAECs to retract in response 
to EphB4 stimulation. However, using the Rho pull down technique I was unable to 
demonstrate an increase in active RhoA. There are a number of possible reasons for
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this. Firstly, activation may be very rapid, occurring prior to the 30sec time point in 
my assay, and I have therefore missed it. Secondly cells grown in serum have high 
basal levels of GTP-Rho due to activation by serum lipids such as LPA and so if the 
increase in active RhoA is small, possibly via a local activation at specific sites, it 
may be hard to detect it in this assay. Although HUAECs are serum-starved for the 
Rho pull down assay, prior to EphB4-Fc treatment and lysis, they do not lose their 
actin stress fibres. The gelatin matrix may bind serum factors that can be utilised 
upon serum-starvation, rendering it less effective. This is implied by the substantial 
level of Rho-GTP present in unstimulated HUAECs compared to that in serum- 
starved Swiss 3T3 fibroblasts (Fig. 5.6b & e). Thirdly, GTP-RhoA may be necessary 
for the ephrinB2-triggered retraction, but RhoA is not activated by ephrin-B2. If  this 
was the case, ROCK would be activated independently of Rho. Some lipids, in 
particular arachidonic acid, can activate ROCKs independently of Rho (Feng et al., 
1999b). However, due to the finding that Rho is required for retraction to take place, 
as demonstrated by the failure of C3 injected cells to undergo retraction in response 
to EphB4 stimulation, this seems unlikely.
Upon EphB4 stimulation of HUAECs, I have shown an increase in ROCK activity, a 
downstream effector of Rho, which correlates with the onset of retraction. ROCK 
activity is transient, reducing to basal levels at the time when cells re-spread their 
lamellae. ROCK activity is therefore necessary for EphB4 triggered retraction and is 
down regulated upon recovery. Despite the lack of a demonstrable increase in the 
levels of active RhoA at the onset of retraction, a striking finding is that active RhoA 
is switched off at later times coincident with the loss of actin-stress fibres and re­
spreading. It is possibly that downregulation of RhoA could occur in order to allow 
recovery to take place. This could occur via recruitment of a RhoGAP, which would 
promote the hydrolysis of GTP to GDP, inactivating the protein. However, recovery 
could also be the result of other factors, such as internalisation of the ephrin ligand or 
Grb4, since we have recently found a requirement for Grb4 in order for re-spreading 
to occur (Nobes lab data).
Evidence already exists for a role of RhoA downstream of EphA and, to a lesser 
extent, EphB receptors. For example, ephrin-A5 stimulation of retinal ganglion cells 
induces Rho-ROCK dependent growth cone collapse (Wahl et al., 2000). In addition
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stimulation of EphA3 expressing 293T cells with ephrin-A5 has been shown to 
induce rounding, blebbing and de-adhesion, which is mediated by RhoA signalling 
(Lawrenson et al., 2002). Parallels can be seen between these responses, which 
require Rho-ROCK mediated actin-myosin contractility to generate cell/axon 
retraction, and the retraction response I describe after ephrin-B2 stimulation in 
HUAECs. One molecule that links RhoA to EphA receptors in neurons is Ephexin, a 
guanine nucleotide exchange factor that activates RhoA. Ephexin is known to bind to 
EphA4 for example, and becomes phosphorylated upon ephrin-A stimulation leading 
to RhoA activation and mediation of growth cone dynamics (Sahin et al., 2005; 
Shamah et al., 2001). In addition, Vms-Rho-GEF is another exchange factor that 
binds to EphA4 and mediates RhoA activation in rat vascular smooth muscle cells 
(Ogita et al., 2003). It is possible that a Rho-GEF is recruited upon ephrin-B2 
activation that could link ephrin-B2 to RhoA.
EphB receptors have also been linked to Rho. Xenopus Dishevelled associates with 
activated EphBl and EphB2 and stimulation o f EphB2 leads to Rho-ROCK 
activation which is dependent on Dishevelled (Tanaka et al., 2003). In addition, the 
Ras GTPase activating protein pl20RasGAP can bind to activated EphB receptors 
(Holland et al., 1997) and has also been shown to associate with pl90RhoGAP 
(Settleman et al., 1992) which, for example, is known to deactivate RhoA 
downstream from integrins (Arthur and Burridge, 2001). I observe down-regulation 
o f RhoA upon re-spreading, after EphB4-induced retraction in HUAECs, as a 
consequence of ephrin-B2 signalling. This could be regulated by a RhoGAP such 
pl90RhoGAP, known to inhibit Rho-induced stress fibre formation (Ridley et al., 
1993), which has been shown to bind to PTP-BL (Saras et al., 1997) a 
phosphotyrosine phosphatase which is known to associate with activated ephrin-Bs 
(Palmer et al., 2002). Alternatively a PDZ-RhoGEF may be recruited to the PDZ 
binding m otif of ephrin-B2, which would occur independently o f tyrosine 
phosphorylation. Since I have shown that retraction of HUAECs in response to 
ephrin-B2 signalling is independent of Grb4, this suggests that retraction is also 
independent of tyrosine phosphorylation, since Grb4 is known to bind to ephrin-B 1 
in a phosphotyrosine-dependent manner (Cowan and Henkemeyer, 2001). There is 
currently no evidence for the recruitment of a PDZ-RhoGEF to Eph receptors or 
ephrins. However, plexin-Bs, transmembrane proteins which, similarly to ephrin-Bs,
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lack any known catalytic activity of their own, have been shown to mediate RhoA 
activation via PDZ-Rho-GEFs after stimulation with their ligands, the semaphorins 
(Driessens et al., 2002; Perrot et al., 2002; Swiercz et al., 2002).
5.3.2 JNK is required upstream of Rho-ROCK for retraction  
triggered by ephrin-B2 signalling
JNK has previously been implicated in cell rounding as a consequence of ephrin-B 1 
activation (Xu et al., 2003). In this instance cell rounding occurs independently of 
tyrosine phosphorylation and Grb4 but requires JNK activity (Xu et al., 2003). My 
findings corroborate those o f Xu and colleagues. I have demonstrated the 
requirement of JNK activity for retraction and blebbing as a consequence of ephrin- 
B2 signalling, and the retraction induced is independent of Grb4 (see chapter 4). In 
addition, I have demonstrated that JNK activity is needed for ROCK to be activated 
in response to EphB4 stimulation, indicating that JNK is acting upstream of 
Rho/ROCK.
Links between JNK and Rho have been previously reported. For example, the c-jun 
amino-terminal kinase interacting protein-1 (JIP-1) has been found to interact with 
pl90RhoGEF in neurons (Meyer et al., 1999). JIP-1 is a known JNK substrate 
(Dickens et al., 1997), and has been reported to be a scaffolding protein for the 
formation of a JNK activating complex (Dong et al., 1998). Activation of RhoA or 
over-expression of Rho-GEF in neuronal cells causes neurite retraction and cell 
rounding (Gebbink et al., 1997), and this together with the localisation of JIP-1 to the 
tips of neurites in NIE-115 and PC 12 cells, suggested that JIP-1 may function as a 
scaffold protein to localise Rho-GEF into a position to interact with RhoA, and 
regulate neurite retraction (Meyer et al., 1999). It is possible that a protein such as 
JIP-1 may link a Rho-GEF to RhoA downstream of ephrin-B2 in the retraction 
response seen to ephrin-B2 aignalling in HUAECs.
Previous reports of JNK activation downstream from Eph receptors and ephrins have 
been described. As already mentioned, Xu and colleagues have reported JNK 
activation to be a crucial component of the cell rounding seen in response to ephrin-
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B1 activation in 293T cells (Xu et al., 2003). Also, JNK activation has been shown to 
occur downstream from ephrin-B 1 which is required for integrin-mediated cell 
attachment (Huynh-Do et al., 2002). In addition, EphBl has been linked to JNK 
activation via recruitment of the SH2 domain adaptor protein Nek (Stein et al., 
1998a) and more recently, Ste20 kinase Nek interacting protein (NIK) has been 
shown to be activated by EphB 1 and EphB2 and its activation is required for EphB 1 - 
stimulated JNK activation, presumably via Nek, and integrin mediated cell 
attachment to fibrinogen (Becker et al., 2000).
5.3.4 Conclusions
I have reported cell rounding of HUAECs in response to ephrin-B2 signalling that 
requires JNK activation and Rho-ROCK signalling. Activation o f JNK and 
subsequent ROCK activation, presumably via Rho, leads to a cell contraction event 
that is dependent on actomyosin contractility and occurs independently of the 
adaptor protein Grb4. This response is transient. Down-regulation of Rho activity is 
coincident with a loss of actin stress fibres and re-spreading. RhoA downregulation 
may be required for recovery to take place, but this would need to be tested. These 
data corroborate those of Xu and colleagues who show a cell rounding response to 
ephrin-B 1 activation that requires JNK activity but is independent of Grb4 (Xu et al., 
2003).
Interestingly, I have also elucidated a function of JNK upstream from Rho-ROCK 
signalling to cause actomyosin contractility. Rho-ROCK signalling has previously 
been reported to function downstream of ephrin-B 1 in Xenopus, where Dishevelled 
was shown to mediate ephrin-B 1 regulation of cell repulsion via the activation of 
both RhoA and ROCK (Tanaka et al., 2003). My data provide a pathway where JNK 
activation and Rho-ROCK signalling function together to provide a mechanism for 
cell retraction as a result of ephrin-B2 stimulation by EphB4.
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Chapter 6
General Discussion
192
The aim o f this study was to investigate ephrin-B reverse signalling to the actin 
cytoskeleton, and to try and understand how this impinges on cell motility and 
migration throughout development and in the adult. Eph/ephrin signalling has been 
shown to function during many developmental processes, and Eph receptors and 
ephrins are expressed in a large number of tissues. I have focused my study on the 
ligand ephrin-B2 and its activation by two Eph receptors, EphB2 and EphB4.
Stimulation of exogenous ephrin-B2 expressed in confluent, quiescent, Swiss 3T3 
fibroblasts by treatment with soluble, pre-clustered EphB2-Fc or EphB4-Fc triggered 
clustering of ephrin-B2 into distinct membrane patches, and a loss of cell-cell contact 
within lOmin. Maximal loss of contact occurred after lh  and the response did not 
appear to be transient. Loss of cell-cell contact triggered by EphB2-Fc treatment was 
dependent on serum factors or FGF and the adaptor protein Grb4, with Src- 
dependent tyrosine phosphorylation of ephrin-B2 required for a full response. 
Neither interaction with PDZ domain proteins, or activation o f either the Rho 
effector ROCK, or c-jun amino terminal kinase (JNK), was needed for loss of cell­
cell contact.
Interestingly, stimulation o f sub-confluent, cultured endothelial cells that 
endogenously express ephrin-B2, with soluble, pre-clustered EphB4-Fc triggered 
rapid cell retraction and the appearance of long actin-rich retraction fibres. A 
proportion of cells also exhibited signs of membrane blebbing. The response was 
transient, cells recovered to re-spread lamellae, concomitant with a loss of actin 
stress fibres within 30min, in the continued presence of EphB4-Fc. In endothelial 
cells, EphB4 induced membrane retraction required the cytoplasmic domain of the 
ligand, actomyosin driven contraction, Rho/ROCK and JNK activity, but occurred 
independently of serum factors and Grb4. A dramatic down-regulation o f Rho 
activity was observed, coincident with loss of actin stress fibres and cell recovery to 
a well-spread morphology.
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6.1 Two distinct signalling pathways downstream of ephrin-B2
I have shown that ephrin-B2 signalling can trigger two distinct pathways. In 
HUAECs a cell retraction response occurs, independently of serum factors and Grb4 
but dependent on JNK, Rho and ROCK activity. This corroborates the findings of Xu 
and colleagues, who reported a cell rounding response to activation of ephrin-B 1 in 
transfected HEK 293 cells, that was dependent on JNK activity, yet independent of 
Grb4 (Xu et al., 2003). The retraction response I describe in endothelial cells after 
ephrin-B2 signalling is transient, followed by re-spreading of lamellae coincident 
with a loss of actin stress fibres. In Swiss 3T3 cells, exogenously expressing ephrin- 
B2, Grb4-dependent loss of cell-cell contact is triggered by ephrin-B2 clustering, 
which requires serum factors yet is independent of JNK and ROCK activity. Src- 
dependent tyrosine phosphorylation is necessary for the full response to occur. These 
findings corroborate those of Cowan and colleagues who reported a cell rounding 
phenotype, together with a loss of actin stress fibres, as a consequence of ephrin-B 1 
activation in BHK cells, that was dependent on Grb4 binding in a tyrosine 
phosphorylation dependent manner (Cowan and Henkemeyer, 2001). Interestingly, 
although the signalling downstream of ephrin-B2 in HUAECs corroborates work 
from Nancy Ips laboratory (Xu et al., 2003), the loss of actin stress fibres found upon 
re-spreading would corroborate the actin reorganisations described in BHK cells 
after ephrin-B 1 activation (Cowan and Henkemeyer, 2001).
In both cell types, a repulsive response is triggered by ephrin-B2 signalling, but the 
retraction and loss of cell-cell contact are brought about via different signalling 
pathways. There are a number o f possible explanations for this. Signalling 
downstream of ephrin-B2 may be cell type dependent. In endothelial cells, a 
physiologically relevant cell type, since ephrin-B2 is known to play a role in vascular 
development in vivo (Gerety and Anderson, 2002), ephrin-B2 stimulation results in a 
dramatic contraction event. However, expression in Swiss 3T3 fibroblasts, leads to 
loss of cell-cell contact after ephrin-B2 clustering. In addition, the confluency of the 
cells may contribute to the different responses observed. Confluent Swiss 3T3 
fibroblasts not only possess cell-matrix adhesions they also have cell-cell adhesions 
as they are stimulated as a confluent, quiescent monolayer. Sub-confluent HUAECs
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only have to sever cell-matrix adhesions in order to retract. Alternatively, the level of 
ephrin-B2 expression may be important. In HUAECs endogenous levels of ligand are 
stimulated where as in Swiss 3T3 fibroblasts ephrin-B2 was overexpressed, 
presumably resulting in higher expression levels, and rapid formation of higher order 
clustered ephrins. Finally, two different receptors were used to stimulate ephrin-B2. 
EphB4 stimulation may trigger an actomyosin contraction pathway, whereas EphB2- 
Fc triggers a Grb4, tyrosine phosphorylation dependent pathway.
6.2 Ephrin-B2 regulation of the actin cytoskeleton through the Rho 
family of small GTPases
There are previous reports of Eph receptor and ephrin-A activation resulting in RhoA 
activation (Lawrenson et al., 2002; Tanaka et al., 2003), and potential RhoGEFs 
mediating this have been described (Sahin et al., 2005; Shamah et al., 2001). 
Previous evidence that ephrin-B activation triggers activation of Rho and ROCK is 
limited. However during my PhD, a study in Xenopus reported Rho and ROCK 
activity downstream of exogenous ephrin-B 1 activation that is mediated by 
Dishevelled and necessary for the sorting of EphB2 and ephrin-B 1 expressing cells 
during an in vitro re-aggregation assay (Tanaka et al., 2003). This study suggested 
that the increase in Rho/ROCK activity upon co-culture of ephrin-B 1 expressing 
cells with EphB2 expressing cells could require tyrosine phosphorylation of ephrin- 
B 1 and Grb4 binding since although Dishevelled constitutively binds to ephrin-B 1, 
no increase in Rho activity is seen without ephrin-B 1 activation.
I have demonstrated a requirement for Rho activity and activation o f ROCK 
downstream of endogenous ephrin-B2 signalling in HUAECs, in order for cell 
retraction and membrane blebbing to occur. However, cell retraction in HUAECs is 
Grb4 independent. A second study has very recently described a role for ephrin-B 1 
during Xenopus development to control the migration of cells into the eye field, 
through the PCP pathway mediated via Dishevelled. Both of these studies were 
carried out in X enopus. A role for Dishevelled in mediating RhoA activity 
downstream of ephrin-Bs in mammalian cells remains to be determined. 
Interestingly, coincident with the onset of recovery and loss of actin stress fibres
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observed in HUAECs stimulated with pre-clustered EphB4,1 observe a decrease in 
both Rho and ROCK activity, which may be necessary for cell re-spreading to take 
place.
It remains to be determined whether ephrin-B2 signalling in HUAECs causes RhoA 
activation, or if G^P-RhoA is simply recruited to sites of ephrin-B2 activation. 
Similarly, the identity of a potential RhoGAP that could be responsible for the down 
regulation o f active RhoA at the onset of recovery remains elusive. Interestingly, 
although Grb4 is not required for cell retraction after ephrin-B2 stimulation, it is 
necessary for the later re-spreading (data from Nobes lab). Therefore, Grb4 could be 
required for the down-regulation of active Rho and this enables cells to recover, or 
an alternative could be that Grb4 is needed for internalisation of the ligand, which 
could be essential for cell re-spreading to occur.
6.3 JNK activity upstream of Rho/ROCK
Ephrin-B 1 activation has previously been shown to mediate a cell rounding response 
after ephrin-B 1 activation in HEK 293 cells (Xu et al., 2003). Ephrin-B 1 activation 
has also been shown to induce JNK phosphorylation and modulate integrin-mediated 
cell attachment to fibrinogen (Huynh-Do et al., 2002). Interestingly, the retraction 
response observed after ephrin-B2 stimulation in HUAECs involves a loss of 
adhesion. This could be mediated by integrins. Although JNK activity has been 
previously linked to both Eph receptors and ephrins (Becker et al., 2000; Stein et al., 
1998a), a role upstream of Rho/ROCK activation as a consequence of ephrin-B 
activation has not been documented. I have shown that JNK inhibition after EphB4 
stimulation of HUAECs blocks any increase seen in ROCK activity. It is possible 
that a Rho-GEF is recruited that can link JNK with Rho, such as pl90RhoGEF, 
which has been found to interact with JIP-1 (the c-jun amino-terminal kinase 
interacting protein-1) in neurons (Meyer et al., 1999).
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6.4 Ephrin-B2 signalling in the development of the mammalian 
vasculature
In vivo genetic studies have definitively demonstrated the importance of the receptor- 
ligand partnership of ephrin-B2 and EphB4, which has been shown to play essential 
roles during the development of the mammalian vasculature. Endothelial cells 
expressing EphB4 or ephrin-B2 come into contact during blood vessel remodelling, 
resulting in the formation of separate arteries and veins, presumably through 
repulsive cell-cell interactions (Adams et al., 1999; Gerety et al., 1999; Wang et al., 
1998), and cardiovascular ephrin-B2 has been shown to be essential for correct 
vascular remodelling, mesenchymal expression of the ligand cannot compensate for 
loss of ephrin-B2 in the vasculature (Gerety and Anderson, 2002). In addition, 
ephrin-B2 mutant mice have recently been shown to exhibit defects in the migration 
of smooth muscle cells to lymphatic capillaries suggesting an in vivo requirement for 
ephrin-B2 for correct cell migration. (Foo et al., 2006). The evidence I have 
presented, and work from other groups has shed light on how EphB/ephrin-B 
interactions could regulate the cell migration and repulsive interactions needed for 
arterial and venous cells to reach their correct targets.
Supporting the idea that EphB4/ephrin-B2 signalling is necessary for cell-cell 
repulsive events to form boundaries between arteries and veins, two endothelial cell 
populations, one expressing ephrin-B2 and the other EphB4, segregate when mixed 
(Fuller et al., 2003), suggesting the maintenance of boundaries as a result of EphB4- 
ephrin-B signalling. However, in vitro experiments using ephrin-B2 expressing 
endothelial cells stimulated with EphB4, have led to conflicting results. Ephrin-B 
activation has been shown to result in both attractive and repulsive effects on cell 
migration and adhesion. Ephrin-B2 activation by stimulation with EphB4-Fc has 
been reported to increase cell migration, attachment and proliferation (Fuller et al., 
2003; Hamada et al., 2003; Steinle et al., 2003). However, growing ephrin-B2 
expressing cells on EphB4-expressing cells inhibits sprouting angiogenesis (Zhang et 
al., 2001). The reasons behind the different cellular outcomes downstream of ephrin- 
B2 signalling not clear. Experimental conditions have varied as well as the cell type 
used. Endothelial cells of different vascular beds may possess a unique complement
197
of Eph receptors and ephrins, which determines the resultant signalling pathways 
upon activation.
The findings of this study describe a repulsive cell retraction and loss o f matrix 
adhesion phenotype in response to ephrin-B2 signalling, which is followed by rapid 
re-spreading. Cycles of retraction and protrusion of endothelial cells expressing 
ephrin-B2 may be necessary in order for arterial endothelial cells to avoid venous 
endothelial cells expressing EphB4 and ultimately reach their correct location, 
resulting in the formation of distinct arteries and veins.
6.5 A role for ephrin-B2 signalling in cancer progression
Eph/ephrin signalling is well documented to have a role in tumourigenesis. The main 
function of Eph/ephrin signalling seems to be during tumour angiogenesis and 
growth (Surawska et al., 2004). Ephrin-B2 has previously been implicated in 
tumourigenesis (Nikolova et al., 1998; Noren et al., 2004) and the results I have 
presented here would fit with the cell morphologies described for cells during tumour 
invasion. Two different modes of tumour-cell motility through a 3D matrix have 
been reported recently (Sahai and Marshall, 2003; Wilkinson et al., 2005). Rho 
signalling through ROCK promotes rounded cell motility, with cells exhibiting a 
rounded morphology and associated membrane blebs. An elongated mode of 
motility has also been described which functions independently of Rho but is 
associated with Rac-dependent actin-rich protrusions (Sahai and Marshall, 2003). 
There are parallels between the morphological changes observed after ephrin-B2 
activation in HUAECs and both the rounded and elongated modes of tumour-cell 
motility. Initially, EphB4 triggers cell retraction or rounding, and in some cells 
membrane blebbing, which is dependent on Rho and ROCK activity and can be 
favourably compared to the first example of tumour-cell motility described above. 
Subsequently the cells recover and re-spread large lamellae, which are known to be 
Rac-dependent structures (Nobes and Hall, 1995), and at the onset of recovery there 
is a decrease in Rho and ROCK activity suggesting they are not required for re­
spreading. Rac activity throughout the time course of EphB4 stimulation has not 
been investigated but it would be interesting to determine if there is an increase in
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Rac activity at the onset of recovery. Very recently the elongated mode of motility 
has actually been reported to require Cdc42-MRCK (myotonic dystrophy kinase- 
related Cdc42-binding kinase) signalling (Wilkinson et al., 2005). However, the 
activity of Cdc42 across the EphB4 treatment time course in HUAECs is not known.
Figure 6.1 Model o f ephrin-B signalling triggered by EphB  
stimulation
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In HUAECs, endogenous ephrin-B2 signalling leads to actomyosin contractility 
resulting in cell retraction dependent on JNK, Rho and ROCK activity. Retraction is 
transient, followed by re-spreading coincident with a down-regulation of Rho-GTP 
and ROCK. In Swiss 3T3 fibroblasts, clutsering of exogenous ephrin-B2 leads to loss 
of cell-cell contact dependent on serum factors and Grb4. Tyrosine phosphorylation 
of ephrin-B2 is necessary for a full response.
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